Menu
Back to Journals » OncoTargets and Therapy
OncoTargets and Therapy
- View all (2805)
- Volume 11, 2018 (358)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Journal Articles:
- 2,805 records -
An uncommon granulocytic sarcoma of the breast: a case report and literature review
Zhai J, Kong X, Yang X, Gao J, Xuan L, Wang X, Wang J, Fang Y
OncoTargets and Therapy 2018, 11:3685-3690
Published Date: 25 June 2018
CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression
Ji M, Wang L, Chen J, Xue N, Wang C, Lai F, Wang R, Yu SS, Jin J, Chen X
OncoTargets and Therapy 2018, 11:3671-3684
Published Date: 25 June 2018
Prognostic impact of the number of lymph nodes examined in different stages of colorectal mucinous adenocarcinoma
Ma Y, Luo YQ, Lin N, Lv YZ, Zhou Y, Li B, Han KN, Jiang S, Gao JJ
OncoTargets and Therapy 2018, 11:3659-3670
Published Date: 25 June 2018
lincROR influences the stemness and crizotinib resistance in EML–ALK+ non-small-cell lung cancer cells
Yang Y, Huang J, Xie N, Huang H, Xu S, Cai J, Qi S
OncoTargets and Therapy 2018, 11:3649-3657
Published Date: 22 June 2018
TRIM44, a crucial target of miR-410, functions as a potential oncogene in osteosarcoma
Wang H, Fang ZL, Zhang GH, Ma X
OncoTargets and Therapy 2018, 11:3637-3647
Published Date: 21 June 2018
MYO5A inhibition by miR-145 acts as a predictive marker of occult neck lymph node metastasis in human laryngeal squamous cell carcinoma
Zhao X, Zhang W, Ji W
OncoTargets and Therapy 2018, 11:3619-3635
Published Date: 21 June 2018
A small compound spindlactone A sensitizes human endometrial cancer cells to TRAIL-induced apoptosis via the inhibition of NAD(P)H dehydrogenase quinone 1
Zhao XZ, Wu XH
OncoTargets and Therapy 2018, 11:3609-3617
Published Date: 21 June 2018
Whole-body MRI versus 18F-FDG PET/CT for pretherapeutic assessment and staging of lymphoma: a meta-analysis
Wang D, Huo Y, Chen S, Wang H, Ding Y, Zhu X, Ma C
OncoTargets and Therapy 2018, 11:3597-3608
Published Date: 20 June 2018
lncRNA H19 predicts poor prognosis in patients with melanoma and regulates cell growth, invasion, migration and epithelial–mesenchymal transition in melanoma cells
Shi G, Li H, Gao F, Tan Q
OncoTargets and Therapy 2018, 11:3583-3595
Published Date: 20 June 2018
Impact of RNA integrity and blood sample storage conditions on the gene expression analysis
Shen YT, Li R, Tian F, Chen ZZ, Lu N, Bai YF, Ge QY, Lu ZH
OncoTargets and Therapy 2018, 11:3573-3581
Published Date: 20 June 2018
Clinicopathological and prognostic significance of FoxM1 in hepatocellular carcinoma patients: a meta-analysis
Liang C, Zhao J, Ge H, Li G, Wu J
OncoTargets and Therapy 2018, 11:3561-3571
Published Date: 19 June 2018
The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER
Tang J, Kong D, Cui Q, Wang K, Zhang D, Liao X, Gong Y, Wu G
OncoTargets and Therapy 2018, 11:3551-3560
Published Date: 19 June 2018
Prognostic value of miR-17-5p in cancers: a meta-analysis
Kong W, Cheng Y, Liang H, Chen Q, Xiao C, Li K, Huang Z, Zhang J
OncoTargets and Therapy 2018, 11:3541-3549
Published Date: 19 June 2018
Multiple biological functions of transcription factor 21 in the development of various cancers
Jiang X, Yang Z
OncoTargets and Therapy 2018, 11:3533-3539
Published Date: 19 June 2018
Curcumin suppresses the progression of laryngeal squamous cell carcinoma through the upregulation of miR-145 and inhibition of the PI3K/Akt/mTOR pathway
Zhu X, Zhu R
OncoTargets and Therapy 2018, 11:3521-3531
Published Date: 19 June 2018
The prognosis for patients with newly diagnosed glioblastoma receiving bevacizumab combination therapy: a meta-analysis
Liao KL, Huang S, Wu YP
OncoTargets and Therapy 2018, 11:3513-3520
Published Date: 19 June 2018
Combined small-cell lung carcinoma
Qin J, Lu H
OncoTargets and Therapy 2018, 11:3505-3511
Published Date: 19 June 2018
Association between common polymorphisms in ERCC gene and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis
Li C, Yu X, Guo D, Liu G, Zhang K, Teng Q, Lin H
OncoTargets and Therapy 2018, 11:3495-3504
Published Date: 18 June 2018
Downregulation of ribophorin II suppresses tumor growth, migration, and invasion of nasopharyngeal carcinoma
Hong F, Li Y, Ni H, Li J
OncoTargets and Therapy 2018, 11:3485-3494
Published Date: 15 June 2018
STAT3 induces colorectal carcinoma progression through a novel miR-572-MOAP-1 pathway
Wang N, He X, Zhou R, Jia G, Qiao Q
OncoTargets and Therapy 2018, 11:3475-3484
Published Date: 15 June 2018
MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS
Chang J, Xu W, Du X, Hou J
OncoTargets and Therapy 2018, 11:3461-3473
Published Date: 15 June 2018
The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis
Li J, Cheng Y, Liu G, Ji Z
OncoTargets and Therapy 2018, 11:3449-3459
Published Date: 15 June 2018
Comparison of the prognosis of neoadjuvant chemoradiotherapy treatment with surgery alone in esophageal carcinoma: a meta-analysis
Ma HF, Lv GX, Cai ZF, Zhang DH
OncoTargets and Therapy 2018, 11:3441-3447
Published Date: 14 June 2018
Effectiveness of lomustine and bevacizumab in progressive glioblastoma: a meta-analysis
Song J, Xue YQ, Zhao MM, Xu P
OncoTargets and Therapy 2018, 11:3435-3439
Published Date: 13 June 2018
Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML
Chen EC, Fathi AT, Brunner AM
OncoTargets and Therapy 2018, 11:3425-3434
Published Date: 12 June 2018
Twenty-gene-based prognostic model predicts lung adenocarcinoma survival
Zhao K, Li Z, Tian H
OncoTargets and Therapy 2018, 11:3415-3424
Published Date: 12 June 2018
Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study
Wang Y, Gou Q, Xu R, Chen X, Zhou Z
OncoTargets and Therapy 2018, 11:3407-3413
Published Date: 12 June 2018
Identification of CD24 as a marker for tumorigenesis of melanoma
Tang MR, Guo JY, Wang D, Xu N
OncoTargets and Therapy 2018, 11:3401-3406
Published Date: 12 June 2018
Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer
Huang G, Zhu G
OncoTargets and Therapy 2018, 11:3395-3400
Published Date: 11 June 2018
Expression and functional characterization of FOXM1 in non-small cell lung cancer
Zhang Y, Qiao W, Shan L
OncoTargets and Therapy 2018, 11:3385-3393
Published Date: 11 June 2018
Prognostic value of spleen tyrosine kinase in human solid tumors
Ni B, Li S, Liu Y, Huang Y, Li Z
OncoTargets and Therapy 2018, 11:3377-3384
Published Date: 8 June 2018
Meta-analysis of segmentectomy versus wedge resection in stage IA non-small-cell lung cancer
Xue WF, Duan GC, Zhang XP, Zhang H, Zhao QT, Xin ZF
OncoTargets and Therapy 2018, 11:3369-3375
Published Date: 7 June 2018
Effect of AQP-5 silencing by siRNA interference on chemosensitivity of breast cancer cells
Li X, Pei B, Wang H, Tang C, Zhu W, Jin F
OncoTargets and Therapy 2018, 11:3359-3368
Published Date: 6 June 2018
Identification of PGAM1 as a putative therapeutic target for pancreatic ductal adenocarcinoma metastasis using quantitative proteomics
Liu X, Weng Y, Liu P, Sui Z, Zhou L, Huang Y, Zhang L, Zhang Y, Tan X
OncoTargets and Therapy 2018, 11:3345-3357
Published Date: 6 June 2018
Comparison of detection methods of EGFR T790M mutations using plasma, serum, and tumor tissue in EGFR-TKI-resistant non-small cell lung cancer
Kobayashi K, Naoki K, Manabe T, Masuzawa K, Hasegawa H, Yasuda H, Kawada I, Soejima K, Betsuyaku T
OncoTargets and Therapy 2018, 11:3335-3343
Published Date: 6 June 2018
Ablation of MCM10 using CRISPR/Cas9 restrains the growth and migration of esophageal squamous cell carcinoma cells through inhibition of Akt signaling
Yan J, Du P, Jia Y, Chang Z, Gan S, Xu X, Wang Y, Qin Y, Kan Q
OncoTargets and Therapy 2018, 11:3323-3333
Published Date: 6 June 2018
Novel quinazoline-based sulfonamide derivative (3D) induces apoptosis in colorectal cancer by inhibiting JAK2–STAT3 pathway
Al-Obeed O, Vaali-Mohammed MA, Eldehna WM, Al-Khayal K, Mahmood A, Abdel-Aziz HA, Zubaidi A, Alafeefy A, Abdulla M, Ahmad R
OncoTargets and Therapy 2018, 11:3313-3322
Published Date: 5 June 2018
Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer
Ni J, Peng Y, Yang F, Xi X, Huang X, He C
OncoTargets and Therapy 2018, 11:3303-3312
Published Date: 5 June 2018
Effects of the combination of As2O3 and AZT on proliferation inhibition and apoptosis induction of hepatoma HepG2 cells following silencing of Egr-1
Zhao C, Wang M, Liu Y, Liang YJ, Han L, Chen C
OncoTargets and Therapy 2018, 11:3293-3301
Published Date: 1 June 2018
Obesity-associated miR-27a upregulation promotes hepatocellular carcinoma metastasis through suppressing SFRP1
Chen Y, Zhang F, Zhao Y, He K, Zheng X, Pan Y, Shao D, Shang P, Yang Y, Zhang D, Xie Y, Yao X, Chen L, Li J, Zhang X
OncoTargets and Therapy 2018, 11:3281-3292
Published Date: 1 June 2018
Association of VDR gene TaqI polymorphism with the susceptibility to prostate cancer in Asian population evaluated by an updated systematic meta-analysis
Chen L, Wei J, Zhang S, Lou Z, Wang X, Ren Y, Qi H, Xie Z, Chen Y, Chen F, Wu Q, Fan X, Xu H, Huang S, Weng G
OncoTargets and Therapy 2018, 11:3267-3280
Published Date: 31 May 2018
A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma
Xie H, Tian S, Yu H, Yang X, Liu J, Wang H, Feng F, Guo Z
OncoTargets and Therapy 2018, 11:3257-3265
Published Date: 31 May 2018
Prognostic role of plasma mammaglobin A expression in breast carcinoma patients: a meta-analysis
Hu YY, Liu P, Wu D, Jiang YH
OncoTargets and Therapy 2018, 11:3245-3255
Published Date: 30 May 2018
Prognostic significance of galectin-1 and vasculogenic mimicry in patients with gastric cancer
You X, Wang Y, Wu J, Liu Q, Chen D, Tang D, Wang D
OncoTargets and Therapy 2018, 11:3237-3244
Published Date: 29 May 2018
Association between KIF1B (rs17401966) polymorphism and hepatocellular carcinoma susceptibility: a meta-analysis
Zhang Y, Zeng X, Lu H, Ji H, Lu L, Liu P, Hong R, Li Y
OncoTargets and Therapy 2018, 11:3225-3235
Published Date: 29 May 2018
Knockdown of long noncoding RNA 00152 (LINC00152) inhibits human retinoblastoma progression
Li S, Wen D, Che S, Cui Z, Sun Y, Ren H, Hao J
OncoTargets and Therapy 2018, 11:3215-3223
Published Date: 6 June 2018
Periostin overexpression is associated with worse prognosis in nasopharyngeal carcinoma from endemic area: a cohort study
Wei YC, Yang SF, Chang SL, Chen TJ, Lee SW, Chen HS, Lin LC, Li CF
OncoTargets and Therapy 2018, 11:3205-3213
Published Date: 29 May 2018
Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion
Gu S, Liang H, Qi D, Mao L, Mao G, Qian L, Zhang S
OncoTargets and Therapy 2018, 11:3195-3203
Published Date: 29 May 2018
Emerging role of long non-coding RNAs in cisplatin resistance
Hu Y, Zhu QN, Deng JL, Li ZX, Wang G, Zhu YS
OncoTargets and Therapy 2018, 11:3185-3194
Published Date: 28 May 2018
A large and aggressive fibromatosis in the axilla: a rare case report and review of the literature
Duan M, Xing H, Wang K, Niu C, Jiang C, Zhang L, Ezzat S, Zhang L
OncoTargets and Therapy 2018, 11:3179-3184
Published Date: 28 May 2018
Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer
Wang K, Ruan H, Xu T, Liu L, Liu D, Yang H, Zhang X, Chen K
OncoTargets and Therapy 2018, 11:3167-3178
Published Date: 28 May 2018
CEACAM6 is associated with osteosarcoma metastasis and facilitates epithelial–mesenchymal transition in osteosarcoma cells
Wang Z, Luo C, Wang H, Yan X, Liu W, Meng Z
OncoTargets and Therapy 2018, 11:3159-3166
Published Date: 28 May 2018
High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer
Zhang M, Li X, Fan Z, Zhao J, Liu S, Zhang M, Li H, Goscinski MA, Fan H, Suo Z
OncoTargets and Therapy 2018, 11:3149-3157
Published Date: 28 May 2018
miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells
Chen K, Chen Y, Chen Z, Shi Y, He Z, Ding B, Wang C, Yu L
OncoTargets and Therapy 2018, 11:3141-3147
Published Date: 25 May 2018
Construction of a specific SVM classifier and identification of molecular markers for lung adenocarcinoma based on lncRNA-miRNA-mRNA network
Zhao J, Cheng W, He X, Liu Y, Li J, Sun J, Li J, Wang F, Gao Y
OncoTargets and Therapy 2018, 11:3129-3140
Published Date: 25 May 2018
The incidence and predictors of symptomatic venous thromboembolism associated with peripherally inserted central catheters in patients with nasopharyngeal carcinoma
Liang YJ, He Y, Li JM, Chen LM, Chen LP, Wang C, Ji L, Li ZX, Tang LQ, Chen QY, Fan YY, Hu W
OncoTargets and Therapy 2018, 11:3119-3127
Published Date: 25 May 2018
Overexpression of MCPH1 inhibits the migration and invasion of lung cancer cells
Wu X, Liu W, Liu X, Ai Q, Yu J
OncoTargets and Therapy 2018, 11:3111-3117
Published Date: 25 May 2018
Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma
Lin MH, Lv D, Zheng YL, Wu ML, Xu C, Zhang Q, Wu LH
OncoTargets and Therapy 2018, 11:3101-3110
Published Date: 25 May 2018
Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis
Liu X, Zhao Y, Zhang W, Gao Y, Huo M, Liu M, Xiao Z, Liang S, Xu N, Zhu H
OncoTargets and Therapy 2018, 11:3087-3100
Published Date: 24 May 2018
An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer
Li D, Hao X, Song Y
OncoTargets and Therapy 2018, 11:3075-3085
Published Date: 24 May 2018
Gene expression and prognosis of NOX family members in gastric cancer
You X, Ma M, Hou G, Hu Y, Shi X
OncoTargets and Therapy 2018, 11:3065-3074
Published Date: 24 May 2018
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
Cicero G, De Luca R, Dieli F
OncoTargets and Therapy 2018, 11:3059-3063
Published Date: 24 May 2018
The synergistic effects of Apatinib combined with cytotoxic chemotherapeutic agents on gastric cancer cells and in a fluorescence imaging gastric cancer xenograft model
Feng JH, Qin SK
OncoTargets and Therapy 2018, 11:3047-3057
Published Date: 24 May 2018
High expression of USP22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis
Yang XH, Zang H, Luo Y, Wu J, Fang Z, Zhu W, Li Y
OncoTargets and Therapy 2018, 11:3035-3046
Published Date: 23 May 2018
LGR6 promotes the progression of gastric cancer through PI3K/AKT/mTOR pathway
Ke J, Ma P, Chen J, Qin J, Qian H
OncoTargets and Therapy 2018, 11:3025-3033
Published Date: 22 May 2018
Expression of HSP90AA1/HSPA8 in hepatocellular carcinoma patients with depression
Xiang X, You XM, Li LQ
OncoTargets and Therapy 2018, 11:3013-3023
Published Date: 22 May 2018
The role of HIF-1α in chemo-/radioresistant tumors
Xia Y, Jiang L, Zhong T
OncoTargets and Therapy 2018, 11:3003-3011
Published Date: 22 May 2018
The methylation profiles of PRDM promoters in non–small cell lung cancer
Tan SX, Hu RC, Xia Q, Tan YL, Liu JJ, Gan GX, Wang LL
OncoTargets and Therapy 2018, 11:2991-3002
Published Date: 22 May 2018
Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of COX-2
Li X, Li F, Wang FF, Li JF, Lin CZ, Du JX
OncoTargets and Therapy 2018, 11:2981-2989
Published Date: 22 May 2018
Intra-arterial chemotherapy improved survival of stage 2–3 gallbladder cancer after curative resection
Chen C, Feng W, Zheng Y, Bao Y, Feng M
OncoTargets and Therapy 2018, 11:2975-2979
Published Date: 22 May 2018
Ovol2 induces mesenchymal–epithelial transition via targeting ZEB1 in osteosarcoma
Liu J, Wu Q, Wang Y, Wei Y, Wu H, Duan L, Zhang Q, Wu Y
OncoTargets and Therapy 2018, 11:2963-2973
Published Date: 22 May 2018
Downregulation of STARD8 in gastric cancer and its involvement in gastric cancer progression
Zhang S, Chang X, Ma J, Chen J, Zhi Y, Li Z, Dai D
OncoTargets and Therapy 2018, 11:2955-2961
Published Date: 21 May 2018
Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells
Wu M, Zhao G, Zhuang X, Zhang T, Zhang C, Zhang W, Zhang Z
OncoTargets and Therapy 2018, 11:2945-2954
Published Date: 18 May 2018
Indirubin inhibits cell proliferation, migration, invasion and angiogenesis in tumor-derived endothelial cells
Li Z, Zhu C, An B, Chen Y, He X, Qian L, Lan L, Li S
OncoTargets and Therapy 2018, 11:2937-2944
Published Date: 18 May 2018
Downregulation of PDIA3 inhibits proliferation and invasion of human acute myeloid leukemia cells
Ye Q, Fu P, Dou J, Wang N
OncoTargets and Therapy 2018, 11:2925-2935
Published Date: 17 May 2018
miR-598 acts as a tumor suppressor in human gastric cancer by targeting IGF-1R
Liu N, Yang H, Wang H
OncoTargets and Therapy 2018, 11:2911-2923
Published Date: 17 May 2018
High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients
Mandó P, Rizzo M, Roberti MP, Juliá EP, Pampena MB, Pérez de la Puente C, Loza CM, Ponce C, Nadal J, Coló FA, Mordoh J, Levy EM
OncoTargets and Therapy 2018, 11:2901-2910
Published Date: 17 May 2018
Bacillus Calmette–Guérin and anti-PD-L1 combination therapy boosts immune response against bladder cancer
Wang Y, Liu J, Yang X, Liu Y, Liu Y, Li Y, Sun L, Yang X, Niu H
OncoTargets and Therapy 2018, 11:2891-2899
Published Date: 16 May 2018
RIP1 regulates TNF-α-mediated lymphangiogenesis and lymphatic metastasis in gallbladder cancer by modulating the NF-κB-VEGF-C pathway
Li C, Jiang X, Lin B, Hong H, Zhu S, Jiang L, Wang X, Tang N, She F, Chen Y
OncoTargets and Therapy 2018, 11:2875-2890
Published Date: 16 May 2018
Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials
Rim CH, Yoon WS
OncoTargets and Therapy 2018, 11:2865-2874
Published Date: 16 May 2018
circSMAD2 inhibits the epithelial–mesenchymal transition by targeting miR-629 in hepatocellular carcinoma
Zhang XW, Luo P, Jing W, Zhou H, Liang CZ, Tu JC
OncoTargets and Therapy 2018, 11:2853-2863
Published Date: 16 May 2018
NDRG3 facilitates colorectal cancer metastasis through activating Src phosphorylation
Li T, Sun R, Lu MD, Chang J, Meng X, Wu H
OncoTargets and Therapy 2018, 11:2843-2852
Published Date: 15 May 2018
Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect
Shen J, Zhu X, Fei J, Shi P, Yu S, Zhou J
OncoTargets and Therapy 2018, 11:2831-2841
Published Date: 15 May 2018
Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis
Zhou X, Huang X, Liang S, Tang S, Wu S, Huang T, Mo Z, Wang Q
OncoTargets and Therapy 2018, 11:2815-2830
Published Date: 15 May 2018
5-Azacytidine treatment induces demethylation of DAPK1 and MGMT genes and inhibits growth in canine mammary gland tumor cells
Ren XL, Li HT, Song XY, Wu YH, Liu Y
OncoTargets and Therapy 2018, 11:2805-2813
Published Date: 15 May 2018
Long noncoding RNA GAPLINC promotes gastric cancer cell proliferation by acting as a molecular sponge of miR-378 to modulate MAPK1 expression
Diao L, Wang S, Sun Z
OncoTargets and Therapy 2018, 11:2797-2804
Published Date: 14 May 2018
Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer
D'Cruz OJ, Qazi S, Hwang L, Ng K, Trieu V
OncoTargets and Therapy 2018, 11:2779-2796
Published Date: 14 May 2018
Peritoneal carcinomatosis index as a predictor of diaphragmatic involvement in stage III and IV ovarian cancer
Llueca A, Serra A, Herraiz JL, Rivadulla I, Gomez-Quiles L, Gilabert-Estelles J, Escrig J
OncoTargets and Therapy 2018, 11:2771-2777
Published Date: 15 May 2018
ZNF418 overexpression protects against gastric carcinoma and prompts a good prognosis
Hui H, Hu Z, Jiang C, Wu J, Gao Y, Wang X
OncoTargets and Therapy 2018, 11:2763-2770
Published Date: 11 May 2018
Upregulation of circ_0066444 promotes the proliferation, invasion, and migration of gastric cancer cells
Rong D, Dong C, Fu K, Wang H, Tang W, Cao H
OncoTargets and Therapy 2018, 11:2753-2761
Published Date: 11 May 2018
Leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter
Zhang Q, Huang R, Tang Q, Yu Y, Huang Q, Chen Y, Wang G, Wang X
OncoTargets and Therapy 2018, 11:2745-2752
Published Date: 11 May 2018
Aloperine executes antitumor effects through the induction of apoptosis and cell cycle arrest in prostate cancer in vitro and in vivo
Ling Z, Guan H, You Z, Wang C, Hu L, Zhang L, Wang Y, Chen S, Xu B, Chen M
OncoTargets and Therapy 2018, 11:2735-2743
Published Date: 11 May 2018
Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer
Feng Y, Dai Y, Gong Z, Cheng JN, Zhang L, Sun C, Zeng X, Jia Q, Zhu B
OncoTargets and Therapy 2018, 11:2725-2733
Published Date: 10 May 2018
Association between NR5A2 and the risk of pancreatic cancer, especially among Caucasians: a meta-analysis of case–control studies
Chen Q, Yuan H, Shi GD, Wu Y, Liu D, Lin YT, Chen L, Ge W, Jiang K, Miao Y
OncoTargets and Therapy 2018, 11:2709-2723
Published Date: 9 May 2018
Clinical relevance of lysyl oxidase-like 2 and functional mechanisms in glioma
Du XG, Zhu MJ
OncoTargets and Therapy 2018, 11:2699-2708
Published Date: 9 May 2018
Traditional Chinese medicine Astragalus polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosis
Wu J, Wang J, Su Q, Ding W, Li T, Yu J, Cao B
OncoTargets and Therapy 2018, 11:2685-2698
Published Date: 9 May 2018
Delivery of bevacizumab by intracranial injection: assessment in glioma model
Liu YX, Liu WJ, Zhang HR, Zhang ZW
OncoTargets and Therapy 2018, 11:2673-2683
Published Date: 8 May 2018
Influence of different ex vivo cell culture methods on the proliferation and anti-tumor activity of cytokine-induced killer cells from gastric cancer patients
Shi B, Sun AX, Zhang XR
OncoTargets and Therapy 2018, 11:2657-2672
Published Date: 8 May 2018
Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis
Zhang T, Feng F, Zhao W, Tian J, Yao Y, Zhou C, Dong S, Wang C, Zang C, Lv Q, Sun C
OncoTargets and Therapy 2018, 11:2647-2656
Published Date: 8 May 2018
The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients
Cao L, Long L, Li M, Yang H, Deng P, Mao X, Xiang J, Li B, Zhang T, Hu C
OncoTargets and Therapy 2018, 11:2637-2646
Published Date: 8 May 2018
Predicting initial margin status in breast cancer patients during breast-conserving surgery
Pan Z, Zhu L, Li Q, Lai J, Peng J, Su F, Li S, Chen K
OncoTargets and Therapy 2018, 11:2627-2635
Published Date: 8 May 2018
Are ovarian cancer stem cells the target for innovative immunotherapy?
Wang L, Xu T, Cui M
OncoTargets and Therapy 2018, 11:2615-2626
Published Date: 8 May 2018
A 5-serum miRNA panel for the early detection of colorectal cancer
Guo S, Zhang J, Wang B, Zhang B, Wang X, Huang L, Liu H, Jia B
OncoTargets and Therapy 2018, 11:2603-2614
Published Date: 8 May 2018
Chelerythrine induced cell death through ROS-dependent ER stress in human prostate cancer cells
Wu S, Yang Y, Li F, Huang L, Han Z, Wang G, Yu H, Li H
OncoTargets and Therapy 2018, 11:2593-2601
Published Date: 8 May 2018
WWC3 inhibits epithelial–mesenchymal transition of lung cancer by activating Hippo-YAP signaling
Han Q, Kremerskothen J, Lin X, Zhang X, Rong X, Zhang D, Wang E
OncoTargets and Therapy 2018, 11:2581-2591
Published Date: 8 May 2018
Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study
Bai Y, Gao XS, Qin SB, Chen JY, Su MM, Liu Q, Qin XB, Ma MW, Zhao B, Gu XB, Xie M, Cui M, Qi X, Li XY
OncoTargets and Therapy 2018, 11:2571-2579
Published Date: 8 May 2018
Fatal hemoptysis in patients with advanced esophageal cancer treated with apatinib
Wang W, Zhang L, Xie Y, Zhen TC, Su GZ, Zang Q
OncoTargets and Therapy 2018, 11:2565-2570
Published Date: 7 May 2018
Perioperative chemotherapy with pemetrexed and cisplatin for pulmonary large-cell neuroendocrine carcinoma: a case report and literature review
Tang H, Wang HY, Xi SY, He CY, Chang YX, Wang QM, Wu YF
OncoTargets and Therapy 2018, 11:2557-2563
Published Date: 7 May 2018
Patterns of local failures and suggestions for reduction of clinical target volume for nasopharyngeal carcinoma patients without cervical lymph node metastasis
Li Y, Ou X, Shen C, Xu T, Li W, Hu C
OncoTargets and Therapy 2018, 11:2545-2555
Published Date: 7 May 2018
Prognostic factors for operable biliary tract cancer: serum levels of lactate dehydrogenase, a strong association with survival
Ma L, Qiu JR, Zhang YD, Qiu TZ, Wang B, Chen WS, Li X, Sun J, Wang K, Li XC, Gu YH, Shu YQ, Chen XF
OncoTargets and Therapy 2018, 11:2533-2543
Published Date: 4 May 2018
Low circulating total adiponectin, especially its non-high-molecular weight fraction, represents a promising risk factor for colorectal cancer: a meta-analysis
Lu W, Huang Z, Li N, Liu H
OncoTargets and Therapy 2018, 11:2519-2531
Published Date: 4 May 2018
Clinical and radiological characteristics of central pulmonary adenocarcinoma: a comparison with central squamous cell carcinoma and small cell lung cancer and the impact on treatment response
Wang Z, Li M, Huang Y, Ma L, Zhu H, Kong L, Yu J
OncoTargets and Therapy 2018, 11:2509-2517
Published Date: 4 May 2018
The genetic association between iNOS and eNOS polymorphisms and gastric cancer risk: a meta-analysis
Zhu Y, Jiang HG, Chen ZH, Lu BH, Li J, Peng YP, Shen XN
OncoTargets and Therapy 2018, 11:2497-2507
Published Date: 3 May 2018
Pretreatment hematologic markers as prognostic predictors of gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis
Zhou Y, Li D, Lin Y, Yu M, Lu X, Jian Z, Na N, Hou B
OncoTargets and Therapy 2018, 11:2489-2496
Published Date: 1 May 2018
UCA1 promotes cell proliferation and invasion and inhibits apoptosis through regulation of the miR129–SOX4 pathway in renal cell carcinoma
Liu Q, Li Y, Lv W, Zhang G, Tian X, Li X, Cheng H, Zhu C
OncoTargets and Therapy 2018, 11:2475-2487
Published Date: 1 May 2018
Rechallenge of oxaliplatin-containing regimens in the third- or later-line therapy for patients with heavily treated metastatic colorectal cancer
Yang Q, Huang YY, Jiang ZM, Wang HZ, Li WY, Zhang B, Xie DR
OncoTargets and Therapy 2018, 11:2467-2473
Published Date: 1 May 2018
Comprehensive analysis of a long noncoding RNA-associated competing endogenous RNA network in colorectal cancer
Fan Q, Liu B
OncoTargets and Therapy 2018, 11:2453-2466
Published Date: 1 May 2018
The CXCL12 rs1801157 polymorphism and risk of colorectal cancer: a meta-analysis
Xu K, Dai H, Wang S, Zhang J, Liu T
OncoTargets and Therapy 2018, 11:2445-2452
Published Date: 1 May 2018
A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failure
Xiao W, Que Y, Peng RQ, Ding Y, Zhao JJ, Wen XZ, Weng DS, Zhang XS, Guan YX, Zhang X
OncoTargets and Therapy 2018, 11:2439-2443
Published Date: 1 May 2018
Role of miR-613 as a tumor suppressor in glioma cells by targeting SOX9
Sang S, Liu X, Sun D
OncoTargets and Therapy 2018, 11:2429-2438
Published Date: 30 April 2018
A meta-analytic review of the association between two common SNPs in miRNAs and lung cancer susceptibility
Xiao S, Sun S, Long W, Kuang S, Liu Y, Huang H, Zhou J, Zhou Y, Lu X
OncoTargets and Therapy 2018, 11:2419-2427
Published Date: 30 April 2018
Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell-cycle arrest
Yang LF, Liu HR, Long M, Wang X, Lin F, Gao ZW, Zhang HZ
OncoTargets and Therapy 2018, 11:2409-2417
Published Date: 30 April 2018
A Phase Ib study of ruxolitinib + gemcitabine ± nab-paclitaxel in patients with advanced solid tumors
Bauer TM, Patel MR, Forero-Torres A, George TJ Jr, Assad A, Du Y, Hurwitz H
OncoTargets and Therapy 2018, 11:2399-2407
Published Date: 30 April 2018
Role of Beclin1 expression in patients with hepatocellular carcinoma: a meta-analysis
Liang C, Li W, Ge H, Zhang KT, Li GM, Wu J
OncoTargets and Therapy 2018, 11:2387-2397
Published Date: 27 April 2018
MicroRNA-328 inhibits migration and epithelial–mesenchymal transition by targeting CD44 in nasopharyngeal carcinoma cells
Lin CH, Chiang MC, Chen YJ
OncoTargets and Therapy 2018, 11:2375-2385
Published Date: 27 April 2018
LDH-A promotes epithelial–mesenchymal transition by upregulating ZEB2 in intestinal-type gastric cancer
Zhang Y, Lin S, Chen Y, Yang F, Liu S
OncoTargets and Therapy 2018, 11:2363-2373
Published Date: 27 April 2018
Retrospective study of survival in human papillomavirus-negative oropharyngeal squamous cell carcinoma treated with primary surgery and associated prognostic factors
Yuan Y, Wang L, Li QX, Zhang JY, Xu ZX, Guo CB
OncoTargets and Therapy 2018, 11:2355-2362
Published Date: 27 April 2018
The effect of icotinib combined with chemotherapy in untreated non-small-cell lung cancer that harbored EGFR-sensitive mutations in a real-life setting: a retrospective analysis
Wang LL, Li Y, Li LC, Wu ZJ, Yang D, Ma HW, Wang DL
OncoTargets and Therapy 2018, 11:2345-2353
Published Date: 26 April 2018
Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer
Wang WW, Zhou XL, Song YJ, Yu CH, Zhu WG, Tong YS
OncoTargets and Therapy 2018, 11:2333-2344
Published Date: 24 April 2018
MicroRNA-150 suppresses triple-negative breast cancer metastasis through targeting HMGA2
Tang W, Xu P, Wang H, Niu Z, Zhu D, Lin Q, Tang L, Ren L
OncoTargets and Therapy 2018, 11:2319-2332
Published Date: 24 April 2018
Risk factors for esophageal fistula in patients with locally advanced esophageal carcinoma receiving chemoradiotherapy
Zhang Y, Li Z, Zhang W, Chen W, Song Y
OncoTargets and Therapy 2018, 11:2311-2317
Published Date: 23 April 2018
Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report
Duan H, Peng Y, Cui H, Qiu Y, Li Q, Zhang J, Shen W, Sun C, Luo C
OncoTargets and Therapy 2018, 11:2303-2309
Published Date: 23 April 2018
Neuroendocrine tumor of the common bile duct: a case report and review of the literature
Liu Z, Zhang DY, Lu Z, Zhang P, Sun WL, Ma X, Wu H, Wu BQ, Zhou S
OncoTargets and Therapy 2018, 11:2295-2301
Published Date: 23 April 2018
Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review
Makita S, Maeshima AM, Maruyama D, Izutsu K, Tobinai K
OncoTargets and Therapy 2018, 11:2287-2293
Published Date: 20 April 2018
Oncogene mutational analysis in Chinese gastrointestinal stromal tumor patients
Chen Q, Li R, Zhang Z, Deng Q, Li K, Wang H, Yang X, Wu Y
OncoTargets and Therapy 2018, 11:2279-2286
Published Date: 20 April 2018
Modulation of human melanoma cell proliferation and apoptosis by hydatid cyst fluid of Echinococcus granulosus [Corrigendum]
Gao XY, Zhang GH, Huang L
OncoTargets and Therapy 2018, 11:2277-2278
Published Date: 30 April 2018
Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67
Xu J, Guo X, Jing M, Sun T
OncoTargets and Therapy 2018, 11:2269-2275
Published Date: 19 April 2018
Role of DiGeorge syndrome critical region gene 9, a long noncoding RNA, in gastric cancer
Ni C, Yang P, Guo J, Ye M
OncoTargets and Therapy 2018, 11:2259-2267
Published Date: 19 April 2018
Evidence from an updated meta-analysis of the prognostic impacts of postoperative radiotherapy and chemotherapy in patients with anaplastic thyroid carcinoma
Xia Q, Wang W, Xu J, Chen X, Zhong Z, Sun C
OncoTargets and Therapy 2018, 11:2251-2257
Published Date: 19 April 2018
Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine
De Lorenzo C, Paciello R, Riccio G, Rea D, Barbieri A, Coppola C, Maurea N
OncoTargets and Therapy 2018, 11:2241-2250
Published Date: 19 April 2018
microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma
Gao X, Zhu Y, Li JH, Wang X, Zhang X, Yi C, Yang X
OncoTargets and Therapy 2018, 11:2227-2239
Published Date: 19 April 2018
EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
Lu HY, Qin J, Han N, Lei L, Xie F, Li C
OncoTargets and Therapy 2018, 11:2217-2226
Published Date: 20 April 2018
miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5
Wei X, Yu L, Kong X
OncoTargets and Therapy 2018, 11:2205-2216
Published Date: 18 April 2018
MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial–mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells [Erratum]
Li Y, Huo J, Pan X, Wang C, Ma X
OncoTargets and Therapy 2018, 11:2203-2204
Published Date: 17 April 2018
miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression
Du L, Chen T, Zhao K, Yang D
OncoTargets and Therapy 2018, 11:2195-2202
Published Date: 17 April 2018
The role of Hippo signal pathway in breast cancer metastasis
Wei C, Wang Y, Li X
OncoTargets and Therapy 2018, 11:2185-2193
Published Date: 17 April 2018
Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females
Huang Y, Jian W, Zhao J, Wang G
OncoTargets and Therapy 2018, 11:2177-2184
Published Date: 17 April 2018
Preoperative apolipoprotein B/apolipoprotein A1 ratio: a novel prognostic factor for gastric cancer
Ma MZ, Yuan SQ, Chen Y, Zhou ZW
OncoTargets and Therapy 2018, 11:2169-2176
Published Date: 13 April 2018
Prognostic and clinicopathological value of SIRT3 expression in various cancers: a systematic review and meta-analysis
Zhou Y, Cheng S, Chen S, Zhao Y
OncoTargets and Therapy 2018, 11:2157-2167
Published Date: 13 April 2018
Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer
Wang HY, Yu X, Fan Y, Jiang Y
OncoTargets and Therapy 2018, 11:2149-2155
Published Date: 13 April 2018
Profile of apalutamide in the treatment of metastatic castration-resistant prostate cancer: evidence to date
Chong JT, Oh WK, Liaw BC
OncoTargets and Therapy 2018, 11:2141-2147
Published Date: 12 April 2018
Albumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patients
Liu C, Wang W, Meng XY, Sun B, Cong Y, Liu JN, Wang Q, Liu GX, Wu SK
OncoTargets and Therapy 2018, 11:2131-2139
Published Date: 12 April 2018
Efficacy of pemetrexed-based regimens in advanced non–small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic review
Han BH, Yang LL, Wang X, Yao LD
OncoTargets and Therapy 2018, 11:2121-2129
Published Date: 12 April 2018
Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma
Huang CK, Huang ZC, Zhao XK, Wang YH, Zhao HQ, Zhong ZH, Wang L
OncoTargets and Therapy 2018, 11:2111-2120
Published Date: 12 April 2018
Small ubiquitin-like modifier 1 modification of pyruvate kinase M2 promotes aerobic glycolysis and cell proliferation in A549 human lung cancer cells
An S, Huang L, Miao P, Shi L, Shen M, Zhao X, Liu J, Huang G
OncoTargets and Therapy 2018, 11:2097-2109
Published Date: 13 April 2018
Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients
Abdel-Razeq H, Saadeh SS, Abu-Nasser M, Abdulelah H, Marie L, Salam M, Al-Haj Ali B, Ibrahim M, Rimawi D
OncoTargets and Therapy 2018, 11:2091-2096
Published Date: 11 April 2018
Investigation of LEP and LEPR polymorphisms with the risk of hepatocellular carcinoma: a case–control study in Eastern Chinese Han population
Zhang S, Jiang J, Chen Z, Wang Y, Tang W, Liu C, Liu L, Chen Y
OncoTargets and Therapy 2018, 11:2083-2089
Published Date: 11 April 2018
Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis
Huang CK, Huang ZC, Bai PM, Luo GC, Zhao XK, Wang XJ
OncoTargets and Therapy 2018, 11:2075-2082
Published Date: 11 April 2018
Role of the NFκB-signaling pathway in cancer
Xia LZ, Tan SM, Zhou YJ, Lin JG, Wang HR, Oyang LD, Tian YT, Liu L, Su M, Wang H, Cao D, Liao QJ
OncoTargets and Therapy 2018, 11:2063-2073
Published Date: 11 April 2018
Combination of SIRT1 and Src overexpression suggests poor prognosis in luminal breast cancer
Tan J, Liu Y, Maimaiti Y, Wang C, Yan Y, Zhou J, Ruan S, Huang T
OncoTargets and Therapy 2018, 11:2051-2061
Published Date: 11 April 2018
IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer
Zhang Y, Wang J, Wu D, Li M, Zhao F, Ren M, Cai Y, Dou J
OncoTargets and Therapy 2018, 11:2037-2050
Published Date: 10 April 2018
β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion
Liu S, Ding G, Zhou Z, Feng C
OncoTargets and Therapy 2018, 11:2029-2036
Published Date: 9 April 2018
Crocin induces autophagic apoptosis in hepatocellular carcinoma by inhibiting Akt/mTOR activity
Yao C, Liu B, Qian X, Li L, Cao H, Guo Q, Zhou G
OncoTargets and Therapy 2018, 11:2017-2028
Published Date: 9 April 2018
Butein activates p53 in hepatocellular carcinoma cells via blocking MDM2-mediated ubiquitination
Zhou Y, Wang K, Zhou N, Huang T, Zhu J, Li J
OncoTargets and Therapy 2018, 11:2007-2015
Published Date: 6 April 2018
Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombus
Peng C, Gu L, Wang L, Huang Q, Wang B, Guo G, Fan Y, Gao Y, Ma X, Zhang X
OncoTargets and Therapy 2018, 11:1997-2005
Published Date: 6 April 2018
Multiline treatment combining apatinib with toptecan for platinum-resistant recurrent ovarian cancer patients: a report of three cases
Cheng Y, Zhang J, Geng HY, Qin SK, Hua HQ
OncoTargets and Therapy 2018, 11:1989-1995
Published Date: 6 April 2018
Positioning error and expanding margins of planning target volume with kilovoltage cone beam computed tomography for prostate cancer radiotherapy
Wang G, Wang WL, Liu YQ, Dong HM, Hu YX
OncoTargets and Therapy 2018, 11:1981-1988
Published Date: 6 April 2018
Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy
Chen XX, Xia F, Luo JR, Ma JL, Yang ZZ, Zhang L, Feng Y, Shao ZM, Yu XL, Guo XM
OncoTargets and Therapy 2018, 11:1973-1980
Published Date: 5 April 2018
Knockdown of fibrous sheath interacting protein 1 expression reduces bladder urothelial carcinoma cell proliferation and induces apoptosis via inhibition of the PI3K/AKT pathway
Sun M, Chen Z, Tan S, Liu C, Zhao W
OncoTargets and Therapy 2018, 11:1961-1971
Published Date: 5 April 2018
Fabrication of ultrasmall WS2 quantum dots-coated periodic mesoporous organosilica nanoparticles for intracellular drug delivery and synergistic chemo-photothermal therapy
Liao W, Zhang L, Zhong Y, Shen Y, Li C, An N
OncoTargets and Therapy 2018, 11:1949-1960
Published Date: 5 April 2018
Inhibition of NIPBL enhances the chemosensitivity of non-small-cell lung cancer cells via the DNA damage response and autophagy pathway
Zheng L, Zhou H, Guo L, Xu X, Zhang S, Xu W, Mao W
OncoTargets and Therapy 2018, 11:1941-1948
Published Date: 5 April 2018
Downregulation of miR-542-3p promotes cancer metastasis through activating TGF-β/Smad signaling in hepatocellular carcinoma
Zhang T, Liu W, Meng W, Zhao H, Yang Q, Gu SJ, Xiao CC, Jia CC, Fu BS
OncoTargets and Therapy 2018, 11:1929-1939
Published Date: 5 April 2018
PET-CT evaluation of the curative effect of crizotinib on malignant myofibroblastoma with rare mutation of ALK R401: a case report and literature review
Yang L, Wu Y, Tang H, Zhao J, Zhao D, Yang S, Wang Q
OncoTargets and Therapy 2018, 11:1921-1927
Published Date: 5 April 2018
miR-495 inhibits proliferation, migration, and invasion and induces apoptosis via inhibiting PBX3 in melanoma cells
Chen G, Xie Y
OncoTargets and Therapy 2018, 11:1909-1920
Published Date: 5 April 2018
Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort studies
Zhou Y, Cheng S, Fathy AH, Qian H, Zhao Y
OncoTargets and Therapy 2018, 11:1899-1908
Published Date: 5 April 2018
99mTc-labeled sodium phytate and stannous chloride injection accurately detects sentinel lymph node in axillary of early stage breast cancer: a randomized, controlled study
Yang S, Bao W, Bai X, Gao C, Zhang B, Jiang Z
OncoTargets and Therapy 2018, 11:1891-1898
Published Date: 4 April 2018
Long-term survival with transarterial chemoembolization and radioembolization in a patient with cancers of unknown primary
Aktas G, Kus T, Metin T, Kervancioglu S, Elboga U
OncoTargets and Therapy 2018, 11:1885-1889
Published Date: 4 April 2018
Antiangiogenic effects of AA-PMe on HUVECs in vitro and zebrafish in vivo
Jing Y, Wang G, Xiao Q, Zhou Y, Wei Y, Gong Z
OncoTargets and Therapy 2018, 11:1871-1884
Published Date: 4 April 2018
Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis
Zhou L, Du Y, Kong L, Zhang X, Chen Q
OncoTargets and Therapy 2018, 11:1861-1869
Published Date: 4 April 2018
Integrated bioinformatic analysis unveils significant genes and pathways in the pathogenesis of supratentorial primitive neuroectodermal tumor
Wang G, Li L, Liu B, Han X, Wang CH, Wang JW
OncoTargets and Therapy 2018, 11:1849-1859
Published Date: 4 April 2018
D-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer
Yu X, Lin H, Wang Y, Lv W, Zhang S, Qian Y, Deng X, Feng N, Yu H, Qian B
OncoTargets and Therapy 2018, 11:1833-1847
Published Date: 4 April 2018
Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis
Zhao W, Zang C, Zhang T, Li J, Liu R, Feng F, Lv Q, Zheng L, Tian J, Sun C
OncoTargets and Therapy 2018, 11:1821-1831
Published Date: 3 April 2018
Rare malignant insulinoma with multiple liver metastases derived from ectopic pancreas: 3-year follow-up and literature review
Liu Q, Duan JH, Zheng YM, Luo J, Cai XP, Tan HY
OncoTargets and Therapy 2018, 11:1813-1819
Published Date: 3 April 2018
Association between WWOX and the risk of malignant tumor, especially among Asians: evidence from a meta-analysis
Yuan H, Wu Y, Zhang J, Shi G, Liu D, He Y, Lu Z, Wu P, Jiang K, Miao Y
OncoTargets and Therapy 2018, 11:1801-1811
Published Date: 3 April 2018
Prognostic value of increased integrin-beta 1 expression in solid cancers: a meta-analysis
Sun Q, Zhou C, Ma R, Guo Q, Huang H, Hao J, Liu H, Shi R, Liu B
OncoTargets and Therapy 2018, 11:1787-1799
Published Date: 29 March 2018
Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells
Chiu CM, Huang SY, Chang SF, Liao KF, Chiu SC
OncoTargets and Therapy 2018, 11:1777-1785
Published Date: 29 March 2018
Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells
Mu Q, Jiang M, Zhang Y, Wu F, Li H, Zhang W, Wang F, Liu J, Li L, Wang D, Wang W, Li S, Song H, Tang D
OncoTargets and Therapy 2018, 11:1767-1776
Published Date: 3 April 2018
miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells
Meng X, Fu R
OncoTargets and Therapy 2018, 11:1757-1765
Published Date: 29 March 2018
Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers
Dou YL, Lv YL, Zhou XJ, He LF, Liu LH, Li PF, Sun YL, Wang MH, Gao MJ, Wang C
OncoTargets and Therapy 2018, 11:1743-1756
Published Date: 28 March 2018
MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma
Lu Z, Du M, Qian L, Zhang N, Gu J, Ding K, Wu J, Zhu H, He X, Yin L
OncoTargets and Therapy 2018, 11:1733-1741
Published Date: 27 March 2018
miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer
Bao M, Song YJ, Xia JJ, Li PL, Liu Q, Wan ZR
OncoTargets and Therapy 2018, 11:1721-1732
Published Date: 26 March 2018
KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer
Wu Y, Wang A, Zhu B, Huang J, Lu E, Xu H, Xia W, Dong G, Jiang F, Xu L
OncoTargets and Therapy 2018, 11:1707-1720
Published Date: 28 March 2018
Upregulated VEGFA and DLL4 act as potential prognostic genes for clear cell renal cell carcinoma
Wang X, Zhang J, Wang Y, Tu M, Wang Y, Shi G
OncoTargets and Therapy 2018, 11:1697-1706
Published Date: 26 March 2018
Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer
Yuan W, Xie S, Wang M, Pan S, Huang X, Xiong M, Xiao R, Xiong J, Zhang Q, Shao L
OncoTargets and Therapy 2018, 11:1683-1695
Published Date: 23 March 2018
MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1
Yao YF, Li QR, Wang H
OncoTargets and Therapy 2018, 11:1671-1681
Published Date: 23 March 2018
The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women
Ding J, Guo Y, Li Q, Chen J, Hu P, Liu Q, Cao Y, Wu J
OncoTargets and Therapy 2018, 11:1665-1670
Published Date: 23 March 2018
Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy
Boogerd LS, van der Valk MJM, Boonstra MC, Prevoo HA, Hilling DE, van de Velde CJ, Sier CF, Fariña Sarasqueta A, Vahrmeijer AL
OncoTargets and Therapy 2018, 11:1655-1664
Published Date: 23 March 2018
miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect
Liu W, Kang L, Han J, Wang Y, Shen C, Yan Z, Tai Y, Zhao C
OncoTargets and Therapy 2018, 11:1643-1653
Published Date: 23 March 2018
Effects of isoliquiritigenin on ovarian cancer cells
Li N, Yang L, Deng XN, Sun YN
OncoTargets and Therapy 2018, 11:1633-1642
Published Date: 22 March 2018
Open adrenalectomy versus laparoscopic adrenalectomy for adrenocortical carcinoma: a retrospective comparative study on short-term oncologic prognosis
Zheng G, Li H, Deng J, Zhang X, Wu X
OncoTargets and Therapy 2018, 11:1625-1632
Published Date: 21 March 2018
Tooth loss and risk of colorectal cancer: a dose–response meta-analysis of prospective cohort studies
Ma P, Dai S, Jin C, Yao Y, Zou C
OncoTargets and Therapy 2018, 11:1617-1623
Published Date: 21 March 2018
Targeting DTL induces cell cycle arrest and senescence and suppresses cell growth and colony formation through TPX2 inhibition in human hepatocellular carcinoma cells
Chen YC, Chen IS, Huang GJ, Kang CH, Wang KC, Tsao MJ, Pan HW
OncoTargets and Therapy 2018, 11:1601-1616
Published Date: 21 March 2018
Lung squamous cell carcinoma associated with hypoparathyroidism with sensorineural deafness and renal dysplasia syndrome: a case report
Kojima M, Nagano T, Nakata K, Hara S, Katsurada N, Yamamoto M, Tachihara M, Kamiryo H, Kobayashi K, Usui T, Nishimura Y
OncoTargets and Therapy 2018, 11:1595-1599
Published Date: 20 March 2018
Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblastoma via induction of PUMA-mediated apoptosis
Sun L, Yang S, Chi G, Jin X
OncoTargets and Therapy 2018, 11:1583-1593
Published Date: 20 March 2018
High expression of COL10A1 is associated with poor prognosis in colorectal cancer
Huang H, Li T, Ye G, Zhao L, Zhang Z, Mo D, Wang Y, Zhang C, Deng H, Li G, Liu H
OncoTargets and Therapy 2018, 11:1571-1581
Published Date: 20 March 2018
Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma
Zhu Z, Dong W
OncoTargets and Therapy 2018, 11:1563-1570
Published Date: 20 March 2018
Forecast of actin-binding proteins as the oncotarget in osteosarcoma – a review of mechanism, diagnosis and therapy
Fu Y, Yu W, Cai H, Lu A
OncoTargets and Therapy 2018, 11:1553-1561
Published Date: 20 March 2018
Novel long noncoding RNA GACAT3 promotes colorectal cancer cell proliferation, invasion, and migration through miR-149
Zhou W, Wang L, Miao Y, Xing R
OncoTargets and Therapy 2018, 11:1543-1552
Published Date: 19 March 2018
Functional miRNAs in breast cancer drug resistance
Hu WZ, Tan CL, He YJ, Zhang GQ, Xu Y, Tang JH
OncoTargets and Therapy 2018, 11:1529-1541
Published Date: 19 March 2018
Primary mucinous carcinoma of thyroid gland with prominent signet-ring-cell differentiation: a case report and review of the literature
Wang J, Guli QR, Ming XC, Zhou HT, Cui YJ, Jiang YF, Zhang D, Liu Y
OncoTargets and Therapy 2018, 11:1521-1528
Published Date: 16 March 2018
STK39 blockage by RNA interference inhibits the proliferation and induces the apoptosis of renal cell carcinoma
Zhao Q, Zhu YJ, Liu L, Wang H, Jiang S, Hu X, Guo J
OncoTargets and Therapy 2018, 11:1511-1519
Published Date: 16 March 2018
miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma
Wang R, Ma Q, Ji L, Yao Y, Ma M, Wen Q
OncoTargets and Therapy 2018, 11:1501-1509
Published Date: 16 March 2018
Upregulated long non-coding RNAs demonstrate promising efficacy for breast cancer detection: a meta-analysis
Yu G, Zhang W, Zhu L, Xia L
OncoTargets and Therapy 2018, 11:1491-1499
Published Date: 16 March 2018
Midazolam activates caspase, MAPKs and endoplasmic reticulum stress pathways, and inhibits cell cycle and Akt pathway, to induce apoptosis in TM3 mouse Leydig progenitor cells
Kang FC, Wang SC, Chang MM, Pan BS, Wong KL, Cheng KS, So EC, Huang BM
OncoTargets and Therapy 2018, 11:1475-1490
Published Date: 15 March 2018
Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis
Yang X, Zhu S, Li L, Zhang L, Xian S, Wang Y, Cheng Y
OncoTargets and Therapy 2018, 11:1457-1474
Published Date: 15 March 2018
Modulation of human melanoma cell proliferation and apoptosis by hydatid cyst fluid of Echinococcus granulosus
Gao X, Zhang G, Huang L
OncoTargets and Therapy 2018, 11:1447-1456
Published Date: 15 March 2018
Measurement of serum PODXL concentration for detection of pancreatic cancer
Taniuchi K, Tsuboi M, Sakaguchi M, Saibara T
OncoTargets and Therapy 2018, 11:1433-1445
Published Date: 15 March 2018
Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy
Qian Y, Tao J, Li X, Chen H, Lu Q, Yang J, Pan H, Wang C, Zhou W, Liu X
OncoTargets and Therapy 2018, 11:1423-1432
Published Date: 15 March 2018
Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients
Donizy P, Pagacz K, Marczuk J, Fendler W, Maciejczyk A, Halon A, Matkowski R
OncoTargets and Therapy 2018, 11:1413-1422
Published Date: 14 March 2018
Long non-coding RNA FENDRR inhibits cell proliferation and is associated with good prognosis in breast cancer
Li Y, Zhang W, Liu P, Xu Y, Tang L, Chen W, Guan X
OncoTargets and Therapy 2018, 11:1403-1412
Published Date: 14 March 2018
Fast hemostasis: a win-win strategy for ultrasound and microwave ablation
Guo J, Tian G, Zhao Q, Jiang T
OncoTargets and Therapy 2018, 11:1395-1402
Published Date: 13 March 2018
Rhein inhibits malignant phenotypes of human renal cell carcinoma by impacting on MAPK/NF-κB signaling pathways
Ma YL, Chen F, Shi J
OncoTargets and Therapy 2018, 11:1385-1394
Published Date: 14 March 2018
Reliability of using circulating tumor cells for detecting epidermal growth factor receptor mutation status in advanced non-small-cell lung cancer patients: a meta-analysis and systematic review
Hu F, Mao XW, Zhang YJ, Zheng XX, Gu P, Wang HM, Zhang XY
OncoTargets and Therapy 2018, 11:1373-1384
Published Date: 14 March 2018
Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer
Cymbaluk-Płoska A, Chudecka-Głaz A, Jagodzińska A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Menkiszak J
OncoTargets and Therapy 2018, 11:1363-1372
Published Date: 13 March 2018
Clinicopathological features and prognosis in elderly gastric cancer patients: a retrospective cohort study
Xu G, Feng F, Liu S, Wang F, Zheng G, Wang Q, Cai L, Guo M, Lian X, Zhang H
OncoTargets and Therapy 2018, 11:1353-1362
Published Date: 12 March 2018
IL13Rα2 siRNA inhibited cell proliferation, induced cell apoptosis, and suppressed cell invasion in papillary thyroid carcinoma cells
Gu MJ
OncoTargets and Therapy 2018, 11:1345-1352
Published Date: 9 March 2018
SPP1 promotes ovarian cancer progression via Integrin β1/FAK/Akt signaling pathway
Zeng B, Zhou M, Wu H, Xiong Z
OncoTargets and Therapy 2018, 11:1333-1343
Published Date: 12 March 2018
CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis
Zhang ZX, Zhang WN, Sun YY, Li YH, Xu ZM, Fu WN
OncoTargets and Therapy 2018, 11:1323-1331
Published Date: 8 March 2018
Clinicopathological characteristics and prognosis of adult ovarian granulosa cell tumor: a single-institution experience in China
Wang D, Xiang Y, Wu M, Shen K, Yang J, Huang H, Ren T
OncoTargets and Therapy 2018, 11:1315-1322
Published Date: 7 March 2018
Prognostic significance of preoperative IKBKE expression in esophageal squamous cell carcinoma
Yang WJ, Qu Y, Tan BX, Jia YB, Wang NN, Hu P, Wang JB
OncoTargets and Therapy 2018, 11:1305-1314
Published Date: 7 March 2018
The clinicopathological and prognostic value of HSP27 in hepatocellular carcinoma: a systematic review and meta-analysis
Liang CJ, Xu YC, Ge H, Li GM, Wu JX
OncoTargets and Therapy 2018, 11:1293-1303
Published Date: 7 March 2018
Overexpression of c-kit(CD117), relevant with microvessel density, is an independent survival prognostic factor for patients with HBV-related hepatocellular carcinoma
Yan W, Zhu Z, Pan F, Huang A, Dai G
OncoTargets and Therapy 2018, 11:1285-1292
Published Date: 7 March 2018
MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial–mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells
Li Y, Huo J, Pan X, Wang C, Ma X
OncoTargets and Therapy 2018, 11:1275-1284
Published Date: 6 March 2018
Vascular endothelial growth factor suppresses dendritic cells function of human prostate cancer
Bai WK, Zhang W, Hu B
OncoTargets and Therapy 2018, 11:1267-1274
Published Date: 6 March 2018
Decreased expression of LKB1 predicts poor prognosis in pancreatic neuroendocrine tumor patients undergoing curative resection
Li D, Zhou Y, Liu Y, Lin Y, Yu M, Lu X, Huang B, Sun Z, Jian Z, Hou B
OncoTargets and Therapy 2018, 11:1259-1265
Published Date: 6 March 2018
Icotinib hydrochloride enhances chemo- and radiosensitivity by inhibiting EGFR signaling and attenuating RAD51 expression and function in Hela S3 cells
Wang X, Gu Y, Liu H, Shi L, Sun X
OncoTargets and Therapy 2018, 11:1245-1258
Published Date: 5 March 2018
Clinical value of Xenopus kinesin-like protein 2 as a prognostic marker in patients with digestive system cancers: a systematic review and meta-analysis
Wang G, Wang Q, Li Z, Liu C, He X
OncoTargets and Therapy 2018, 11:1229-1243
Published Date: 5 March 2018
A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study
Yalcin Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyilkan Ö, Sevinç A, Özdemir F, Turna H, Uslu R, Ulay E
OncoTargets and Therapy 2018, 11:1223-1228
Published Date: 5 March 2018
Leukemia-related protein 16 (LRP16) promotes tumor growth and metastasis in pancreatic cancer
Mo Z, Hu MG, Yu F, Shao LJ, Fan KX, Jiao SC
OncoTargets and Therapy 2018, 11:1215-1222
Published Date: 5 March 2018
Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma
Liang CJ, Xu Y, Ge H, Li G, Wu J
OncoTargets and Therapy 2018, 11:1203-1214
Published Date: 5 March 2018
Impact of diabetes mellitus on the risk and survival of nasopharyngeal carcinoma: a meta-analysis
Guo G, Fu M, Wei S, Chen R
OncoTargets and Therapy 2018, 11:1193-1201
Published Date: 2 March 2018
Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma
Wang R, Deng D, Shao N, Xu Y, Xue L, Peng Y, Liu Y, Zhi F
OncoTargets and Therapy 2018, 11:1183-1192
Published Date: 2 March 2018
Hepatitis C virus core impacts expression of miR122 and miR204 involved in carcinogenic progression via regulation of TGFBRAP1 and HOTTIP expression
Wang X, Peng J, Wang J, Li M, Wu D, Wu S, Liao J, Dou J
OncoTargets and Therapy 2018, 11:1173-1182
Published Date: 2 March 2018
SIRT1 overexpression protects non-small cell lung cancer cells against osteopontin-induced epithelial-mesenchymal transition by suppressing NF-κB signaling
Li X, Jiang Z, Li XM, Zhang X
OncoTargets and Therapy 2018, 11:1157-1171
Published Date: 2 March 2018
Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study
Sun H, Tang Q, Chen J, Lv X, Tu Y, Yan D
OncoTargets and Therapy 2018, 11:1149-1155
Published Date: 6 March 2018
Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study
Zheng XY, Wang Y, Dong LL, Zhao S, Wang LP, Chen H, Xu Y, Wang GN
OncoTargets and Therapy 2018, 11:1141-1148
Published Date: 1 March 2018
rs11614913 polymorphism in miRNA-196a2 and cancer risk: an updated meta-analysis
Liu Y, He A, Liu B, Zhong Y, Liao X, Yang J, Chen J, Wu J, Mei H
OncoTargets and Therapy 2018, 11:1121-1139
Published Date: 1 March 2018
Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion
Aguado C, Gil MDLL, Yeste Z, Giménez-Capitán A, Teixidó C, Karachaliou N, Viteri S, Rosell R, Molina-Vila MA
OncoTargets and Therapy 2018, 11:1117-1120
Published Date: 1 March 2018
The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis
Fan JS, Xia ZF, Zhang XL, Chen YQ, Qian RL, Liu SH, You DM, Zhang J, Luo P
OncoTargets and Therapy 2018, 11:1105-1115
Published Date: 1 March 2018
TSPAN12 is overexpressed in NSCLC via p53 inhibition and promotes NSCLC cell growth in vitro and in vivo
Hu Z, Hou D, Wang X, You Z, Cao X
OncoTargets and Therapy 2018, 11:1095-1103
Published Date: 1 March 2018
Comparison between multi-slice spiral CT and magnetic resonance imaging in the diagnosis of peritoneal metastasis in primary ovarian carcinoma
Guo HL, He L, Zhu YC, Wu K, Yuan F
OncoTargets and Therapy 2018, 11:1087-1094
Published Date: 28 February 2018
Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer
Jiang DG, Xiao CT, Xian TZ, Wang LT, Mao YH, Zhang JF, Pang J
OncoTargets and Therapy 2018, 11:1077-1086
Published Date: 28 February 2018
Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis
Wang B, Zhang XB, Wang W, Zhu ZZ, Tang F, Wang D, Liu X, Zhuang H, Yan XL
OncoTargets and Therapy 2018, 11:1067-1075
Published Date: 27 February 2018
Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis
Tang L, Li J, Bao M, Xiang J, Chen Y, Wang Y
OncoTargets and Therapy 2018, 11:1055-1066
Published Date: 1 March 2018
CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis
Zhang Y, Xu L, Peng M
OncoTargets and Therapy 2018, 11:1045-1054
Published Date: 27 February 2018
Clinicopathologic characteristics and prognosis of proximal and distal gastric cancer
Yu X, Hu F, Li C, Yao Q, Zhang H, Xue Y
OncoTargets and Therapy 2018, 11:1037-1044
Published Date: 27 February 2018
Reversine, a substituted purine, exerts an inhibitive effect on human renal carcinoma cells via induction of cell apoptosis and polyploidy
Cheng L, Wang H, Guo KC, Wang ZC, Zhang ZY, Shen C, Chen L, Lin J
OncoTargets and Therapy 2018, 11:1025-1035
Published Date: 26 February 2018
Prognostic value of circulating tumor cells detected with the CellSearch System in patients with gastric cancer: evidence from a meta-analysis
Yang C, Zou K, Yuan Z, Guo T, Xiong B
OncoTargets and Therapy 2018, 11:1013-1023
Published Date: 26 February 2018
How many ELNs are optimal for breast cancer patients with more than three PLNs who underwent MRM? A large population-based study
Wang X, Ji C, Chi H, Wang H
OncoTargets and Therapy 2018, 11:1005-1011
Published Date: 26 February 2018
Prognostic significance of Epstein–Barr virus DNA in NK/T-cell lymphoma: a meta-analysis
Fei Q, Tian X, Wu J, Zhu H, Wang Y, Peng F, Zhang W, Yin L, He X
OncoTargets and Therapy 2018, 11:997-1004
Published Date: 26 February 2018
Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway
Yang C, Hou A, Yu C, Dai L, Wang W, Zhang K, Shao H, Ma J, Xu W
OncoTargets and Therapy 2018, 11:983-996
Published Date: 26 February 2018
Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis
Zhou B, Zhan C, Ding Y, Yan S, Zheng S
OncoTargets and Therapy 2018, 11:975-982
Published Date: 23 February 2018
Prognostic significance of mucinous component in gastric adenocarcinoma after radical D2 gastrectomy
Cai L, Li Y, Yang X, Lian X, Guo M, Xiao S, Wang W, Zhang H
OncoTargets and Therapy 2018, 11:967-973
Published Date: 23 February 2018
Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
Sacdalan DB, Lucero JA, Sacdalan DL
OncoTargets and Therapy 2018, 11:955-965
Published Date: 23 February 2018
Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells
Wang X, Liu Y, Wu R, Guo F, Zhang L, Cui M, Wu X, Zhang Y, Liu W
OncoTargets and Therapy 2018, 11:943-953
Published Date: 22 February 2018
Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines
Sipos E, Dobos N, Rozsa D, Fodor K, Olah G, Szabo Z, Szekvolgyi L, Schally AV, Halmos G
OncoTargets and Therapy 2018, 11:933-941
Published Date: 22 February 2018
The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing
Yang F, Xu S, Liu RW, Shi T, Li XF, Li XB, Chen G, Liu HY, Zhou QH, Chen J
OncoTargets and Therapy 2018, 11:919-932
Published Date: 21 February 2018
Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma
Sheng XR, Xing SG, Wang RD, Chen K, Jia WD
OncoTargets and Therapy 2018, 11:909-917
Published Date: 21 February 2018
Postoperative hepatic arterial infusion chemotherapy improved survival of pancreatic cancer after radical pancreatectomy: a retrospective study
Wang Y, Xu Y, Zheng Y, Bao Y, Wang P
OncoTargets and Therapy 2018, 11:903-907
Published Date: 21 February 2018
CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker
Shen Z, Yu X, Zheng Y, Lai X, Li J, Hong Y, Zhang H, Chen C, Su Z, Guo R
OncoTargets and Therapy 2018, 11:891-901
Published Date: 20 February 2018
Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review
Bi MH, Yang JR, Wang YP, Zhang HR, Gao ZY, Zhou HR, Shi MH
OncoTargets and Therapy 2018, 11:883-890
Published Date: 19 February 2018
Klotho ameliorates sepsis-induced acute kidney injury but is irrelevant to autophagy
Chen X, Tong H, Chen Y, Chen C, Ye J, Mo Q, Zhao G, Hong G, Zheng C, Lu Z
OncoTargets and Therapy 2018, 11:867-881
Published Date: 19 February 2018
Effects of four single nucleotide polymorphisms of EZH2 on cancer risk: a systematic review and meta-analysis
Ling Z, You Z, Hu L, Zhang L, Wang Y, Zhang M, Zhang G, Chen S, Xu B, Chen M
OncoTargets and Therapy 2018, 11:851-865
Published Date: 16 February 2018
Interleukin-33 enhanced the migration and invasiveness of human lung cancer cells
Yang Z, Gao X, Wang J, Xu L, Zheng Y, Xu Y
OncoTargets and Therapy 2018, 11:843-849
Published Date: 16 February 2018
Developments in the management of advanced soft-tissue sarcoma – olaratumab in context
Moroncini G, Maccaroni E, Fiordoliva I, Pellei C, Gabrielli A, Berardi R
OncoTargets and Therapy 2018, 11:833-842
Published Date: 16 February 2018
MiR-1180-5p regulates apoptosis of Wilms’ tumor by targeting p73
Jiang X, Li H
OncoTargets and Therapy 2018, 11:823-831
Published Date: 16 February 2018
Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell
Zhang Y, Xu Z, Sun Y, Chi P, Lu X
OncoTargets and Therapy 2018, 11:809-821
Published Date: 16 February 2018
Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting
Wu Z, Xu S, Zhou L, Yin W, Lin Y, Du Y, Wang Y, Jiang Y, Yin K, Zhang J, Lu J
OncoTargets and Therapy 2018, 11:801-808
Published Date: 15 February 2018
The association between HOTAIR polymorphisms and cancer susceptibility: an updated systemic review and meta-analysis
Min L, Mu X, Tong A, Qian Y, Ling C, Yi T, Zhao X
OncoTargets and Therapy 2018, 11:791-800
Published Date: 14 February 2018
ISL1 is upregulated in breast cancer and promotes cell proliferation, invasion, and angiogenesis
Li L, Sun F, Chen X, Zhang M
OncoTargets and Therapy 2018, 11:781-789
Published Date: 14 February 2018
Antitumor effect of triptolide in T-cell lymphoblastic lymphoma by inhibiting cell viability, invasion, and epithelial–mesenchymal transition via regulating the PI3K/AKT/mTOR pathway
Huang Y, Wu S, Zhang Y, Wang L, Guo Y
OncoTargets and Therapy 2018, 11:769-779
Published Date: 12 February 2018
Raptor mediates the antiproliferation of cardamonin by mTORC1 inhibition in SKOV3 cells
Shi D, Zhu Y, Niu P, Zhou J, Chen H
OncoTargets and Therapy 2018, 11:757-767
Published Date: 9 February 2018
Molecular features of giant-cell carcinoma of the lung: a case report and literature review
Li X, Zhang ZH, Liu JH, Wang D, Wei S, Chen J
OncoTargets and Therapy 2018, 11:751-756
Published Date: 9 February 2018
Expression of Nemo-like kinase in cervical squamous cell carcinoma: a clinicopathological study
Yang W, Gu L, Yang C, Liu T
OncoTargets and Therapy 2018, 11:743-749
Published Date: 8 February 2018
Prognostic significance of epidermal growth factor receptor expression in glioma patients
Li JH, Liang RF, Song C, Xiang YF, Liu YH
OncoTargets and Therapy 2018, 11:731-742
Published Date: 7 February 2018
Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis
Dai P, Li J, Ma XP, Huang J, Meng JJ, Gong P
OncoTargets and Therapy 2018, 11:721-730
Published Date: 5 February 2018
Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies
Han X, Han Y, Zheng Y, Sun Q, Ma T, Dai L, Zhang J, Xu L
OncoTargets and Therapy 2018, 11:711-720
Published Date: 5 February 2018
Association between IL-17A G197A polymorphism and gastric cancer risk: an updated meta-analysis based on 6,624 cases and 7,631 controls
Hu L, Kong F, Pan Y
OncoTargets and Therapy 2018, 11:703-710
Published Date: 5 February 2018
Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins
Ying H, Xu Z, Chen M, Zhou S, Liang X, Cai X
OncoTargets and Therapy 2018, 11:689-702
Published Date: 2 February 2018
PUMA mediates the anti-cancer effect of osimertinib in colon cancer cells [Corrigendum]
Guo L, Huang S, Wang X
OncoTargets and Therapy 2018, 11:687-688
Published Date: 2 February 2018
Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer
Xie L, Li X, Wang Q, Zhou J, Shen J, Luo L, Lu Y, Wang L
OncoTargets and Therapy 2018, 11:677-685
Published Date: 1 February 2018
Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis
Tang LN, Zhang CL, He HR, Pan ZY, Fan D, He YL, You HS, Li YJ
OncoTargets and Therapy 2018, 11:665-675
Published Date: 1 February 2018
Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significance
Li J, Ye D, Wang L, Peng Y, Li Q, Deng H, Zhou C
OncoTargets and Therapy 2018, 11:651-663
Published Date: 1 February 2018
LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1
Shang M, Wang X, Zhang Y, Gao Z, Wang T, Liu R
OncoTargets and Therapy 2018, 11:639-649
Published Date: 31 January 2018
The lncRNA PCAT1 is correlated with poor prognosis and promotes cell proliferation, invasion, migration and EMT in osteosarcoma
Zhang X, Zhang Y, Mao Y, Ma X
OncoTargets and Therapy 2018, 11:629-638
Published Date: 31 January 2018
The application of a three-dimensional visualized seed planning and navigation system in 125I seed implantation for pancreatic cancer
Hu YY, Qi EP, Liu FY, Lu YH, Tan SL, Sun Y, Han ZY, Liang P, Yu XL
OncoTargets and Therapy 2018, 11:619-627
Published Date: 31 January 2018
Identification of genomic expression differences between right-sided and left-sided colon cancer based on bioinformatics analysis
Peng Q, Lin K, Chang T, Zou L, Xing P, Shen Y, Zhu Y
OncoTargets and Therapy 2018, 11:609-618
Published Date: 31 January 2018
ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3
Wang Y, Shao F, Chen L
OncoTargets and Therapy 2018, 11:599-608
Published Date: 31 January 2018
Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China
Yang YL, Chen K, Zhou YC, Hu ZX, Chen S, Huang YC
OncoTargets and Therapy 2018, 11:587-597
Published Date: 30 January 2018
miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway
Shi DM, Bian XY, Qin CD, Wu WZ
OncoTargets and Therapy 2018, 11:571-585
Published Date: 26 January 2018
A non-synonymous polymorphism in NBS1 is associated with progression from chronic hepatitis B virus infection to hepatocellular carcinoma in a Chinese population
Zhen YN, Xiao RX, Chen X, Yuan CJ, Sun YL, Li J
OncoTargets and Therapy 2018, 11:563-569
Published Date: 26 January 2018
Clinical manifestations of pulmonary mucosa-associated lymphoid tissue lymphoma: single-center experience with 18 patients
Zhao S, Zhang L, Gu Z, Zhu C, Fang S, Yang N, Wang F, Guan L, Luo L, Gao C
OncoTargets and Therapy 2018, 11:555-561
Published Date: 24 January 2018
Quantification of heart, pericardium, and left ventricular myocardium movements during the cardiac cycle for thoracic tumor radiotherapy
Tong Y, Yin Y, Lu J, Liu T, Chen J, Cheng P, Gong G
OncoTargets and Therapy 2018, 11:547-554
Published Date: 24 January 2018
Nomogram for predicting survival in patients with pancreatic cancer
Song W, Miao DL, Chen L
OncoTargets and Therapy 2018, 11:539-545
Published Date: 24 January 2018
Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients
Wang LY, Cui JJ, Guo AX, Yin JY
OncoTargets and Therapy 2018, 11:529-538
Published Date: 24 January 2018
The role of bevacizumab in targeted vascular endothelial growth factor therapy for epithelial ovarian cancer: an updated systematic review and meta-analysis
Ruan GY, Ye LX, Liu GF, An J, Sehouli J, Sun PM
OncoTargets and Therapy 2018, 11:521-528
Published Date: 23 January 2018
The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review
Zhang S, Xu XS, Yang JX, Guo JH, Chao TF, Tong YX
OncoTargets and Therapy 2018, 11:509-519
Published Date: 23 January 2018
Prognostic role of neutrophil–lymphocyte ratio in multiple myeloma: a dose–response meta-analysis
Mu S, Ai L, Fan F, Sun C, Hu Y
OncoTargets and Therapy 2018, 11:499-507
Published Date: 23 January 2018
ROS-dependent Bax/Bcl2 and caspase 3 pathway-mediated apoptosis induced by zineb in human keratinocyte cells
Ali D, Tripathi A, Al Ali H, Shahi Y, Mishra KK, Alarifi S, Alkahtane AA, Manohardas S
OncoTargets and Therapy 2018, 11:489-497
Published Date: 23 January 2018
Synovial sarcoma of the maxillary sinus: an extremely rare case with excellent response to chemotherapy
Saito S, Ozawa H, Ikari Y, Nakahara N, Ito F, Sekimizu M, Fukada J, Kameyama K, Ogawa K
OncoTargets and Therapy 2018, 11:483-488
Published Date: 23 January 2018
Homeobox C10 knockdown suppresses cell proliferation and promotes cell apoptosis in osteosarcoma cells through regulating caspase 3
Xie X, Xiao Y, Huang X
OncoTargets and Therapy 2018, 11:473-482
Published Date: 22 January 2018
Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer
Qiu TZ, Chen WS, Li P, Sun J, Gu YH, Chen XF
OncoTargets and Therapy 2018, 11:465-471
Published Date: 22 January 2018
Apatinib-treated advanced medullary thyroid carcinoma: a case report
Chen K, Gao Y, Shi F, Cao G, Bao J
OncoTargets and Therapy 2018, 11:459-463
Published Date: 19 January 2018
Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran
Boostani F, Dolatkhah R, Fakhrjou A, Farassati F, Sanaat Z
OncoTargets and Therapy 2018, 11:449-457
Published Date: 19 January 2018
Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
Chen JW, Huang CQ, Chen K, Li SM, Zhang X, Cheng J, Cai MY, Xiao Y
OncoTargets and Therapy 2018, 11:441-448
Published Date: 19 January 2018
Long noncoding RNA H19 promotes transforming growth factor-β-induced epithelial–mesenchymal transition by acting as a competing endogenous RNA of miR-370-3p in ovarian cancer cells
Li J, Huang YY, Deng XJ, Luo ML, Wang XF, Hu HY, Liu CD, Zhong M
OncoTargets and Therapy 2018, 11:427-440
Published Date: 18 January 2018
Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia
Sevinç A, Özkan M, Özet A, Dane F, Öksüzoğlu B, Işıkdoğan A, Özdemir F, Uncu D, Gümüş M, Evrensel T, Yaren A, Kara O, Tekin SB
OncoTargets and Therapy 2018, 11:419-426
Published Date: 18 January 2018
Neoadjuvant chemoradiotherapy followed by surgery in patients with unresectable locally advanced colon cancer: a prospective observational study
Chang H, Yu X, Xiao W, Wang QX, Zhou WH, Zeng ZF, Ding PR, Li L, Gao YH
OncoTargets and Therapy 2018, 11:409-418
Published Date: 17 January 2018
Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway
Daya M, Loilome W, Techasen A, Thanee M, Sa-Ngiamwibool P, Titapun A, Yongvanit P, Namwat N
OncoTargets and Therapy 2018, 11:395-408
Published Date: 18 January 2018
Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients
Wan T, Shao J, Hu B, Liu G, Luo P, Zhou Y
OncoTargets and Therapy 2018, 11:383-393
Published Date: 17 January 2018
Comparison of FOLFOX and DOF regimens as first-line treatment in East Asian patients with advanced gastric cancer
Liu M, Hu G, Wang Y, Guo J, Liu L, Han X, Wang Z
OncoTargets and Therapy 2018, 11:375-381
Published Date: 17 January 2018
Combination of betulinic acid with diazen-1-ium-1,2-diolate nitric oxide moiety donating a novel anticancer candidate
Zhang L, Hou S, Li B, Pan J, Jiang L, Zhou G, Gu H, Zhao C, Lu H, Ma F
OncoTargets and Therapy 2018, 11:361-373
Published Date: 15 January 2018
Prognostic role of HSPs in human gastrointestinal cancer: a systematic review and meta-analysis
Ge H, Yan Y, Guo L, Tian F, Wu D
OncoTargets and Therapy 2018, 11:351-359
Published Date: 15 January 2018
Safety and efficacy of transarterial chemoembolization with degradable starch microspheres (DSM-TACE) in the treatment of secondary liver malignancies
Schicho A, Pereira PL, Michalik K, Beyer LP, Stroszczynski C, Wiggermann P
OncoTargets and Therapy 2018, 11:345-350
Published Date: 12 January 2018
The clinical characteristics and prognostic analysis of Chinese advanced NSCLC patients based on circulating tumor DNA sequencing
Rao C, Nie L, Miao X, Xu Y, Li B, Zhang T
OncoTargets and Therapy 2018, 11:337-344
Published Date: 12 January 2018
High-frequency deregulated expression of Wnt signaling pathway members in breast carcinomas
Khan Z, Arafah M, Shaik JP, Mahale A, Alanazi MS
OncoTargets and Therapy 2018, 11:323-335
Published Date: 11 January 2018
The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway
Jia L, Tian Y, Chen Y, Zhang G
OncoTargets and Therapy 2018, 11:313-321
Published Date: 11 January 2018
A novel tumor suppressor gene NCOA5 is correlated with progression in papillary thyroid carcinoma
Zheng Z, Wang Q, Zhang W, Zhang X, Huang D
OncoTargets and Therapy 2018, 11:307-311
Published Date: 11 January 2018
Comparative study of clinical efficacy using three-dimensional and two-dimensional laparoscopies in the treatment of distal gastric cancer
Liu JG, Zhou HT, Qin HQ, Ru HM, Huang JH, Liang SY, Mo XW, Tang WZ
OncoTargets and Therapy 2018, 11:301-306
Published Date: 11 January 2018
Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer
Zhang P, Zhou H, Lu K, Lu Y, Wang Y, Feng T
OncoTargets and Therapy 2018, 11:291-299
Published Date: 9 January 2018
Over-expression of ARHGAP18 suppressed cell proliferation, migration, invasion, and tumor growth in gastric cancer by restraining over-activation of MAPK signaling pathways
Li Y, Ji S, Fu L, Jiang T, Wu D, Meng F
OncoTargets and Therapy 2018, 11:279-290
Published Date: 9 January 2018
Experimental study of inhibitory effects of diallyl trisulfide on the growth of human osteosarcoma Saos-2 cells by downregulating expression of glucose-regulated protein 78
Zhang Y, Xie WP, Zhang YK, Chen YQ, Wang DL, Li G, Guan DH
OncoTargets and Therapy 2018, 11:271-277
Published Date: 9 January 2018
A support vector machine and a random forest classifier indicates a 15-miRNA set related to osteosarcoma recurrence
He Y, Ma J, Wang A, Wang W, Luo S, Liu Y, Ye X
OncoTargets and Therapy 2018, 11:253-269
Published Date: 5 January 2018
miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells
Tsai TF, Lin JF, Chou KY, Lin YC, Chen HE, Hwang TIS
OncoTargets and Therapy 2018, 11:239-252
Published Date: 4 January 2018
Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistance
Vert A, Castro J, Ribó M, Vilanova M, Benito A
OncoTargets and Therapy 2018, 11:221-237
Published Date: 4 January 2018
RACK1 induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression
Liu B, Wang C, Chen P, Cheng B, Cheng Y
OncoTargets and Therapy 2018, 11:211-220
Published Date: 4 January 2018
KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth
Wang Y, Zang J, Zhang D, Sun Z, Qiu B, Wang X
OncoTargets and Therapy 2018, 11:201-209
Published Date: 8 January 2018
Autophagy suppresses proliferation of HepG2 cells via inhibiting glypican-3/wnt/β-catenin signaling
Hu P, Cheng B, He Y, Wei Z, Wu D, Meng Z
OncoTargets and Therapy 2018, 11:193-200
Published Date: 4 January 2018
The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA.MB231 cells
Bimonte S, Barbieri A, Cascella M, Rea D, Palma G, Del Vecchio V, Forte CA, Del Prato F, Arra C, Cuomo A
OncoTargets and Therapy 2018, 11:185-191
Published Date: 3 January 2018
Cancer stem cells, the ultimate targets in cancer therapy
Shabbir A, Esfandyari T, Farassati F
OncoTargets and Therapy 2018, 11:183-184
Published Date: 3 January 2018
Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy
Weisberg E, Sattler M, Manley PW, Griffin JD
OncoTargets and Therapy 2018, 11:175-182
Published Date: 29 December 2017
Identification of key pathways and genes in TP53 mutation acute myeloid leukemia: evidence from bioinformatics analysis
Huang R, Liao X, Li Q
OncoTargets and Therapy 2018, 11:163-173
Published Date: 28 December 2017
A patient with classic biphasic pulmonary blastoma harboring CD74–ROS1 fusion responds to crizotinib
Meng Z, Chen P, Zang F, Liu Y, Xu X, Su Y, Chen J, Lin L, Zhang L, Zhang T
OncoTargets and Therapy 2018, 11:157-161
Published Date: 28 December 2017
Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy
Castelli G, Pelosi E, Testa U
OncoTargets and Therapy 2018, 11:131-155
Published Date: 28 December 2017
Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC
Tang XM, Chen H, Li Q, Song YL, Zhang SP, Xu XS, Xu YW, Chen SL
OncoTargets and Therapy 2018, 11:123-129
Published Date: 28 December 2017
A retrospective examination of the US Food and Drug Administration’s clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring
Fleisher B, Ait-Oudhia S
OncoTargets and Therapy 2018, 11:113-121
Published Date: 27 December 2017
The putative tumor suppressor, miR-199a, regulated by Snail, modulates clear cell renal cell carcinoma aggressiveness by repressing ROCK1
Zhang X, Li P, Ding Z, Wang H, Wang J, Han L, Ding S
OncoTargets and Therapy 2018, 11:103-112
Published Date: 27 December 2017
The RNASEL −1385G/A polymorphism is associated with risk of prostate cancer in Africans
Liu X, Zheng D, Lu G, Yang B
OncoTargets and Therapy 2018, 11:97-102
Published Date: 22 December 2017
Prognosis of patients with primary malignant main stem bronchial tumors: 7,418 cases based on the SEER database
Ma K, Sun F, Yang X, Wang S, Wang L, Jin Y, Shi Y, Jiang W, Zhan C, Wang Q
OncoTargets and Therapy 2018, 11:83-95
Published Date: 22 December 2017
Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA
DiBonaventura MD, Wong W, Shah-Manek B, Schulz M
OncoTargets and Therapy 2018, 11:75-82
Published Date: 22 December 2017
miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition
Ren H, Qi Y, Yin X, Gao J
OncoTargets and Therapy 2018, 11:67-74
Published Date: 22 December 2017
Pretreatment platelet count as a prognostic factor in patients with pancreatic cancer: a systematic review and meta-analysis
Chen S, Na N, Jian Z
OncoTargets and Therapy 2018, 11:59-65
Published Date: 21 December 2017
Clinicopathological and prognostic significance of OCT4 in patients with hepatocellular carcinoma: a meta-analysis
Liang CJ, Xu YC, Ge H, Li GM, Wu JX
OncoTargets and Therapy 2018, 11:47-57
Published Date: 21 December 2017
Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer
Wang Y, Jin Y, Bhandari A, Yao Z, Yang F, Pan Y, Zheng Z, Lv S, Wang O
OncoTargets and Therapy 2018, 11:37-46
Published Date: 21 December 2017
Four-miRNA signature as a prognostic tool for lung adenocarcinoma
Lin Y, Lv Y, Liang R, Yuan C, Zhang J, He D, Zheng X, Zhang J
OncoTargets and Therapy 2018, 11:29-36
Published Date: 21 December 2017
Quercetin suppresses DNA double-strand break repair and enhances the radiosensitivity of human ovarian cancer cells via p53-dependent endoplasmic reticulum stress pathway
Gong C, Yang Z, Zhang L, Wang Y, Gong W, Liu Y
OncoTargets and Therapy 2018, 11:17-27
Published Date: 21 December 2017
Identification of epigenetically altered genes and potential gene targets in melanoma using bioinformatic methods
Duan HH, Jiang K, Wei DK, Zhang LJ, Cheng DL, Lv M, Xu YB, He AM
OncoTargets and Therapy 2018, 11:9-15
Published Date: 20 December 2017
ERCC1 rs3212986 A/C polymorphism is not associated with chemotherapy treatment outcomes in gastric cancer patients: evidence from 11 publications in Chinese populations
Tang WW, Wang H, Wang YM, Wang XW
OncoTargets and Therapy 2018, 11:1-8
Published Date: 20 December 2017
ALK-positive anaplastic large cell lymphoma with soft tissue involvement in a young woman [Retraction]
Gao K, Li H, Huang C, Li H, Fang J, Tian C
OncoTargets and Therapy 2017, 10:5945-5946
Published Date: 18 December 2017
Myometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging
Guo Y, Wang P, Wang P, Gao W, Li F, Yang X, Ni H, Shen W, Guo Z
OncoTargets and Therapy 2017, 10:5937-5943
Published Date: 15 December 2017
SUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma [Retraction]
Huang W, Huang H, Wang L, Hu J, Song W
OncoTargets and Therapy 2017, 10:5935-5936
Published Date: 18 December 2017
Nuclear expression of XBP1s is correlated with breast cancer survival: a retrospective analysis based on tissue microarray
Wang M, Ruan S, Ming J, Dong F
OncoTargets and Therapy 2017, 10:5927-5934
Published Date: 13 December 2017
Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules
He Y, Yang Y, Kuang P, Ren S, Rozeboom L, Rivard CJ, Li X, Zhou C, Hirsch FR
OncoTargets and Therapy 2017, 10:5915-5926
Published Date: 13 December 2017
High expression of CIP2A protein is associated with tumor aggressiveness in stage I–III NSCLC and correlates with poor prognosis
Cha GQ, Xu JY, Xu XY, Li B, Lu S, Nanding AB, Hu SL, Liu SL
OncoTargets and Therapy 2017, 10:5907-5914
Published Date: 12 December 2017
miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α
Feng X, Liu N, Deng S, Zhang DD, Wang KX, Lu MS
OncoTargets and Therapy 2017, 10:5899-5906
Published Date: 12 December 2017
Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer
Yuan NJ, Zhang G, Bie FJ, Ma M, Ma Y, Jiang X, Wang Y, Hao X
OncoTargets and Therapy 2017, 10:5883-5897
Published Date: 12 December 2017
Targeting of GIT1 by miR-149* in breast cancer suppresses cell proliferation and metastasis in vitro and tumor growth in vivo
Dong Y, Chang C, Liu J, Qiang J
OncoTargets and Therapy 2017, 10:5873-5882
Published Date: 11 December 2017
Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance
Peng R, Huang X, Zhang C, Yang X, Xu Y, Bai D
OncoTargets and Therapy 2017, 10:5863-5872
Published Date: 11 December 2017
Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells
Cheng X, Liu Z, Shang L, Cai H, Zhang Y, Cai Y, Xu X, Hao J, Wang M
OncoTargets and Therapy 2017, 10:5855-5862
Published Date: 11 December 2017
Long noncoding RNA NEAT1 promotes nasopharyngeal carcinoma progression through regulation of miR-124/NF-κB pathway
Cheng N, Guo Y
OncoTargets and Therapy 2017, 10:5843-5853
Published Date: 11 December 2017
Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma
Huang JF, Zou QZ, Qian DQ, Zhou LY, Yang B, Chu JJ, Pang QF, Wang KW, Zhang FZ
OncoTargets and Therapy 2017, 10:5835-5841
Published Date: 8 December 2017
The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer
Wu Y, Gong L, Xu J, Mou Y, Xu X, Qian Z
OncoTargets and Therapy 2017, 10:5827-5834
Published Date: 8 December 2017
Chemotherapy induces ovarian cancer cell repopulation through the caspase 3-mediated arachidonic acid metabolic pathway
Cui LZ, Zhao YW, Pan Y, Zheng X, Shao D, Jia Y, He K, Li K, Chen L
OncoTargets and Therapy 2017, 10:5817-5826
Published Date: 8 December 2017
Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies
Zhu J, Miao C, Liu S, Tian Y, Zhang C, Liang C, Xu A, Cao Q, Wang Z
OncoTargets and Therapy 2017, 10:5805-5816
Published Date: 6 December 2017
The combination astemizole–gefitinib as a potential therapy for human lung cancer
Chávez-López MDG, Zúñiga-García V, Hernández-Gallegos E, Vera E, Chasiquiza-Anchatuña CA, Viteri-Yánez M, Sanchez-Ramos J, Garrido E, Camacho J
OncoTargets and Therapy 2017, 10:5795-5803
Published Date: 6 December 2017
CircRNA_100782 regulates pancreatic carcinoma proliferation through the IL6-STAT3 pathway
Chen G, Shi Y, Zhang Y, Sun J
OncoTargets and Therapy 2017, 10:5783-5794
Published Date: 5 December 2017
Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy
Zhong W, Zhang L, Ma J, Shao S, Lin R, Li X, Xiong G, Fang D, Zhou L
OncoTargets and Therapy 2017, 10:5775-5782
Published Date: 5 December 2017
Hopea odorata extract inhibits hepatocellular carcinoma via induction of caspase-dependent apoptosis
Nguyen ST, Huynh KL, Nguyen HL, Nguyen Thi Thanh M, Nguyen Trung N, Nguyen Xuan H, Ngoc KP, Truong Dinh K, Pham PV
OncoTargets and Therapy 2017, 10:5765-5774
Published Date: 4 December 2017
Differential radiation response between normal astrocytes and glioma cells revealed by comparative transcriptome analysis
Gong L, Gu JC, Ge JW, Wu X, Zhang C, Yang C, Weng WJ, Gao GY, Feng JF, Mao Q
OncoTargets and Therapy 2017, 10:5755-5764
Published Date: 4 December 2017
Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
Qi X, Jia B, Zhao X, Yu D
OncoTargets and Therapy 2017, 10:5745-5754
Published Date: 1 December 2017
Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
Huang L, Liu Q, Chen S, Shao ZM
OncoTargets and Therapy 2017, 10:5739-5744
Published Date: 1 December 2017
Predictive value of interim PET/CT visual interpretation in the prognosis of patients with aggressive non-Hodgkin’s lymphoma
Liao CC, Qin YY, Tan XH, Hu JJ, Tang Q, Rong Y, Cen H, Li LQ
OncoTargets and Therapy 2017, 10:5727-5738
Published Date: 30 November 2017
Low expression of DAB2IP predicts an unfavorable prognosis in human bladder carcinoma
Zheng L, Chen K, Zhu L, Su D, Cheng G
OncoTargets and Therapy 2017, 10:5719-5726
Published Date: 29 November 2017
Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer
Li P, Dong J, Zhou X, Sun W, Huang H, Chen T, Ye B, Zheng Z, Lu M
OncoTargets and Therapy 2017, 10:5711-5718
Published Date: 28 November 2017
Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo
Mori Y, Shirai T, Terauchi R, Tsuchida S, Mizoshiri N, Hayashi D, Arai Y, Kishida T, Mazda O, Kubo T
OncoTargets and Therapy 2017, 10:5703-5710
Published Date: 28 November 2017
Diagnostic significance of circulating long noncoding RNA PCAT6 in patients with non-small cell lung cancer
Wan L, Zhang L, Fan K, Wang JJ
OncoTargets and Therapy 2017, 10:5695-5702
Published Date: 28 November 2017
PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer
Li H, Sun G, Liu C, Wang J, Jing R, Wang J, Zhao X, Xu X, Yang Y
OncoTargets and Therapy 2017, 10:5685-5694
Published Date: 27 November 2017
The combination of systemic therapy and locoregional radiotherapy prolongs survival in newly diagnosed metastatic nasopharyngeal carcinoma patients
Yin Z, Zhang X, Wang Y, Wang P, Yuan Z
OncoTargets and Therapy 2017, 10:5677-5683
Published Date: 27 November 2017
MicroRNA-211 promotes non-small-cell lung cancer proliferation and invasion by targeting MxA
Kang M, Shi J, Peng N, He S
OncoTargets and Therapy 2017, 10:5667-5675
Published Date: 28 November 2017
The combination therapy of salinomycin and gefitinib using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells
Zhang Y, Zhang Q, Sun J, Liu H, Li Q
OncoTargets and Therapy 2017, 10:5653-5666
Published Date: 27 November 2017
18F-fluorodeoxyglucose uptake predicts MET expression in lung adenocarcinoma
An S, Zhou X, Liu J, Huang G
OncoTargets and Therapy 2017, 10:5643-5651
Published Date: 27 November 2017
Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism
Markowitz D, Ha G, Ruggieri R, Symons M
OncoTargets and Therapy 2017, 10:5633-5642
Published Date: 24 November 2017
Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer
He L, Zhang S, Zhang X, Liu R, Guan H, Zhang H
OncoTargets and Therapy 2017, 10:5621-5631
Published Date: 24 November 2017
RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer
Xie SY, Li G, Han C, Yu YY, Li N
OncoTargets and Therapy 2017, 10:5605-5619
Published Date: 23 November 2017
Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma
Feng SD, Mao ZM, Liu CY, Nie YS, Sun B, Guo MG, Su CQ
OncoTargets and Therapy 2017, 10:5591-5604
Published Date: 23 November 2017
Clinical application of carbon nanoparticles in curative resection for colorectal carcinoma
Wang LY, Li JH, Zhou X, Zheng QC, Cheng X
OncoTargets and Therapy 2017, 10:5585-5589
Published Date: 22 November 2017
Lymphocyte-to-monocyte ratio before chemoradiotherapy represents a prognostic predictor for locally advanced rectal cancer
Deng YX, Lin JZ, Peng JH, Zhao YJ, Sui QQ, Wu XJ, Lu ZH, Gao YH, Zeng ZF, Pan ZZ
OncoTargets and Therapy 2017, 10:5575-5583
Published Date: 22 November 2017
The clinical significance of CXCL5 in non-small cell lung cancer
Wu K, Yu S, Liu Q, Bai X, Zheng X, Wu K
OncoTargets and Therapy 2017, 10:5561-5573
Published Date: 21 November 2017
Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis
Zhao F, Ge YZ, Zhou LH, Xu LW, Xu Z, Ping WW, Wang M, Zhou CC, Wu R, Jia RP
OncoTargets and Therapy 2017, 10:5551-5559
Published Date: 22 November 2017
Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ
Cui J, Chen S, Bo Q, Wang S, Zhang N, Yu M, Wang W, Han J, Zhu Y, Shi B
OncoTargets and Therapy 2017, 10:5541-5550
Published Date: 21 November 2017
Prognostic and clinicopathological significance of ubiquitin-specific protease 22 overexpression in cancers: evidence from a meta-analysis
Ao N, Wang L, Liu Y
OncoTargets and Therapy 2017, 10:5533-5540
Published Date: 21 November 2017
The relationship between IGF2BP2 and PPARG polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population
Qiu H, Wang Y, Kang M, Ding H, Liu C, Tang W, Xiao Z, Chen Y
OncoTargets and Therapy 2017, 10:5525-5532
Published Date: 21 November 2017
The crossroads of breast cancer progression: insights into the modulation of major signaling pathways
Velloso FJ, Bianco AFR, Farias JO, Torres NEC, Ferruzo PY, Anschau V, Jesus-Ferreira HC, Chang TH, Sogayar MC, Zerbini LF, Correa RG
OncoTargets and Therapy 2017, 10:5491-5524
Published Date: 20 November 2017
Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma [Corrigendum]
Zhang MC, Yan ZL, Wang JJ, Yao XQ
OncoTargets and Therapy 2017, 10:5489-5490
Published Date: 16 November 2017
Cytomembranic PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma
Zheng L, Cao C, Cheng G, Hu Q, Chen X
OncoTargets and Therapy 2017, 10:5483-5487
Published Date: 16 November 2017
Curcumin potentiates the potent antitumor activity of ACNU against glioblastoma by suppressing the PI3K/AKT and NF-κB/COX-2 signaling pathways
Zhao J, Zhu J, Lv X, Xing J, Liu S, Chen C, Xu Y
OncoTargets and Therapy 2017, 10:5471-5482
Published Date: 15 November 2017
Identification of COX5B as a novel biomarker in high-grade glioma patients
Hu T, Xi J
OncoTargets and Therapy 2017, 10:5463-5470
Published Date: 15 November 2017
Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature
Zhang L, Zhang C, Yang Z, He M, Zhang L, Ezzat S, Liang X
OncoTargets and Therapy 2017, 10:5459-5462
Published Date: 14 November 2017
Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma
Li Z, Li Y, Yan S, Fu J, Zhou Q, Huang X, Shen L
OncoTargets and Therapy 2017, 10:5445-5458
Published Date: 14 November 2017
Clinical significance of CMTM4 expression in hepatocellular carcinoma
Bei CH, Zhang Y, Wei RM, Zhu XN, Wang ZG, Zeng W, Chen QY, Tan SK
OncoTargets and Therapy 2017, 10:5439-5443
Published Date: 14 November 2017
The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis
Lu J, Li H, Guo P, Shen R, Luo Y, Ge Q, Shi WF, Li Y, Zhu W
OncoTargets and Therapy 2017, 10:5429-5437
Published Date: 13 November 2017
Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms
Ye X, Chen D, Zheng Y, Zhu X, Fu J, Huang J
OncoTargets and Therapy 2017, 10:5425-5428
Published Date: 13 November 2017
Expression and significance of B7-H3 and Tie-2 in the tumor vasculature of clear cell renal carcinoma
Zhang X, Ji J, Zhang G, Fang C, Jiang F, Ma S, Hou J
OncoTargets and Therapy 2017, 10:5417-5424
Published Date: 13 November 2017
In vitro study on anti-cancer properties of genistein in tongue cancer
Ardito F, Pellegrino MR, Perrone D, Troiano G, Cocco A, Lo Muzio L
OncoTargets and Therapy 2017, 10:5405-5415
Published Date: 13 November 2017
Therapeutic efficacy and safety of combined BRAF and MEK inhibition in patients with malignant melanoma: a meta-analysis
Chen P, Chen FC, Zhou BH
OncoTargets and Therapy 2017, 10:5391-5403
Published Date: 13 November 2017
LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194
An J, Lv W, Zhang Y
OncoTargets and Therapy 2017, 10:5377-5390
Published Date: 10 November 2017
The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis
Chen X, Cheng J, Huang A, Zhang X, Wang J, Fan J, Zhou J, Yang X
OncoTargets and Therapy 2017, 10:5363-5375
Published Date: 10 November 2017
LncRNA expression and implication in osteosarcoma: a systematic review and meta-analysis
Wang Y, Huang YL, Xiang P, Tian W
OncoTargets and Therapy 2017, 10:5355-5361
Published Date: 9 November 2017
Amatuximab and novel agents targeting mesothelin for solid tumors
Baldo P, Cecco S
OncoTargets and Therapy 2017, 10:5337-5353
Published Date: 8 November 2017
Interleukin-6 upregulates SOX18 expression in osteosarcoma
Wu Z, Yang W, Liu J, Zhang F
OncoTargets and Therapy 2017, 10:5329-5336
Published Date: 8 November 2017
FGF2 promotes metastasis of uveal melanoma cells via store-operated calcium entry
Wang Y, Bao X, Zhang Z, Sun Y, Zhou X
OncoTargets and Therapy 2017, 10:5317-5328
Published Date: 8 November 2017
Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based database
Wang S, Gao W, Chen S, Bai L, Luo L, Zheng X, Luo Y
OncoTargets and Therapy 2017, 10:5311-5315
Published Date: 8 November 2017
UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis
Wang B, Shen J, Wang J
OncoTargets and Therapy 2017, 10:5303-5309
Published Date: 6 November 2017
The associations between common SNPs of EFEMP1 gene and glioma risk in Chinese population
Hu J, Dong D, Lu DD
OncoTargets and Therapy 2017, 10:5297-5302
Published Date: 6 November 2017
Analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients
Liu XJ, Song YC, Liang P, Su TS, Zhang HJ, Zhao XZ, Yuan ZY, Wang P
OncoTargets and Therapy 2017, 10:5289-5295
Published Date: 6 November 2017
PUMA mediates the anti-cancer effect of osimertinib in colon cancer cells
Guo L, Huang S, Wang X
OncoTargets and Therapy 2017, 10:5281-5288
Published Date: 3 November 2017
S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma
Katono K, Sato Y, Kobayashi M, Nagashio R, Ryuge S, Igawa S, Ichinoe M, Murakumo Y, Saegusa M, Masuda N
OncoTargets and Therapy 2017, 10:5273-5279
Published Date: 2 November 2017
Association of GEMIN4 gene polymorphism and the risk of cancer: a meta-analysis
Wu N, Zhang X, Tian J, Yu S, Qiao Y
OncoTargets and Therapy 2017, 10:5263-5271
Published Date: 2 November 2017
Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma
Li YJ, Yao K, Lu MX, Zhang WB, Xiao C, Tu CQ
OncoTargets and Therapy 2017, 10:5255-5261
Published Date: 2 November 2017
Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia
Huang R, Liao XW, Li Q
OncoTargets and Therapy 2017, 10:5243-5254
Published Date: 2 November 2017
Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report
Ma FC, Yu Q, Zeng ZM, He RQ, Mo CH, Zhong JC, Ma J, Feng ZB, Chen G, Hu XH
OncoTargets and Therapy 2017, 10:5237-5242
Published Date: 1 November 2017
MicroRNAs as a novel class of diagnostic biomarkers for the detection of osteosarcoma: a meta-analysis
Liu H, Li P, Chen L, Jian C, Li ZH, Yu AX
OncoTargets and Therapy 2017, 10:5229-5236
Published Date: 1 November 2017
Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis
Gao XL, Zhang M, Tang YL, Liang XH
OncoTargets and Therapy 2017, 10:5219-5228
Published Date: 27 October 2017
Matrine suppresses the migration and invasion of NSCLC cells by inhibiting PAX2-induced epithelial-mesenchymal transition
Yang J, He D, Peng Y, Zhong HZ, Deng YH, Yu Z, Guan C, Zuo Y, Xu Z
OncoTargets and Therapy 2017, 10:5209-5217
Published Date: 27 October 2017
Current status of poly(ADP-ribose) polymerase inhibitors and future directions
Ohmoto A, Yachida S
OncoTargets and Therapy 2017, 10:5195-5208
Published Date: 26 October 2017
The expression profile and clinical significance of circRNA0003906 in colorectal cancer
Zhuo F, Lin HS, Chen ZX, Huang ZJ, Hu JP
OncoTargets and Therapy 2017, 10:5187-5193
Published Date: 25 October 2017
Frequency and clinical relevance of EGFR mutations and EML4–ALK translocations in octogenarians with non-small cell lung cancer
Tufman A, Kahnert K, Duell T, Kauffmann-Guerrero D, Milger K, Schneider C, Stump J, Syunyaeva Z, Huber RM, Reu S
OncoTargets and Therapy 2017, 10:5179-5186
Published Date: 25 October 2017
Impact of hypertrophic pulmonary osteoarthropathy on patients with lung cancer
Fang YH, Hsu CC, Hsieh MJ, Hung MS, Tsai YH, Lin YC
OncoTargets and Therapy 2017, 10:5173-5177
Published Date: 25 October 2017
Low-grade central osteosarcoma in proximal humerus: a rare entity
Tang F, Min L, Zhou Y, Luo Y, Tu CQ
OncoTargets and Therapy 2017, 10:5165-5172
Published Date: 24 October 2017
Overexpression of MPC1 inhibits the proliferation, migration, invasion, and stem cell-like properties of gastric cancer cells
Zhou X, Xiong ZJ, Xiao SM, Zhou J, Ding Z, Tang LC, Chen XD, Xu R, Zhao P
OncoTargets and Therapy 2017, 10:5151-5163
Published Date: 24 October 2017
LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis
Wang P, Chen D, Ma H, Li Y
OncoTargets and Therapy 2017, 10:5137-5149
Published Date: 25 October 2017
Increased histone deacetylase 6 expression serves as a favorable prognostic factor for diffuse large B-cell lymphoma
Lin X, Cai L, Qian Z, Wang C, Sun N, Sun X, Huang H, Guo W, Lin H, Yao R
OncoTargets and Therapy 2017, 10:5129-5136
Published Date: 24 October 2017
Long noncoding RNA and mRNA profiling in MDA-MB-231 cells following RNAi-mediated knockdown of SIRT7
Chen KL, Li L, Wang YR, Li CM, Badri TM, Wang GL
OncoTargets and Therapy 2017, 10:5115-5128
Published Date: 24 October 2017
Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer
Ichiki M, Wataya H, Yamada K, Tsuruta N, Takeoka H, Okayama Y, Sasaki J, Hoshino T
OncoTargets and Therapy 2017, 10:5107-5113
Published Date: 24 October 2017
The matrix metalloproteinase and insulin-like growth factor system in oral cancer – a prospective clinical study
Schiegnitz E, Kämmerer PW, Schön H, Gülle C, Berres M, Sagheb K, Al-Nawas B
OncoTargets and Therapy 2017, 10:5099-5105
Published Date: 24 October 2017
Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports
Xie HJ, Xie B, Liu CY, Wang J, Xu Y
OncoTargets and Therapy 2017, 10:5089-5097
Published Date: 24 October 2017
Developing a novel dual PI3K–mTOR inhibitor from the prodrug of a metabolite
Zhou Y, Zhang GY, Wang F, Wang J, Ding YW, Li XY, Shi CT, Li JK, Shih CK, You S
OncoTargets and Therapy 2017, 10:5077-5087
Published Date: 20 October 2017
FcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer
Wang D, Wei X, Wang Z, Lu Y, Shi S, Wang N, Qiu M, Wang F, Wang RJ, Li Y, Xu R
OncoTargets and Therapy 2017, 10:5065-5076
Published Date: 19 October 2017
Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma
Gerendash BS, Creel PA
OncoTargets and Therapy 2017, 10:5053-5064
Published Date: 19 October 2017
Adult acute megakaryoblastic leukemia: rare association with cytopenias of undetermined significance and p210 and p190 BCR–ABL transcripts
Dima D, Oprita L, Rosu AM, Trifa A, Selicean C, Moisoiu V, Frinc I, Zdrenghea M, Tomuleasa C
OncoTargets and Therapy 2017, 10:5047-5051
Published Date: 19 October 2017
Clinical significance of Fusobacterium nucleatum, epithelial–mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients
Yan X, Liu L, Li H, Qin H, Sun Z
OncoTargets and Therapy 2017, 10:5031-5046
Published Date: 17 October 2017
Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4
Buzzoni R, Carnaghi C, Strosberg J, Fazio N, Singh S, Herbst F, Ridolfi A, Pavel ME, Wolin EM, Valle JW, Oh DY, Yao JC, Pommier R
OncoTargets and Therapy 2017, 10:5013-5030
Published Date: 16 October 2017
Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis
Zhuan-Sun Y, Huang F, Feng M, Zhao X, Chen W, Zhu Z, Zhang S
OncoTargets and Therapy 2017, 10:5005-5012
Published Date: 16 October 2017
Novel strategy of stents in thyroid mass: a case series report of managing severely dyspneic patients
Bhandari A, Wang Y, Lv S, Xia E, Wang O
OncoTargets and Therapy 2017, 10:4997-5004
Published Date: 16 October 2017
Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study
Xu J, Liu X, Yang S, Zhang X, Shi Y
OncoTargets and Therapy 2017, 10:4989-4995
Published Date: 13 October 2017
Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients
Daoud MA, Aboelnaga EM, Alashry MS, Fathy S, Aletreby MA
OncoTargets and Therapy 2017, 10:4981-4988
Published Date: 12 October 2017
Mutation analysis and copy number alterations of KIF23 in non-small-cell lung cancer exhibiting KIF23 over-expression
Vikberg AL, Vooder T, Lokk K, Annilo T, Golovleva I
OncoTargets and Therapy 2017, 10:4969-4979
Published Date: 11 October 2017
Molecular alterations and clinical prognostic factors for cholangiocarcinoma in Thai population
Trachu N, Sirachainan E, Larbcharoensub N, Rattanadech W, Detarkom S, Monnamo N, Kamprerasart K, MunTham D, Sukasem C, Reungwetwattana T
OncoTargets and Therapy 2017, 10:4955-4968
Published Date: 11 October 2017
Upregulation of long noncoding RNA LOC440040 promotes tumor progression and predicts poor prognosis in patients with prostate cancer
Zhang C, Liu C, Wu J, Zheng Y, Xu H, Cheng G, Hua L
OncoTargets and Therapy 2017, 10:4945-4954
Published Date: 11 October 2017
The expression of microRNA-324-3p as a tumor suppressor in nasopharyngeal carcinoma and its clinical significance
Zhang H, Sun Y, Li J, Huang L, Tan S, Yang F, Li H
OncoTargets and Therapy 2017, 10:4935-4943
Published Date: 11 October 2017
Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysis
Singh AN, Sharma N
OncoTargets and Therapy 2017, 10:4925-4933
Published Date: 10 October 2017
Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia
Song Y, Peng P, Qiao C, Zhang R, Li J, Lu H
OncoTargets and Therapy 2017, 10:4917-4924
Published Date: 9 October 2017
NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2
Ding N, Wu H, Tao T, Peng E
OncoTargets and Therapy 2017, 10:4905-4915
Published Date: 6 October 2017
let-7d suppresses proliferation and invasion and promotes apoptosis of meningioma by targeting AEG-1
Li H, Zhao J
OncoTargets and Therapy 2017, 10:4895-4904
Published Date: 6 October 2017
Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib
Koutsoukos K, Bamias A, Tzannis K, Espinosa Montaño M, Bozionelou V, Christodoulou C, Stefanou D, Kalofonos H, Duran I, Papazisis K
OncoTargets and Therapy 2017, 10:4885-4893
Published Date: 6 October 2017
Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents
Ayoub NM, Al-Shami KM, Alqudah MA, Mhaidat NM
OncoTargets and Therapy 2017, 10:4869-4883
Published Date: 5 October 2017
ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy
Song F, Zhang J, Li S, Wu J, Jin T, Qin J, Wang Y, Wang M, Xu J
OncoTargets and Therapy 2017, 10:4859-4867
Published Date: 3 October 2017
TERT-CLPTM1 locus polymorphism (rs401681) is associated with the prognosis of hepatocellular carcinoma
Lee HW, Park W, Heo Y, Park TI, Park SY, Lee J
OncoTargets and Therapy 2017, 10:4853-4858
Published Date: 3 October 2017
Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer
Shi T, Jiang R, Wang P, Xu Y, Yin S, Cheng X, Zang R
OncoTargets and Therapy 2017, 10:4841-4851
Published Date: 3 October 2017
Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta-analysis
Zhang M, Ma H, Zhang J, He L, Ye X, Li X
OncoTargets and Therapy 2017, 10:4829-4839
Published Date: 3 October 2017
Theranostics in nuclear medicine practice
Yordanova A, Eppard E, Kürpig S, Bundschuh RA, Schönberger S, Gonzalez-Carmona M, Feldmann G, Ahmadzadehfar H, Essler M
OncoTargets and Therapy 2017, 10:4821-4828
Published Date: 3 October 2017
Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1
Li S, Yan T, Deng R, Jiang X, Xiong H, Wang Y, Yu Q, Wang X, Chen C, Zhu Y
OncoTargets and Therapy 2017, 10:4809-4819
Published Date: 3 October 2017
Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?
Rabinowits G
OncoTargets and Therapy 2017, 10:4803-4807
Published Date: 28 September 2017
Clinicopathological features and prognoses in younger and older patients with gastric cancer
Song S, Li C, Li S, Cong X, Xue Y
OncoTargets and Therapy 2017, 10:4795-4802
Published Date: 27 September 2017
Sitting time and occupational and recreational physical activity in relation to the risk of esophageal squamous cell carcinoma
Chen P, Song Q, Han J, Xu H, Chen T, Xu J, Cheng Y
OncoTargets and Therapy 2017, 10:4787-4794
Published Date: 27 September 2017
Yttrium-90 radioembolization of unresectable hepatocellular carcinoma – a single center experience
Meyer C, Pieper CC, Ahmadzadehfar H, Lampe NA, Matuschek EME, Maschke TA, Enkirch SJ, Essler M, Spengler U, Schild HH
OncoTargets and Therapy 2017, 10:4773-4785
Published Date: 26 September 2017
Molecular classification of esophagogastric junction carcinoma correlated with prognosis
Zou L, Wu Y, Ma K, Fan Y, Dong D, Geng N, Li E
OncoTargets and Therapy 2017, 10:4765-4772
Published Date: 25 September 2017
HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a
Wang Q, Jiang S, Song A, Hou S, Wu Q, Qi L, Gao X
OncoTargets and Therapy 2017, 10:4753-4763
Published Date: 28 September 2017
DNA hypermethylated status and gene expression of PAX1/SOX1 in patients with colorectal carcinoma
Huang J, Tan ZR, Yu J, Li H, Lv Q, Shao Y, Zhou H
OncoTargets and Therapy 2017, 10:4739-4751
Published Date: 26 September 2017
Characteristics and mutation analysis of Ph-positive leukemia patients with T315I mutation receiving tyrosine kinase inhibitors
Xu PP, Guo D, Shao XY, Peng MX, Chen B
OncoTargets and Therapy 2017, 10:4731-4738
Published Date: 25 September 2017
Quercetin inhibits epithelial–mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial–mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells
Yu D, Ye T, Xiang Y, Shi Z, Zhang J, Lou B, Zhang F, Chen B, Zhou M
OncoTargets and Therapy 2017, 10:4719-4729
Published Date: 25 September 2017
Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors
Ma Z, Huang H, Xu Y, He X, Wang J, Hui B, Ji H, Zhou J, Wang K
OncoTargets and Therapy 2017, 10:4711-4717
Published Date: 25 September 2017
RNAi-mediated knockdown of CAIX enhances the radiosensitivity of nasopharyngeal carcinoma cell line, CNE-2
Jiang L, Xu G, Li Z, Zeng X, Li Z, Liu J, Mei L, Li X
OncoTargets and Therapy 2017, 10:4701-4709
Published Date: 25 September 2017
High expression of Sam68 in sacral chordomas is associated with worse clinical outcomes
Wen H, Li P, Ma H, Zheng J, Yu Y, Lv G
OncoTargets and Therapy 2017, 10:4691-4700
Published Date: 22 September 2017
Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature review
Zhang Y, Qi Y, Wang A, Ma B, Fu X, Zhao L, Gao Q
OncoTargets and Therapy 2017, 10:4687-4690
Published Date: 22 September 2017
Targeting the androgen receptor in triple-negative breast cancer: current perspectives
Mina A, Yoder R, Sharma P
OncoTargets and Therapy 2017, 10:4675-4685
Published Date: 20 September 2017
Clinical significance of SLP-2 in hepatocellular carcinoma tissues and its regulation in cancer cell proliferation, migration, and EMT
Huang Y, Chen Y, Lin X, Lin Q, Han M, Guo G
OncoTargets and Therapy 2017, 10:4665-4673
Published Date: 20 September 2017
DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy
Carloni S, Gallerani G, Tesei A, Scarpi E, Verdecchia GM, Virzì S, Fabbri F, Arienti C
OncoTargets and Therapy 2017, 10:4657-4664
Published Date: 20 September 2017
The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis
Pang Q, Jin H, Qu K, Man Z, Wang Y, Yang S, Zhou L, Liu H
OncoTargets and Therapy 2017, 10:4645-4656
Published Date: 20 September 2017
HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma
Maroto P, Esteban E, Fernández Parra E, Mendez-Vidal MJ, Domenech M, Pérez-Valderrama B, Calderero V, Pérez-Gracia JL, Grande E, Algaba F
OncoTargets and Therapy 2017, 10:4635-4643
Published Date: 20 September 2017
NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy
Chang B, Park MJ, Choi SI, In KH, Kim CH, Lee SH
OncoTargets and Therapy 2017, 10:4625-4633
Published Date: 19 September 2017
The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer
Mahecha AM, Wang H
OncoTargets and Therapy 2017, 10:4617-4624
Published Date: 19 September 2017
Effect of temozolomide on survival in elderly patients with glioblastoma and impaired performance status: a propensity score-matching analysis [Corrigendum]
Liu Y, Liu P, Shao W, Du H, Li Z, Guo C, Li Z
OncoTargets and Therapy 2017, 10:4615-4616
Published Date: 18 September 2017
EGFR with TKI-sensitive mutations in exon 19 is highly expressed and frequently detected in Chinese patients with lung squamous carcinoma
Memon AA, Zhang HP, Gu Y, Luo Q, Shi JJ, Deng Z, Ma J, Ma W
OncoTargets and Therapy 2017, 10:4607-4613
Published Date: 18 September 2017
Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy
Sunakawa Y, Izawa N, Mizukami T, Horie Y, Hirakawa M, Arai H, Ogura T, Tsuda T, Nakajima TE
OncoTargets and Therapy 2017, 10:4599-4605
Published Date: 15 September 2017
Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis
Meng Q, Shi S, Liang C, Liang D, Xu W, Ji S, Zhang B, Ni Q, Xu J, Yu X
OncoTargets and Therapy 2017, 10:4591-4598
Published Date: 15 September 2017
DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival
Banas T, Pitynski K, Okon K, Czerw A
OncoTargets and Therapy 2017, 10:4579-4589
Published Date: 14 September 2017
Polygonatum odoratum lectin promotes BECN1 expression and induces autophagy in malignant melanoma by regulation of miR1290
Luan W, Qian Y, Ni X, Chanda TK, Xia Y, Wang J, Yan Y, Xu B
OncoTargets and Therapy 2017, 10:4569-4577
Published Date: 14 September 2017
CYP19A1 gene polymorphism and colorectal cancer etiology in Saudi population: case–control study
Al-Mukaynizi FB, Alanazi M, Al-Daihan S, Parine NR, Almadi M, Aljebreen A, Azzam N, Alharbi O, Arafah M, Warsy A
OncoTargets and Therapy 2017, 10:4559-4567
Published Date: 14 September 2017
Case report of a KIT-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapy
Luo C, Shen JY, Ying J, Fang XH, Wang XH, Fu ZX, Liu P
OncoTargets and Therapy 2017, 10:4553-4557
Published Date: 14 September 2017
Clinicopathological significance of HSP27 in gastric cancer: a meta-analysis
Ge H, He X, Guo L, Yang X
OncoTargets and Therapy 2017, 10:4543-4551
Published Date: 13 September 2017
Anaplastic lymphoma kinase inhibition in metastatic non-small cell lung cancer: clinical impact of alectinib
Muller IB, de Langen AJ, Giovannetti E, Peters GJ
OncoTargets and Therapy 2017, 10:4535-4541
Published Date: 13 September 2017
Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
Tang Y, Qiao G, Xu E, Xuan Y, Liao M, Yin G
OncoTargets and Therapy 2017, 10:4527-4534
Published Date: 12 September 2017
Adenocarcinoma of the lung with EGFR gene mutation and subsequent resistance mechanisms exploration: case report
Xu L, Wang QZ, Wu L
OncoTargets and Therapy 2017, 10:4517-4525
Published Date: 12 September 2017
The non-small cell lung cancer EGFR extracellular domain mutation, M277E, is oncogenic and drug-sensitive
Yu S, Zhang Y, Pan YJ, Cheng C, Sun YH, Chen HQ
OncoTargets and Therapy 2017, 10:4507-4515
Published Date: 12 September 2017
Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
Liao X, Huang K, Huang R, Liu X, Han C, Yu L, Yu T, Yang C, Wang X, Peng T
OncoTargets and Therapy 2017, 10:4493-4506
Published Date: 12 September 2017
Predictive factors and prognosis for recurrent laryngeal nerve invasion in papillary thyroid carcinoma
Chen W, Lei J, You J, Lei Y, Li Z, Gong R, Tang H, Zhu J
OncoTargets and Therapy 2017, 10:4485-4491
Published Date: 11 September 2017
Cervical level IIb metastases in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis
Kou Y, Zhao T, Huang S, Liu J, Duan W, Wang Y, Wang Z, Li D, Ning C, Sun C
OncoTargets and Therapy 2017, 10:4475-4483
Published Date: 11 September 2017
Oncogenic role of microRNA-20a in human multiple myeloma
Wang T, Tao W, Zhang L, Li SL
OncoTargets and Therapy 2017, 10:4465-4474
Published Date: 11 September 2017
miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells
Li X, Li Y, Wan L, Chen R, Chen F
OncoTargets and Therapy 2017, 10:4455-4464
Published Date: 11 September 2017
Targeted interfering DEP domain containing 1 protein induces apoptosis in A549 lung adenocarcinoma cells through the NF-κB signaling pathway
Wang Q, Li A, Jin J, Huang G
OncoTargets and Therapy 2017, 10:4443-4454
Published Date: 11 September 2017
Intraoperative measurement of thyroglobulin in lymph node aspirates for the detection of metastatic papillary thyroid carcinoma
Wang Y, Liu Y, Wang X, Li X, Jiang R, He X
OncoTargets and Therapy 2017, 10:4435-4441
Published Date: 11 September 2017
Prognostic immune-related gene models for breast cancer: a pooled analysis
Zhao J, Wang Y, Lao Z, Liang S, Hou J, Yu Y, Yao H, You N, Chen K
OncoTargets and Therapy 2017, 10:4423-4433
Published Date: 11 September 2017
Targeted inhibition of the phosphoinositide 3-kinase impairs cell proliferation, survival, and invasion in colon cancer
Yang F, Gao JY, Chen H, Du ZH, Zhang XQ, Gao W
OncoTargets and Therapy 2017, 10:4413-4422
Published Date: 11 September 2017
Marketed drugs used for the management of hypercholesterolemia as anticancer armament
Papanagnou P, Stivarou T, Papageorgiou I, Papadopoulos GE, Pappas A
OncoTargets and Therapy 2017, 10:4393-4411
Published Date: 8 September 2017
Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway
Hu B, Lv X, Gao F, Chen S, Wang S, Qing X, Liu J, Wang B, Shao Z
OncoTargets and Therapy 2017, 10:4379-4391
Published Date: 8 September 2017
Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population
Lin Y, Fu F, Chen Y, Qiu W, Lin S, Yang P, Huang M, Wang C
OncoTargets and Therapy 2017, 10:4369-4378
Published Date: 7 September 2017
Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt’s lymphoma and acute lymphoblastic leukemia
Weagel EG, Meng W, Townsend MH, Velazquez EJ, Brog RA, Boyer MW, Weber KS, Robison RA, O'Neill KL
OncoTargets and Therapy 2017, 10:4355-4367
Published Date: 6 September 2017
Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report
Jovanovic D, Stevic R, Velinovic M, Kontic M, Maric D, Spasic J, Radosavljevic D
OncoTargets and Therapy 2017, 10:4347-4354
Published Date: 6 September 2017
Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma
Zhang MC, Yan ZL, Wang JJ, Yao XQ
OncoTargets and Therapy 2017, 10:4339-4346
Published Date: 1 September 2017
Inhibitory effects of a selective Jak2 inhibitor on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT20 cells
Asari Y, Kageyama K, Nakada Y, Tasso M, Takayasu S, Niioka K, Ishigame N, Daimon M
OncoTargets and Therapy 2017, 10:4329-4338
Published Date: 1 September 2017
Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression in gastric cancer: a systematic review and meta-analysis
Liu G, Xiong DS, Zeng JJ, Chen BR, Huang ZJ
OncoTargets and Therapy 2017, 10:4321-4328
Published Date: 1 September 2017
The role and significance of VEGFR2+ regulatory T cells in tumor immunity
Zhu PR, Hu CX, Hui KY, Jiang XD
OncoTargets and Therapy 2017, 10:4315-4319
Published Date: 1 September 2017
Nuclear factor-kappa B1 inhibits early apoptosis of glioma cells by promoting the expression of Bcl-2
Yang TQ, Chen M, Wang YQ, Xu W, Han Y, Xu J, Xiang YJ, Yuan B, Wang HZ, Zhou YX
OncoTargets and Therapy 2017, 10:4305-4313
Published Date: 31 August 2017
Improvement of survival for non-small cell lung cancer over time
Xia W, Yu X, Mao Q, Xia W, Wang A, Dong G, Chen B, Ma W, Xu L, Jiang F
OncoTargets and Therapy 2017, 10:4295-4303
Published Date: 29 August 2017
Synaptotagmin-7 is overexpressed in hepatocellular carcinoma and regulates hepatocellular carcinoma cell proliferation via Chk1–p53 signaling
Jin H, Xu G, Zhang Q, Pang Q, Fang M
OncoTargets and Therapy 2017, 10:4283-4293
Published Date: 29 August 2017
Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer
Liang S, Xu K, Niu L, Wang X, Liang Y, Zhang M, Chen J, Lin M
OncoTargets and Therapy 2017, 10:4273-4281
Published Date: 28 August 2017
Apatinib in the treatment of advanced lung adenocarcinoma with KRAS mutation
Zeng D, Wang C, Huang J, Jiang J
OncoTargets and Therapy 2017, 10:4269-4272
Published Date: 28 August 2017
Continuous EGFR tyrosine kinase inhibitor treatment with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients
Peng L, Wang YN, Tang YM, Zeng L, Liu JF, Zeng Z, Liu J, Shi P, Ye XH, Zhao Q
OncoTargets and Therapy 2017, 10:4261-4267
Published Date: 28 August 2017
LEF1-AS1, a long non-coding RNA, promotes malignancy in glioblastoma
Wang J, Liu X, Yan C, Liu J, Wang S, Hong Y, Gu A, Zhao P
OncoTargets and Therapy 2017, 10:4251-4260
Published Date: 28 August 2017
Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors
Creelan BC, Gabrilovich DI, Gray JE, Williams CC, Tanvetyanon T, Haura EB, Weber JS, Gibney GT, Markowitz J, Proksch JW, Reisman SA, McKee MD, Chin MP, Meyer CJ, Antonia SJ
OncoTargets and Therapy 2017, 10:4239-4250
Published Date: 29 August 2017
miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples
Braicu OL, Budisan L, Buiga R, Jurj A, Achimas-Cadariu P, Pop LA, Braicu C, Irimie A, Berindan-Neagoe I
OncoTargets and Therapy 2017, 10:4225-4238
Published Date: 28 August 2017
Initial experience of correlating diffusion spectral parameters with histopathologic indexes in murine colorectal tumor homografts
Zhang XY, Li XT, Sun J, Sun YS
OncoTargets and Therapy 2017, 10:4213-4223
Published Date: 26 August 2017
HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer
Cao S, Sun J, Lin S, Zhao L, Wu D, Liang T, Sheng W
OncoTargets and Therapy 2017, 10:4205-4211
Published Date: 26 August 2017
Investigation of proliferation and migration of tongue squamous cell carcinoma promoted by three chemokines, MIP-3α, MIP-1β, and IP-10
Chu H, Jia B, Qiu X, Pan J, Sun X, Wang Z, Zhao J
OncoTargets and Therapy 2017, 10:4193-4203
Published Date: 29 August 2017
Clinical applications of dendritic cells–cytokine-induced killer cells mediated immunotherapy for pancreatic cancer: an up-to-date meta-analysis
Zhang YC, Zhang X, Zhang AQ, Li K, Qu K
OncoTargets and Therapy 2017, 10:4173-4192
Published Date: 23 August 2017
miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer
Ma M, Chen S, Liu Z, Xie H, Deng H, Shang S, Wang X, Xia M, Zuo C
OncoTargets and Therapy 2017, 10:4161-4171
Published Date: 22 August 2017
AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells
Lee D, Yu EJ, Ham I, Hur H, Kim Y
OncoTargets and Therapy 2017, 10:4153-4159
Published Date: 22 August 2017
RASSF1A hypermethylation is associated with ASXL1 mutation and indicates an adverse outcome in non-M3 acute myeloid leukemia
Liu F, Gong M, Gao L, Cai X, Zhang H, Ma Y
OncoTargets and Therapy 2017, 10:4143-4151
Published Date: 22 August 2017
Survival significance of epidermal growth factor receptor tyrosine kinase inhibitors and current staging system for survival after recurrence in patients with completely resected lung adenocarcinoma
Saji H, Sakai H, Kimura H, Miyazawa T, Marushima H, Nakamura H
OncoTargets and Therapy 2017, 10:4135-4141
Published Date: 21 August 2017
Response to crizotinib in a lung adenocarcinoma patient harboring a novel SLC34A2-ROS1 fusion variant
Zhao Z, Song ZJ, Wang XW, Sun HF, Yang XM, Yuan Y, Yu P
OncoTargets and Therapy 2017, 10:4129-4133
Published Date: 21 August 2017
Osteopontin and vasculogenic mimicry formation are associated with response to neoadjuvant chemotherapy in advanced breast cancer
Gu M, Zheng X
OncoTargets and Therapy 2017, 10:4121-4127
Published Date: 18 August 2017
Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer
Chen Y, Tang W, Pan X, Wu C, Cao Y, Yang W
OncoTargets and Therapy 2017, 10:4113-4119
Published Date: 17 August 2017
Clinicopathologic characteristics, therapy and outcomes of patients with primary ureteral small cell carcinoma: a case series and systematic review of the literature
Zhong W, Lin R, Zhang L, Jin C, Li X, He Q, Gong K, He Z, Zhou L
OncoTargets and Therapy 2017, 10:4105-4111
Published Date: 17 August 2017
Chest reconstruction using a custom-designed polyethylene 3D implant after resection of the sternal manubrium
Lipińska J, Kutwin L, Wawrzycki M, Olbrzymek L, Jabłoński S
OncoTargets and Therapy 2017, 10:4099-4103
Published Date: 17 August 2017
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations
Patel SA, Hoffman-Censits J
OncoTargets and Therapy 2017, 10:4089-4098
Published Date: 17 August 2017
CT-guided 125I interstitial brachytherapy for pelvic recurrent cervical carcinoma after radiotherapy
Tong L, Liu P, Huo B, Guo Z, Ni H
OncoTargets and Therapy 2017, 10:4081-4088
Published Date: 17 August 2017
Carcinogenicity of chromium and chemoprevention: a brief update
Wang Y, Su H, Gu Y, Song X, Zhao J
OncoTargets and Therapy 2017, 10:4065-4079
Published Date: 16 August 2017
The role of desmosomes in carcinogenesis
Zhou G, Yang L, Gray A, Srivastava AK, Li C, Zhang G, Cui T
OncoTargets and Therapy 2017, 10:4059-4063
Published Date: 14 August 2017
Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer
Lv RB, Wang QG, Liu C, Liu F, Zhao Q, Han JG, Ren DL, Liu B, Li CL
OncoTargets and Therapy 2017, 10:4051-4057
Published Date: 14 August 2017
An integrated analysis for long noncoding RNAs and microRNAs with the mediated competing endogenous RNA network in papillary renal cell carcinoma
Huang CG, Yuan NJ, Wu LY, Wang XF, Dai JQ, Song P, Li FX, Xu CB, Zhao XH
OncoTargets and Therapy 2017, 10:4037-4050
Published Date: 14 August 2017
Effect of temozolomide on survival in elderly patients with glioblastoma and impaired performance status: a propensity score–matching analysis
Liu Y, Liu P, Shao W, Du H, Li Z, Guo C, Li Z
OncoTargets and Therapy 2017, 10:4029-4035
Published Date: 14 August 2017
Low concentration of quercetin antagonizes the invasion and angiogenesis of human glioblastoma U251 cells
Liu Y, Tang Z, Yang J, Zhou Y, Meng L, Wang H, Li C
OncoTargets and Therapy 2017, 10:4023-4028
Published Date: 11 August 2017
Perihippocampal metastasis following hippocampus-avoiding prophylactic cranial irradiation for small cell lung cancer: a case report
Yeo SG
OncoTargets and Therapy 2017, 10:4017-4021
Published Date: 11 August 2017
Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy
Chen L, Hao Y, Zhu LH, Li S, Zuo YJ, Zhang YX, Song HJ, Xue YW
OncoTargets and Therapy 2017, 10:4007-4016
Published Date: 10 August 2017
Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases
Xie ZC, Dang YW, Wei DM, Chen P, Tang RX, Huang Q, Liu JH, Luo DZ
OncoTargets and Therapy 2017, 10:3991-4005
Published Date: 10 August 2017
Enhancement of antitumor activity by using a fully human gene encoding a single-chain fragmented antibody specific for carcinoembryonic antigen
Shibaguchi H, Luo N, Shirasu N, Kuroki M, Kuroki M
OncoTargets and Therapy 2017, 10:3979-3990
Published Date: 22 August 2017
Fucosyltransferase VII promotes proliferation via the EGFR/AKT/mTOR pathway in A549 cells
Liang J, Gao W, Cai L
OncoTargets and Therapy 2017, 10:3971-3978
Published Date: 7 August 2017
Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma
Li J, Wang L
OncoTargets and Therapy 2017, 10:3965-3969
Published Date: 7 August 2017
Therapies for acute myeloid leukemia: vosaroxin
Sayar H, Bashardoust P
OncoTargets and Therapy 2017, 10:3957-3963
Published Date: 7 August 2017
Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target
Sun M, Zhao W, Zeng Y, Zhang D, Chen Z, Liu C, Wu B
OncoTargets and Therapy 2017, 10:3949-3956
Published Date: 7 August 2017
NRAS-mutant melanoma: current challenges and future prospect
Muñoz-Couselo E, Zamora Adelantado E, Ortiz C, Soberino García J, Perez-Garcia J
OncoTargets and Therapy 2017, 10:3941-3947
Published Date: 8 August 2017
Bystander signaling via oxidative metabolism
Sawal HA, Asghar K, Bureik M, Jalal N
OncoTargets and Therapy 2017, 10:3925-3940
Published Date: 4 August 2017
Prognosis of neutrophil-to-lymphocyte ratio in clinical early-stage tongue (cT1/T2N0) cancer
Wu CN, Chuang HC, Lin YT, Fang FM, Li SH, Chien CY
OncoTargets and Therapy 2017, 10:3917-3924
Published Date: 4 August 2017
Clinicopathological and prognostic significance of circulating tumor cells in patients with head and neck cancer: a meta-analysis
Sun T, Zou K, Yuan Z, Yang C, Lin X, Xiong B
OncoTargets and Therapy 2017, 10:3907-3916
Published Date: 4 August 2017
microRNA-130a is an oncomir suppressing the expression of CRMP4 in gastric cancer
Zhou Y, Li R, Yu H, Wang R, Shen Z
OncoTargets and Therapy 2017, 10:3893-3905
Published Date: 3 August 2017
SHP2 overexpression enhances the invasion and metastasis of ovarian cancer in vitro and in vivo
Hu ZQ, Li J, Gao Q, Wei S, Yang B
OncoTargets and Therapy 2017, 10:3881-3891
Published Date: 2 August 2017
A practical guide to the handling and administration of talimogene laherparepvec in Europe
Harrington KJ, Michielin O, Malvehy J, Pezzani Grüter I, Grove L, Frauchiger AL, Dummer R
OncoTargets and Therapy 2017, 10:3867-3880
Published Date: 2 August 2017
IGF2BP3 as a potential tissue marker for the diagnosis of esophageal high-grade intraepithelial neoplasia
Zhang JJ, Ji Q, Jiao CH, Ren LH, Zhao Y, Chen YF, Shi RH, Feng YD
OncoTargets and Therapy 2017, 10:3861-3866
Published Date: 1 August 2017
Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study
Lan XW, Xiao Y, Zou XB, Zhang XM, OuYang PY, Xie FY
OncoTargets and Therapy 2017, 10:3853-3860
Published Date: 1 August 2017
Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma
Liu W, Hu J, Zhou K, Chen F, Wang Z, Liao B, Dai Z, Cao Y, Fan J, Zhou J
OncoTargets and Therapy 2017, 10:3843-3851
Published Date: 1 August 2017
The effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCT
Sun HL, Ni JY, Jiang XY, Chen D, Chen YT, Xu LF
OncoTargets and Therapy 2017, 10:3835-3842
Published Date: 1 August 2017
Elevated expression of neuropilin-2 associated with unfavorable prognosis in hepatocellular carcinoma
Dong X, Guo W, Zhang S, Wu T, Sun Z, Yan S, Zheng S
OncoTargets and Therapy 2017, 10:3827-3833
Published Date: 31 July 2017
CD155 expression and its correlation with clinicopathologic characteristics, angiogenesis, and prognosis in human cholangiocarcinoma
Huang DW, Huang M, Lin XS, Huang Q
OncoTargets and Therapy 2017, 10:3817-3825
Published Date: 31 July 2017
Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer
Roviello G, Corona SP, Bonetta A, Cappelletti MR, Generali D
OncoTargets and Therapy 2017, 10:3811-3815
Published Date: 31 July 2017
The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy
Sisay M, Mengistu G, Edessa D
OncoTargets and Therapy 2017, 10:3801-3810
Published Date: 27 July 2017
Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival
Peng JH, Li H, Ou QJ, Lin JZ, Wu XJ, Lu ZH, Yuan YF, Wan DS, Fang YJ, Pan ZZ
OncoTargets and Therapy 2017, 10:3789-3799
Published Date: 27 July 2017
Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas
Wu M, Wanggou S, Li X, Liu Q, Xie Y
OncoTargets and Therapy 2017, 10:3781-3788
Published Date: 27 July 2017
MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects
Hua WF, Zhang A, Duan P, Zhu J, Zhao Y, He J, Zhang Z
OncoTargets and Therapy 2017, 10:3773-3780
Published Date: 27 July 2017
Volumetric modulated arc therapy for treatment of solid tumors: current insights
Macchia G, Deodato F, Cilla S, Cammelli S, Guido A, Ferioli M, Siepe G, Valentini V, Morganti AG, Ferrandina G
OncoTargets and Therapy 2017, 10:3755-3772
Published Date: 26 July 2017
KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity
Xie ZH, Yu J, Shang L, Zhu YQ, Hao JJ, Cai Y, Xu X, Zhang Y, Wang MR
OncoTargets and Therapy 2017, 10:3743-3754
Published Date: 26 July 2017
Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma
Shan Y, Chang T, Shi S, Tang M, Bao L, Li L, You B, You Y
OncoTargets and Therapy 2017, 10:3733-3741
Published Date: 24 July 2017
Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma
Liao X, Huang R, Liu X, Han C, Yu L, Wang SJ, Sun N, Li B, Ning X, Peng T
OncoTargets and Therapy 2017, 10:3719-3732
Published Date: 24 July 2017
The prognostic value of decreased miR-101 in various cancers: a meta-analysis of 12 studies
Hu J, Wu C, Zhao X, Liu C
OncoTargets and Therapy 2017, 10:3709-3718
Published Date: 24 July 2017
Emerging role of nivolumab in the management of patients with non-small-cell lung cancer: current data and future perspectives
Feld E, Horn L
OncoTargets and Therapy 2017, 10:3697-3708
Published Date: 24 July 2017
miR-203 as a novel biomarker for the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis
Ye H, Hao H, Wang J, Chen R, Huang Z
OncoTargets and Therapy 2017, 10:3685-3696
Published Date: 21 July 2017
Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study
Gao L, Li SH, Tian YX, Zhu QQ, Chen G, Pang YY, Hu XH
OncoTargets and Therapy 2017, 10:3667-3683
Published Date: 20 July 2017
Clinical targeting recombinant immunotoxins for cancer therapy
Li M, Liu ZS, Liu XL, Hui Q, Lu SY, Qu LL, Li YS, Zhou Y, Ren HL, Hu P
OncoTargets and Therapy 2017, 10:3645-3665
Published Date: 20 July 2017
Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia
Guo H, Zhang T, Wen X, Zhou JD, Ma J, An C, Zhang W, Xu Z, Lin J, Qian J
OncoTargets and Therapy 2017, 10:3635-3644
Published Date: 20 July 2017
Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis
Dai C, Wang M, Lu J, Dai Z, Lin S, Yang P, Tian T, Liu X, Min WL, Dai Z
OncoTargets and Therapy 2017, 10:3625-3634
Published Date: 21 July 2017
A systematic comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages between concurrent chemoradiotherapy and sequential chemotherapy
Qian M, Tao HM, Xu W, Ji HZ
OncoTargets and Therapy 2017, 10:3617-3623
Published Date: 20 July 2017
Impact of combined treatment with nimesulide and cisplatin on oral carcinoma cells
Barac A, Mitulovic G, Hallström S, Zehetmayer S, Grasl MC, Erovic BM
OncoTargets and Therapy 2017, 10:3607-3616
Published Date: 19 July 2017
Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysis
Fan QW, Liu BR
OncoTargets and Therapy 2017, 10:3591-3606
Published Date: 19 July 2017
Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo
Lu JJ, Xu Y, Zhao Z, Ke XN, Wei X, Kang J, Zong X, Mao HL, Liu PS
OncoTargets and Therapy 2017, 10:3579-3589
Published Date: 19 July 2017
Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia – role of blinatumomab
Queudeville M, Handgretinger R, Ebinger M
OncoTargets and Therapy 2017, 10:3567-3578
Published Date: 19 July 2017
The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy
Wang Y, Hu GF, Wang ZH
OncoTargets and Therapy 2017, 10:3557-3566
Published Date: 19 July 2017
Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer
Shen L, Wu X, Tan J, Gu M, Teng Y, Wang Z, Yue W
OncoTargets and Therapy 2017, 10:3545-3556
Published Date: 18 July 2017
Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer
Pan HW, Su HH, Hsu C, Huang GJ, Wu TT
OncoTargets and Therapy 2017, 10:3531-3543
Published Date: 17 July 2017
Circ-104916 is downregulated in gastric cancer and suppresses migration and invasion of gastric cancer cells
Li J, Zhen L, Zhang Y, Zhao L, Liu H, Cai D, Chen H, Yu J, Qi X, Li G
OncoTargets and Therapy 2017, 10:3521-3529
Published Date: 17 July 2017
Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors
Liu Z, Fan H, Li Y, Liu C
OncoTargets and Therapy 2017, 10:3515-3520
Published Date: 17 July 2017
Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer
Heerma van Voss MR, Vesuna F, Bol GM, Meeldijk J, Raman A, Offerhaus GJ, Buerger H, Patel AH, van der Wall E, van Diest PJ, Raman V
OncoTargets and Therapy 2017, 10:3501-3513
Published Date: 17 July 2017
An evaluation of the clinical diagnostic value of contrast-enhanced ultrasound combined with contrast-enhanced computed tomography in space-occupying lesions of the kidney
Tian W, Lu JB, Jiao D, Cong ZB
OncoTargets and Therapy 2017, 10:3493-3499
Published Date: 14 July 2017
Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy
Zhou CC, Zhang J, Chen Y, Wang H, Hou JQ
OncoTargets and Therapy 2017, 10:3485-3491
Published Date: 14 July 2017
Association between polymorphisms in DNA repair gene XRCC1 and non-melanoma skin cancer risk: a meta-analysis
Wang L, Xu J, Duan B
OncoTargets and Therapy 2017, 10:3475-3483
Published Date: 13 July 2017
Ergosterol peroxide inhibits ovarian cancer cell growth through multiple pathways
Tan W, Pan M, Liu H, Tian H, Ye Q, Liu H
OncoTargets and Therapy 2017, 10:3467-3474
Published Date: 13 July 2017
PD-1 blockade restores impaired function of ex vivo expanded CD8+ T cells and enhances apoptosis in mismatch repair deficient EpCAM+PD-L1+ cancer cells
Kumar R, Yu F, Zhen YH, Li B, Wang J, Yang Y, Ge HX, Hu P, Xiu J
OncoTargets and Therapy 2017, 10:3453-3465
Published Date: 13 July 2017
Recent progress on the effects of microRNAs and natural products on tumor epithelial–mesenchymal transition
He SJ, Xiang CQ, Zhang Y, Lu XT, Chen HW, Xiong LX
OncoTargets and Therapy 2017, 10:3435-3451
Published Date: 12 July 2017
Evaluation of p53 gene expression and prognosis characteristics in uveal melanoma cases
Liu H, Zhou M
OncoTargets and Therapy 2017, 10:3429-3434
Published Date: 12 July 2017
RNA sequencing identifies gene expression profile changes associated with β-estradiol treatment in U2OS osteosarcoma cells
Chen B, Liu Z, Zhang J, Wang H, Yu B
OncoTargets and Therapy 2017, 10:3421-3427
Published Date: 11 July 2017
A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma
Liang HW, Ye ZH, Yin SY, Mo WJ, Wang HL, Zhao JC, Liang GM, Feng ZB, Chen G, Luo DZ
OncoTargets and Therapy 2017, 10:3405-3419
Published Date: 11 July 2017
ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma
Mao Y, Wu S
OncoTargets and Therapy 2017, 10:3399-3404
Published Date: 11 July 2017
Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis
Li W, Tao L, Zhang L, Xiu D
OncoTargets and Therapy 2017, 10:3391-3397
Published Date: 11 July 2017
Sex-related differences in clinicopathological features and survival of patients with primary urethral carcinoma: a population-based study
Wei Y, Wu YP, Xu N, Li XD, Chen SH, Cai H, Zheng QS, Xue XY
OncoTargets and Therapy 2017, 10:3381-3389
Published Date: 10 July 2017
The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia
Aberuyi N, Rahgozar S, Khosravi Dehaghi Z, Moafi A, Masotti A, Paolini A
OncoTargets and Therapy 2017, 10:3373-3380
Published Date: 10 July 2017
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
Kourie HR, El Rassy E, Clatot F, de Azambuja E, Lambertini M
OncoTargets and Therapy 2017, 10:3363-3372
Published Date: 10 July 2017
The long noncoding RNA, TINCR, functions as a competing endogenous RNA to regulate PDK1 expression by sponging miR-375 in gastric cancer
Chen ZL, Liu H, Yang HL, Gao YK, Zhang GW, Hu JJ
OncoTargets and Therapy 2017, 10:3353-3362
Published Date: 10 July 2017
Preoperative serum carcinoembryonic antigen levels are associated with histologic subtype, EGFR mutations, and ALK fusion in patients with completely resected lung adenocarcinoma
Wang Z, Yang S, Lu H
OncoTargets and Therapy 2017, 10:3345-3351
Published Date: 7 July 2017
Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer
Guo Y, Shi JJ, Zhang J, Li HX, Liu B, Guo H
OncoTargets and Therapy 2017, 10:3337-3344
Published Date: 7 July 2017
Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3-4 nasopharyngeal carcinoma
Xue F, Hu C, He X
OncoTargets and Therapy 2017, 10:3329-3336
Published Date: 6 July 2017
Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cells
Woitok M, Klose D, Di Fiore S, Richter W, Stein C, Gresch G, Grieger E, Barth S, Fischer R, Kolberg K, Niesen J
OncoTargets and Therapy 2017, 10:3313-3327
Published Date: 6 July 2017
Conventional real-time PCR-based detection of T790M using tumor tissue or blood in patients with EGFR TKI-resistant NSCLC
Wu Y, Tong R, Zhang Y, Hu B, Zheng K, Ding Z, Peng F, Gong Y, Liu Y, Lu Y
OncoTargets and Therapy 2017, 10:3307-3312
Published Date: 5 July 2017
Novel agents for the treatment of childhood leukemia: an update
Eryılmaz E, Canpolat C
OncoTargets and Therapy 2017, 10:3299-3306
Published Date: 4 July 2017
Reactive oxygen species mediate soft corals-derived sinuleptolide-induced antiproliferation and DNA damage in oral cancer cells
Chang YT, Huang C, Tang J, Liaw C, Li R, Liu J, Sheu J, Chang HW
OncoTargets and Therapy 2017, 10:3289-3297
Published Date: 4 July 2017
Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report
Yeo SG
OncoTargets and Therapy 2017, 10:3285-3288
Published Date: 4 July 2017
Therapeutic value of 3-D printing template-assisted 125I-seed implantation in the treatment of malignant liver tumors
Han T, Yang X, Xu Y, Zheng Z, Yan Y, Wang N
OncoTargets and Therapy 2017, 10:3277-3283
Published Date: 3 July 2017
The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases
Pan DH, Wen DY, Luo YH, Chen G, Yang H, Chen JQ, He Y
OncoTargets and Therapy 2017, 10:3261-3276
Published Date: 3 July 2017
Hedgehog signaling pathway in colorectal cancer: function, mechanism, and therapy
Wu C, Zhu X, Liu W, Ruan T, Tao K
OncoTargets and Therapy 2017, 10:3249-3259
Published Date: 30 June 2017
LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism
Ding G, Peng Z, Shang J, Kang Y, Ning HB, Mao CS
OncoTargets and Therapy 2017, 10:3241-3247
Published Date: 30 June 2017
Targeted regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia cells K562/A02
Huang YD, Hong XL, Hu J, Lu Q
OncoTargets and Therapy 2017, 10:3233-3239
Published Date: 29 June 2017
Exploration of the molecular mechanism of prostate cancer based on mRNA and miRNA expression profiles
Zhang X, Sun YY, Wang P, Yang CF, Li SW
OncoTargets and Therapy 2017, 10:3225-3232
Published Date: 29 June 2017
CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells
Wang M, Lin T, Wang YC, Gao S, Yang ZY, Hong X, Chen GY
OncoTargets and Therapy 2017, 10:3215-3224
Published Date: 29 June 2017
Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction
Shimada M, Fukuda M, Fukuda M, Kitazaki T, Hashiguchi K, Ikeda T, Yamaguchi H, Nakatomi K, Ashizawa K, Mukae H
OncoTargets and Therapy 2017, 10:3211-3214
Published Date: 29 June 2017
Association of estrogen receptor α PvuII and XbaI polymorphisms with prostate cancer susceptibility and risk stratification: a meta-analysis from case-control studies
Zhao YN, Zheng X, Zhang LJ, Hu Q, Guo YT, Jiang H, Shi SN, Zhang X
OncoTargets and Therapy 2017, 10:3203-3210
Published Date: 29 June 2017
The effect of circulating miR-223 on surveillance of different cancers: a meta-analysis
Zhang YF, Lin JB, Huang WJ, Cao Y, Liu Y, Wang TQ, Zhong WY, Wang DL, Mao RR, Chen XL
OncoTargets and Therapy 2017, 10:3193-3201
Published Date: 28 June 2017
Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report
Zhu Y, Liao X, Wang W, Xu C, Zhuang W, Zhong L, Du K, Chen Y, Chen G, Fang M
OncoTargets and Therapy 2017, 10:3187-3192
Published Date: 27 June 2017
Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors
Yao JC, Chan JA, Mita AC, Kundu MG, Hermosillo Reséndiz K, Hu K, Ravichandran S, Strosberg JR, Wolin EM
OncoTargets and Therapy 2017, 10:3177-3186
Published Date: 27 June 2017
Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients
Cymbaluk-Ploska A, Chudecka-Głaz A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Surowiec A, Menkiszak J
OncoTargets and Therapy 2017, 10:3169-3175
Published Date: 27 June 2017
Optimizing the treatment of bevacizumab as first-line therapy for human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer: an updated meta-analysis of published randomized trials
Li C, Xiang A, Chen X, Yin K, Lu J, Yin W
OncoTargets and Therapy 2017, 10:3155-3168
Published Date: 27 June 2017
Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer
Song S, Li C, Li S, Gao H, Lan X, Xue Y
OncoTargets and Therapy 2017, 10:3145-3154
Published Date: 26 June 2017
Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo
Kuang Y, Lu F, Guo J, Xu H, Wang Q, Xu C, Zeng L, Yi S
OncoTargets and Therapy 2017, 10:3131-3144
Published Date: 26 June 2017
The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis
Zhang X, Yin X, Shen P, Sun G, Yang Y, Liu J, Chen N, Zeng H
OncoTargets and Therapy 2017, 10:3123-3130
Published Date: 22 June 2017
Clinical efficacy evaluation of tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations
Song X, Wang Z
OncoTargets and Therapy 2017, 10:3119-3122
Published Date: 22 June 2017
Plasma fibrinogen and serum albumin levels (FA score) act as a promising prognostic indicator in non-small cell lung cancer
Chen P, Wang C, Cheng B, Nesa EU, Liu Y, Jia Y, Qu Y, Jiang Z, Han J, Cheng Y
OncoTargets and Therapy 2017, 10:3107-3118
Published Date: 21 June 2017
Comprehensive analysis of differential co-expression patterns reveal transcriptional dysregulation mechanism and identify novel prognostic lncRNAs in esophageal squamous cell carcinoma
Li Z, Yao Q, Zhao S, Wang Y, Li Y, Wang Z
OncoTargets and Therapy 2017, 10:3095-3105
Published Date: 21 June 2017
Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis
Zhang Y, Xu X, Chen Z, Zhao Z
OncoTargets and Therapy 2017, 10:3083-3093
Published Date: 20 June 2017
Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapy
Bai Y, Wu HW, Ma X, Liu Y, Zhang YH
OncoTargets and Therapy 2017, 10:3071-3081
Published Date: 19 June 2017
The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis
Xu H, Ma Y, Deng F, Ju W, Sun X, Wang H
OncoTargets and Therapy 2017, 10:3059-3070
Published Date: 19 June 2017
Isolated thoracic perfusion with chemofiltration for progressive malignant pleural mesothelioma
Aigner KR, Selak E, Gailhofer S
OncoTargets and Therapy 2017, 10:3049-3057
Published Date: 19 June 2017
Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma
Ni W, Song E, Gong M, Li Y, Yao J, An R
OncoTargets and Therapy 2017, 10:3039-3047
Published Date: 19 June 2017
Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer
Dockery LE, Gunderson CC, Moore KN
OncoTargets and Therapy 2017, 10:3029-3037
Published Date: 19 June 2017
Identification of key genes and molecular mechanisms associated with dedifferentiated liposarcoma based on bioinformatic methods
Yu H, Pei D, Chen L, Zhou X, Zhu H
OncoTargets and Therapy 2017, 10:3017-3027
Published Date: 16 June 2017
Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts
De Tursi M, Zilli M, Carella C, Auriemma M, Lisco MN, Di Nicola M, Di Martino G, Natoli C, Amerio P
OncoTargets and Therapy 2017, 10:3007-3015
Published Date: 16 June 2017
Hepatic artery-infusion chemotherapy improved survival of hepatocellular carcinoma after radical hepatectomy
Feng M, Tang C, Feng W, Bao Y, Zheng Y, Shen J
OncoTargets and Therapy 2017, 10:3001-3005
Published Date: 14 June 2017
Combination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells
Yang Y, Yin W, Wu FY, Fan J
OncoTargets and Therapy 2017, 10:2993-2999
Published Date: 14 June 2017
Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors
Chang H, Kim JS, Choi YJ, Cho J, Woo J, Kim A, Kim JS, Kang EJ
OncoTargets and Therapy 2017, 10:2983-2992
Published Date: 13 June 2017
Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials
Liu YY, Kou CG, Su YY, Zhang YY, You YY, Zhang LL, Wang MH, Fu YL, Ren XJ, Yang YM
OncoTargets and Therapy 2017, 10:2971-2981
Published Date: 13 June 2017
Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy
de Groot S, Gelderblom H, Fiocco M, Bovée JVMG, van der Hoeven JJM, Pijl H, Kroep JR
OncoTargets and Therapy 2017, 10:2963-2970
Published Date: 13 June 2017
Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis
Yang B, Yan X, Liu L, Jiang C, Hou S
OncoTargets and Therapy 2017, 10:2951-2961
Published Date: 13 June 2017
Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis
Kan HC, Hou CP, Lin YH, Tsui KH, Chang PL, Chen CL
OncoTargets and Therapy 2017, 10:2943-2949
Published Date: 12 June 2017
WWC3 downregulation correlates with poor prognosis and inhibition of Hippo signaling in human gastric cancer
Hou J, Zhou J
OncoTargets and Therapy 2017, 10:2931-2942
Published Date: 12 June 2017
Vasculogenic mimicry is associated with increased tumor-infiltrating neutrophil and poor outcome in esophageal squamous cell carcinoma
Zhang J, Zhang G, Hu P, Deng G, Liu Q, Qiao L, Luo H, Zhang J
OncoTargets and Therapy 2017, 10:2923-2930
Published Date: 9 June 2017
Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
Chen X, Zhu X, Liang Z, Li L, Qu S, Chen K, Pan X
OncoTargets and Therapy 2017, 10:2909-2921
Published Date: 9 June 2017
Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment
Noronha V, Choughule A, Patil VM, Joshi A, Kumar R, Susan Joy Philip D, Banavali S, Dutt A, Prabhash K
OncoTargets and Therapy 2017, 10:2903-2908
Published Date: 9 June 2017
The prognostic value of cyclooxygenase-2 expression in patients with esophageal cancer: evidence from a meta-analysis
Hu Z, Yang Y, Zhao Y, Huang Y
OncoTargets and Therapy 2017, 10:2893-2901
Published Date: 9 June 2017
Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis
Li M, Yang X, Chen Y, Yang X, Dai X, Sun F, Zhang L, Zhan C, Feng M, Wang Q
OncoTargets and Therapy 2017, 10:2885-2892
Published Date: 7 June 2017
Upregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinoma
Xu Y, Jiang X, Cui Y
OncoTargets and Therapy 2017, 10:2873-2883
Published Date: 6 June 2017
PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy
Liu H, Zhang L, Zhang X, Cui Z
OncoTargets and Therapy 2017, 10:2865-2871
Published Date: 6 June 2017
Prognostic value of high IMP3 expression in solid tumors: a meta-analysis
Chen L, Xie Y, Li X, Gu L, Gao Y, Tang L, Chen J, Zhang X
OncoTargets and Therapy 2017, 10:2849-2863
Published Date: 6 June 2017
Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial–mesenchymal transition in esophageal squamous cell carcinoma
Bai X, Li Y, Zhang H, Wang F, He H, Yao J, Liu L, Li S
OncoTargets and Therapy 2017, 10:2837-2847
Published Date: 2 June 2017
Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Retraction]
Yu L, Wang XL, Zhu D, Ding W, Wang L, Zhang C, Jiang X, Shen H, Liao S, Ma D, Hu Z, Wang H
OncoTargets and Therapy 2017, 10:2835-2836
Published Date: 2 June 2017
SUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma
Huang W, Huang H, Wang L, Hu J, Song W
OncoTargets and Therapy 2017, 10:2825-2833
Published Date: 2 June 2017
Letter to the editor regarding the article “Prognostic role of long noncoding RNA NEAT1 in various carcinomas: a meta-analysis”
Yu H, Wang P, Zhang X
OncoTargets and Therapy 2017, 10:2823-2824
Published Date: 6 June 2017
MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2
Wu MH, Ye XX, Wang SC, Li QH, Lai YX, Yi YM
OncoTargets and Therapy 2017, 10:2815-2822
Published Date: 2 June 2017
Panel of seven long noncoding RNA as a candidate prognostic biomarker for ovarian cancer
Zhan XH, Dong C, Liu G, Li YX, Liu L
OncoTargets and Therapy 2017, 10:2805-2813
Published Date: 1 June 2017
Silencing of AQP3 induces apoptosis of gastric cancer cells via downregulation of glycerol intake and downstream inhibition of lipogenesis and autophagy
Chen L, Li Z, Zhang Q, Wei S, Li B, Zhang X, Zhang L, Li Q, Xu H, Xu Z
OncoTargets and Therapy 2017, 10:2791-2804
Published Date: 1 June 2017
The critical role of EGF-β-catenin signaling in the epithelial-mesenchymal transition in human glioblastoma
Wang X, Wang S, Li X, Jin S, Xiong F, Wang X
OncoTargets and Therapy 2017, 10:2781-2789
Published Date: 31 May 2017
Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corrigendum]
Ye T, Su J, Huang C, Yu D, Dai S, Huang X, Chen B, Zhou M
OncoTargets and Therapy 2017, 10:2779-2780
Published Date: 31 May 2017
The role of long noncoding RNA-LET in cell proliferation and invasion of nasopharyngeal carcinoma and its mechanism
Chen L, Sun L, Dong L, Cui P, Xia Z, Li C, Zhu Y
OncoTargets and Therapy 2017, 10:2769-2778
Published Date: 30 May 2017
Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study
Wu J, Li A, Yang J, Lu Y, Li J
OncoTargets and Therapy 2017, 10:2761-2768
Published Date: 29 May 2017
Pretreatment combination of platelet counts and neutrophil–lymphocyte ratio predicts survival of nasopharyngeal cancer patients receiving intensity-modulated radiotherapy
Lin YH, Chang KP, Lin YS, Chang TS
OncoTargets and Therapy 2017, 10:2751-2760
Published Date: 26 May 2017
Neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of Enneking stage II: a retrospective study
Yuan G, Chen J, Wu D, Gao C
OncoTargets and Therapy 2017, 10:2745-2750
Published Date: 26 May 2017
Overexpression of ecotropic viral integration site-1 is a prognostic factor of lung squamous cell cancer
Xu X, Liu S, Ji X
OncoTargets and Therapy 2017, 10:2739-2744
Published Date: 26 May 2017
Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis [Corrigendum]
Xia S, Wang C, Postma EL, Yang Y, Ni X, Zhan W
OncoTargets and Therapy 2017, 10:2737-2738
Published Date: 29 May 2017
The prognostic value of nodal skip metastasis in resectable thoracic esophageal squamous cell carcinoma
Song G, Jing W, Xue S, Guo H, Yu J
OncoTargets and Therapy 2017, 10:2729-2736
Published Date: 25 May 2017
Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma
Kwon NS, Kim DS, Yun HY
OncoTargets and Therapy 2017, 10:2721-2728
Published Date: 24 May 2017
miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4
Hu H, Wang G, Li C
OncoTargets and Therapy 2017, 10:2711-2720
Published Date: 23 May 2017
MicroRNA-216a promotes the metastasis and epithelial–mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway
Liu H, Pan Y, Han X, Liu J, Li R
OncoTargets and Therapy 2017, 10:2701-2709
Published Date: 23 May 2017
Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials
Veettil SK, Teerawattanapong N, Ching SM, Lim KG, Saokaew S, Phisalprapa P, Chaiyakunapruk N
OncoTargets and Therapy 2017, 10:2689-2700
Published Date: 23 May 2017
Ezh2, a novel target in detection and therapy of breast cancer
Pourakbar S, Pluard TJ, Accurso AD, Farassati F
OncoTargets and Therapy 2017, 10:2685-2687
Published Date: 22 May 2017
Bisdemethoxycurcumin in combination with α-PD-L1 antibody boosts immune response against bladder cancer
Shao Y, Zhu W, Da J, Xu M, Wang Y, Zhou J, Wang Z
OncoTargets and Therapy 2017, 10:2675-2683
Published Date: 22 May 2017
Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer
Mearini E, Poli G, Cochetti G, Boni A, Egidi MG, Brancorsini S
OncoTargets and Therapy 2017, 10:2665-2673
Published Date: 22 May 2017
The prognostic value of neutrophil–lymphocyte ratio is superior to derived neutrophil–lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up
Jin H, Sun J, Zhu K, Liu X, Zhang Q, Shen Q, Gao Y, Yu J
OncoTargets and Therapy 2017, 10:2655-2664
Published Date: 22 May 2017
Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation
Pang X, Li Q, Ma Z, Shi Y, Ma Y, Li X, Cui W, Zhang W
OncoTargets and Therapy 2017, 10:2645-2654
Published Date: 19 May 2017
The novel long noncoding RNA RP11–357H14.17 acts as an oncogene by promoting cell proliferation and invasion in diffuse-type gastric cancer
Yang B, Luo TH, Zhang MJ, Lu ZM, Xue XC, Fang GN
OncoTargets and Therapy 2017, 10:2635-2643
Published Date: 18 May 2017
FOLFOX regimen plus dendritic cells–cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis
Liu Y, Zheng Z, Zhang QX, Zhou XL, Feng YK, Yan AQ
OncoTargets and Therapy 2017, 10:2621-2633
Published Date: 18 May 2017
RNA-binding protein HuR promotes bladder cancer progression by competitively binding to the long noncoding HOTAIR with miR-1
Yu DP, Zhang C, Gui JQ
OncoTargets and Therapy 2017, 10:2609-2619
Published Date: 17 May 2017
Holliday junction–recognizing protein promotes cell proliferation and correlates with unfavorable clinical outcome of hepatocellular carcinoma
Hu B, Wang Q, Wang Y, Chen J, Li P, Han M
OncoTargets and Therapy 2017, 10:2601-2607
Published Date: 17 May 2017
Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study
Sun Y, Wang Y, Han S, Xing B, Li H, Zhu Y, Zhou S, Wang X, Xu J, Tao R
OncoTargets and Therapy 2017, 10:2595-2600
Published Date: 17 May 2017
The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia
Meier-Stephenson V, Riemer J, Narendran A
OncoTargets and Therapy 2017, 10:2581-2593
Published Date: 16 May 2017
Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy
Chen L, Zuo YJ, Zhu LH, Zhang YX, Li S, Ma F, Han Y, Song HJ, Xue YW
OncoTargets and Therapy 2017, 10:2569-2580
Published Date: 17 May 2017
Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
Du E, Wang L, Li C, Zhang C, Qu Y, Liu R, Xu Y, Yang K, Zhang Z
OncoTargets and Therapy 2017, 10:2561-2567
Published Date: 15 May 2017
Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients
Tang H, Wu Y, Qin Y, Wang H, Jia Y, Yang S, Luo S, Wang Q
OncoTargets and Therapy 2017, 10:2553-2560
Published Date: 15 May 2017
Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer
Hollis RL, Churchman M, Gourley C
OncoTargets and Therapy 2017, 10:2539-2551
Published Date: 11 May 2017
MicroRNA-381 enhances radiosensitivity in esophageal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein
Zhou S, Cui Y, Yu D, Liang J, Zhang M, Ye W
OncoTargets and Therapy 2017, 10:2527-2538
Published Date: 11 May 2017
New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib
Hirsh V
OncoTargets and Therapy 2017, 10:2513-2526
Published Date: 11 May 2017
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives [Corrigendum]
McCulloch D, Brown C, Iland H
OncoTargets and Therapy 2017, 10:2511-2512
Published Date: 8 May 2017
Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma
Zhong D, Cen H
OncoTargets and Therapy 2017, 10:2501-2509
Published Date: 8 May 2017
Clinicopathological significance of p14ARF expression in lung cancer: a meta-analysis
Wang F, Li H, Long J, Ye S
OncoTargets and Therapy 2017, 10:2491-2499
Published Date: 8 May 2017
Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment
Shi Y, Jia R, Fan X
OncoTargets and Therapy 2017, 10:2483-2489
Published Date: 8 May 2017
Tyrosine kinase inhibitor combination therapy in first-line treatment of non-small-cell lung cancer: systematic review and network meta-analysis
Batson S, Mitchell SA, Windisch R, Damonte E, Munk VC, Reguart N
OncoTargets and Therapy 2017, 10:2473-2482
Published Date: 5 May 2017
Downregulation of long noncoding RNA TUG1 inhibits proliferation and induces apoptosis through the TUG1/miR-142/ZEB2 axis in bladder cancer cells
Liu Q, Liu H, Cheng HP, Li Y, Li XD, Zhu CY
OncoTargets and Therapy 2017, 10:2461-2471
Published Date: 5 May 2017
A retrospective study on the prognostic value of preoperative neutrophil/lymphocyte ratio in patients with primary small-cell carcinoma of the esophagus
Wang Y, Liu JF
OncoTargets and Therapy 2017, 10:2453-2459
Published Date: 5 May 2017
An isolated unusual digit metastasis from esophageal carcinoma: a case report
Chen Y, Tang W, Xiao H, Chen J, Zhao H, Shi J
OncoTargets and Therapy 2017, 10:2449-2452
Published Date: 9 May 2017
Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide
Haq S, Samuel V, Haxho F, Akasov R, Leko M, Burov SV, Markvicheva E, Szewczuk MR
OncoTargets and Therapy 2017, 10:2427-2447
Published Date: 4 May 2017
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]
Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M
OncoTargets and Therapy 2017, 10:2425-2426
Published Date: 4 May 2017
Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response
Sun WW, Xu ZH, Lian P, Gao BL, Hu JA
OncoTargets and Therapy 2017, 10:2413-2424
Published Date: 4 May 2017
FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer [Retraction]
Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W
OncoTargets and Therapy 2017, 10:2411-2412
Published Date: 3 May 2017
The voice quality after laser surgery versus radiotherapy of T1a glottic carcinoma: systematic review and meta-analysis
Huang GJ, Luo MS, Zhang JX, Liu HB
OncoTargets and Therapy 2017, 10:2403-2410
Published Date: 3 May 2017
Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes
Heinrich B, Klein J, Delic M, Goepfert K, Engel V, Geberzahn L, Lusky M, Erbs P, Preville X, Moehler M
OncoTargets and Therapy 2017, 10:2389-2401
Published Date: 2 May 2017
Curcumin exerts its antitumor activity through regulation of miR-7/Skp2/p21 in nasopharyngeal carcinoma cells
Feng S, Wang Y, Zhang R, Yang G, Liang Z, Wang Z, Zhang G
OncoTargets and Therapy 2017, 10:2377-2388
Published Date: 2 May 2017
Knockdown of a DIS3L2 promoter upstream long noncoding RNA (AC105461.1) enhances colorectal cancer stem cell properties in vitro by down-regulating DIS3L2
Liu W, Yu Q, Ma J, Cheng Y, Zhang H, Luo W, Yao J, Zhang H
OncoTargets and Therapy 2017, 10:2367-2376
Published Date: 2 May 2017
Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches [Corrigendum]
Pathan AAK, Panthi B, Khan Z, Koppula PR, Alanazi M, Sachchidanand, Parine NR, Chourasia M
OncoTargets and Therapy 2017, 10:2365-2366
Published Date: 28 April 2017
Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies
Ilcus C, Bagacean C, Tempescul A, Popescu C, Parvu A, Cenariu M, Bocsan C, Zdrenghea M
OncoTargets and Therapy 2017, 10:2349-2363
Published Date: 28 April 2017
Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin
Hu Y, Zang J, Qin X, Yan D, Cao H, Zhou L, Ni J, Yu S, Wu J, Feng JF
OncoTargets and Therapy 2017, 10:2341-2348
Published Date: 28 April 2017
The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
Bai H, Xiong L, Han B
OncoTargets and Therapy 2017, 10:2335-2340
Published Date: 27 April 2017
No genetic relationship between TLR2 rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations
Semlali A, Almutairi M, Parine NR, Al Amri A, Shaik JP, Al Naeem A, Abdulla Ajaj S, Rouabhia M, Alanazi MS
OncoTargets and Therapy 2017, 10:2325-2333
Published Date: 27 April 2017
B-cell-specific Moloney murine leukemia virus integration site 1: potential stratification factor and therapeutic target for epithelial ovarian cancer [Corrigendum]
Zhao Q, Gui T, Qian Q, Li L, Shen K
OncoTargets and Therapy 2017, 10:2323-2324
Published Date: 27 April 2017
Identification of potential biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma by bioinformatics analysis
Yang B, Chen Z, Huang Y, Han G, Li W
OncoTargets and Therapy 2017, 10:2315-2321
Published Date: 26 April 2017
Maintenance therapy with all-trans retinoic acid and arsenic trioxide improves relapse-free survival in adults with low- to intermediate-risk acute promyelocytic leukemia who have achieved complete remission after consolidation therapy
Liang B, Zheng ZY, Shi YF, Chen JJ, Hu XD, Qian HL, Shen ZJ, Jiang SF, Yu K, Feng JH
OncoTargets and Therapy 2017, 10:2305-2313
Published Date: 26 April 2017
Role of CT scan in differentiating the type of colorectal cancer
Li ZH, You DY, Gao DP, Yang GJ, Dong XX, Zhang DF, Ding YY
OncoTargets and Therapy 2017, 10:2297-2303
Published Date: 26 April 2017
Apatinib to combat EGFR-TKI resistance in an advanced non-small cell lung cancer patient with unknown EGFR status: a case report
Peng Y, Cui H, Liu Z, Liu D, Liu F, Song Y, Duan H, Qiu Y, Li Q
OncoTargets and Therapy 2017, 10:2289-2295
Published Date: 26 April 2017
Treatment-related severe and fatal adverse events with molecular targeted agents in the treatment of advanced gastric cancer: a meta-analysis
Wang L, Liu Y, Zhou W, Li W
OncoTargets and Therapy 2017, 10:2281-2287
Published Date: 26 April 2017
Meta-analysis of the impact of de novo and acquired EGFR T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIs
Liu Y, Sun L, Xiong Z, Sun X, Zhang S, Ma J, Han C
OncoTargets and Therapy 2017, 10:2267-2279
Published Date: 24 April 2017
Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection
Leng KM, Liu YP, Wang ZD, Zhong XY, Liao GQ, Kang PC, Cui YF, Jiang XM
OncoTargets and Therapy 2017, 10:2257-2266
Published Date: 21 April 2017
Relationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer
Ma J, Yang Y, Wang Y, Zhang X, Gu X, Wang Z
OncoTargets and Therapy 2017, 10:2249-2256
Published Date: 21 April 2017
PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro
Cui W, Zheng S, Liu Z, Wang W, Cai Y, Bi R, Cao B, Zhou X
OncoTargets and Therapy 2017, 10:2239-2247
Published Date: 20 April 2017
Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer
Zhang J, Liu Q, Qiao L, Hu P, Deng G, Liang N, Xie J, Luo H, Zhang J
OncoTargets and Therapy 2017, 10:2227-2237
Published Date: 20 April 2017
NVP-AUY922, a novel HSP90 inhibitor, inhibits the progression of malignant pheochromocytoma in vitro and in vivo
Lian JP, Lin D, Xie X, Xu Y, Xu L, Meng L, Zhu Y
OncoTargets and Therapy 2017, 10:2219-2226
Published Date: 19 April 2017
Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer
Huang BT, Wu LL, Guo LJ, Xu LY, Huang RH, Lin PX, Chen JZ, Li DR, Chen CZ
OncoTargets and Therapy 2017, 10:2209-2217
Published Date: 19 April 2017
Impact of platelet to lymphocyte ratio and metabolic syndrome on the prognosis of colorectal cancer patients
You J, Zhang H, Shen Y, Chen C, Liu W, Zheng M, Van Poucke S, Guo G, Huang Z
OncoTargets and Therapy 2017, 10:2199-2208
Published Date: 18 April 2017
Allergic conditions are not associated with the risk of non-Hodgkin’s lymphoma or Hodgkin’s lymphoma: a systematic review and meta-analysis
Yang J, Xu H, Liang X, Lv S, Lin B, Jia Y
OncoTargets and Therapy 2017, 10:2189-2198
Published Date: 18 April 2017
Novel insights into circular RNAs in clinical application of carcinomas
Rong D, Tang W, Li Z, Zhou J, Shi J, Wang H, Cao H
OncoTargets and Therapy 2017, 10:2183-2188
Published Date: 18 April 2017
Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients
Luo D, Chen W, Tian Y, Li J, Xu X, Chen C, Li F
OncoTargets and Therapy 2017, 10:2173-2181
Published Date: 18 April 2017
Monosomal karyotype in myeloid neoplasias: a literature review
Anelli L, Pasciolla C, Zagaria A, Specchia G, Albano F
OncoTargets and Therapy 2017, 10:2163-2171
Published Date: 20 April 2017
Prognostic value of pretreatment albumin–globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection
Liu J, Chen S, Geng Q, Liu X, Kong P, Zhan Y, Xu D
OncoTargets and Therapy 2017, 10:2155-2162
Published Date: 13 April 2017
Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy
Liu Q, Hu P, Deng G, Zhang J, Liang N, Xie J, Qiao L, Luo H, Zhang J
OncoTargets and Therapy 2017, 10:2147-2154
Published Date: 12 April 2017
Inhibition of PCSK9 protects against radiation-induced damage of prostate cancer cells
Gan S, Ye J, Wang L, Qu F, Chu C, Tian Y, Yang W, Cui X
OncoTargets and Therapy 2017, 10:2139-2146
Published Date: 12 April 2017
miR-762 can negatively regulate menin in ovarian cancer
Hou R, Yang Z, Wang S, Chu D, Liu Q, Liu J, Jiang L
OncoTargets and Therapy 2017, 10:2127-2137
Published Date: 12 April 2017
A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/AkT/MTOR signaling pathway
Zhao L, Li C, Liu F, Zhao Y, Liu J, Hua Y, Liu J, Huang J, Ge C
OncoTargets and Therapy 2017, 10:2115-2126
Published Date: 12 April 2017
Gastric cancer, nutritional status, and outcome
Liu X, Qiu H, Kong P, Zhou Z, Sun X
OncoTargets and Therapy 2017, 10:2107-2114
Published Date: 12 April 2017
Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
Wagner LM, Adams VR
OncoTargets and Therapy 2017, 10:2097-2106
Published Date: 12 April 2017
Can involved-field irradiation replace elective nodal irradiation in chemoradiotherapy for esophageal cancer? A systematic review and meta-analysis
Wang X, Miao C, Chen Z, Li W, Yuan S, Yu J, Hu X
OncoTargets and Therapy 2017, 10:2087-2095
Published Date: 11 April 2017
Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors
Rossmeisl JH, Hall-Manning K, Robertson JL, King JN, Davalos RV, Debinski W, Elankumaran S
OncoTargets and Therapy 2017, 10:2077-2085
Published Date: 12 April 2017
Therapeutic outcome of nasopharyngeal carcinoma with cranial nerve palsy: a single institution experience of 104 patients
Huang CC, Fang FM, Chen HC, Hsu HC, Huang TL, Su YL, Chang YC
OncoTargets and Therapy 2017, 10:2069-2075
Published Date: 10 April 2017
The role of KPNβ1 in neuro-oncology
Lilley M, Farassati F
OncoTargets and Therapy 2017, 10:2067-2068
Published Date: 10 April 2017
Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date
Levin PA, Dowell JE
OncoTargets and Therapy 2017, 10:2057-2066
Published Date: 7 April 2017
Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7
Tang W, Ji M, He G, Yang L, Niu Z, Jian M, Wei Y, Ren L, Xu J
OncoTargets and Therapy 2017, 10:2045-2056
Published Date: 7 April 2017
Patient considerations in metastatic colorectal cancer – role of panitumumab
Rogers JE
OncoTargets and Therapy 2017, 10:2033-2044
Published Date: 7 April 2017
Expression and significance of GRHL2 in esophageal cancer
Shao CC, Ji CS, Wang XQ, Hu B
OncoTargets and Therapy 2017, 10:2025-2031
Published Date: 7 April 2017
REG3A promotes the proliferation, migration, and invasion of gastric cancer cells
Chen ZF, Huang ZM, Xue HB, Lin XQ, Chen RP, Chen MJ, Jin RF
OncoTargets and Therapy 2017, 10:2017-2023
Published Date: 6 April 2017
Role of postmastectomy radiotherapy in early-stage (T1–2N0–1M0) triple-negative breast cancer: a systematic review
Chen F, Pu F
OncoTargets and Therapy 2017, 10:2009-2016
Published Date: 6 April 2017
Altered status of programmed death-ligand 1 after recurrence in resected lung adenocarcinoma patients
Chen J, Li H, Pang RL, Huang J
OncoTargets and Therapy 2017, 10:2003-2007
Published Date: 6 April 2017
Long noncoding RNA NBAT-1 suppresses tumorigenesis and predicts favorable prognosis in ovarian cancer
Yan CS, Jiang Y, Wan YC, Zhang L, Liu JH, Zhou SL, Cheng WJ
OncoTargets and Therapy 2017, 10:1993-2002
Published Date: 6 April 2017
The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
Sabari JK, Santini FC, Schram AM, Bergagnini I, Chen R, Mrad C, Lai WV, Arbour KC, Drilon A
OncoTargets and Therapy 2017, 10:1983-1992
Published Date: 6 April 2017
Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation
Andersen MN, Ludvigsen M, Abildgaard N, Petruskevicius I, Hjortebjerg R, Bjerre M, Honoré B, Møller HJ, Andersen NF
OncoTargets and Therapy 2017, 10:1977-1982
Published Date: 4 April 2017
HSD17B12 gene rs11037575 C>T polymorphism confers neuroblastoma susceptibility in a Southern Chinese population
Zhang ZR, Zou Y, Zhu JH, Zhang RZ, Yang TY, Wang FH, Xia HM, He J, Feng ZC
OncoTargets and Therapy 2017, 10:1969-1975
Published Date: 4 April 2017
Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors
Sun S, Yu H, Wang H, Zhao X, Zhao X, Wu X, Qiao J, Chang J, Wang J
OncoTargets and Therapy 2017, 10:1955-1967
Published Date: 3 April 2017
Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer
Yan Y, Zhou K, Wang L, Wang F, Chen X, Fan Q
OncoTargets and Therapy 2017, 10:1947-1954
Published Date: 3 April 2017
Apoptotic and genomic effects of corilagin on SKOV3 ovarian cancer cell line
Attar R, Cincin ZB, Bireller ES, Cakmakoglu B
OncoTargets and Therapy 2017, 10:1941-1946
Published Date: 31 March 2017
FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer
Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W
OncoTargets and Therapy 2017, 10:1933-1939
Published Date: 30 March 2017
Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane
Townsend MH, Anderson MD, Weagel EG, Velazquez EJ, Weber KS, Robison RA, O'Neill KL
OncoTargets and Therapy 2017, 10:1921-1932
Published Date: 30 March 2017
Expression of SHP-1 and SOCS6 in patients with acute leukemia and their clinical implication
Liu J, Zheng Y, Gao J, Zhu G, Gao K, Zhang W, Shi F, Shi Q
OncoTargets and Therapy 2017, 10:1915-1920
Published Date: 29 March 2017
Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia
Khan M, Gibbons JL, Ferrajoli A
OncoTargets and Therapy 2017, 10:1909-1914
Published Date: 29 March 2017
Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis
Liu Y, Mu Y, Zhang A, Ren SD, Wang WH, Xie JP, Zhang YX, Zhou CH
OncoTargets and Therapy 2017, 10:1897-1908
Published Date: 29 March 2017
Clinical course and outcome of patients with high-level microsatellite instability cancers in a real-life setting: a retrospective analysis
Halpern N, Goldberg Y, Kadouri L, Duvdevani M, Hamburger T, Peretz T, Hubert A
OncoTargets and Therapy 2017, 10:1889-1896
Published Date: 29 March 2017
Genetic variants and increased risk of meningioma: an updated meta-analysis
Han X, Wang W, Wang L, Wang X, Li G
OncoTargets and Therapy 2017, 10:1875-1888
Published Date: 28 March 2017
DNMT1 regulates human endometrial carcinoma cell proliferation
Wang X, Li B
OncoTargets and Therapy 2017, 10:1865-1873
Published Date: 29 March 2017
EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?
Joshi A, Zanwar S, Noronha V, Patil VM, Chougule A, Kumar R, Janu A, Mahajan A, Kapoor A, Prabhash K
OncoTargets and Therapy 2017, 10:1859-1863
Published Date: 28 March 2017
Pancreatic solitary fibrous tumor in a toddler managed by pancreaticoduodenectomy: a case report and review of the literature
Sheng Q, Xu W, Liu J, Shen B, Deng X, Wu Y, Wu W, Yu S, Wang X, Lv Z
OncoTargets and Therapy 2017, 10:1853-1858
Published Date: 27 March 2017
Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis
Wu J, Cheng G, Zhang C, Zheng Y, Xu H, Yang H, Hua L
OncoTargets and Therapy 2017, 10:1843-1852
Published Date: 27 March 2017
Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial
Lazzari G, Terlizzi A, Della Vittoria Scarpati G, Perri F, De Chiara V, Turi B, Silvano G
OncoTargets and Therapy 2017, 10:1835-1842
Published Date: 24 March 2017
Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression
Xu X, Shen H, Zhu L, Lu J, Zhang L, Luo Z, Wu Y
OncoTargets and Therapy 2017, 10:1827-1834
Published Date: 23 March 2017
Salvage treatment with apatinib for advanced non-small-cell lung cancer
Song Z, Yu X, Lou G, Shi X, Zhang Y
OncoTargets and Therapy 2017, 10:1821-1825
Published Date: 23 March 2017
Role of Nrf2 signaling pathway in the radiation tolerance of patients with head and neck squamous cell carcinoma: an in vivo and in vitro study
Wang T, Hu P, Li B, Zhang J, Cheng Y, Liang Y
OncoTargets and Therapy 2017, 10:1809-1819
Published Date: 23 March 2017
Understanding the role of PD-L1/PD1 pathway blockade and autophagy in cancer therapy
Robainas M, Otano R, Bueno S, Ait-Oudhia S
OncoTargets and Therapy 2017, 10:1803-1807
Published Date: 23 March 2017
Associations of NQO1 C609T and NQO1 C465T polymorphisms with acute leukemia risk: a PRISMA-compliant meta-analysis
He H, Zhai X, Liu X, Zheng J, Zhai Y, Gao F, Chen Y, Lu J
OncoTargets and Therapy 2017, 10:1793-1801
Published Date: 23 March 2017
Focal adhesion kinases crucially regulate TGFβ-induced migration and invasion of bladder cancer cells via Src kinase and E-cadherin
Kong D, Chen F, Sima N
OncoTargets and Therapy 2017, 10:1783-1792
Published Date: 23 March 2017
Prognostic value of FOXQ1 in patients with malignant solid tumors: a meta-analysis
Cui X, Zhang J, Lv J, Yan Y, Liu X, Wang J, Lv Y, Zhang J
OncoTargets and Therapy 2017, 10:1777-1781
Published Date: 23 March 2017
Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
Shi L, Zheng H, Hu W, Zhou B, Dai X, Zhang Y, Liu Z, Wu X, Zhao C, Liang G
OncoTargets and Therapy 2017, 10:1767-1776
Published Date: 23 March 2017
Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291)
Saad N, Poudel A, Basnet A, Gajra A
OncoTargets and Therapy 2017, 10:1757-1766
Published Date: 22 March 2017
Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis
Xia S, Wang C, Postma EL, Yang Y, Ni X, Zhan W
OncoTargets and Therapy 2017, 10:1743-1755
Published Date: 22 March 2017
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer
Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M
OncoTargets and Therapy 2017, 10:1735-1742
Published Date: 21 March 2017
The associations between five polymorphisms of vascular endothelial growth factor and renal cell carcinoma risk: an updated meta-analysis
Wang J, Shen CX, Fu Y, Yu T, Song J
OncoTargets and Therapy 2017, 10:1725-1734
Published Date: 21 March 2017
Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas
Ye ZH, Gao L, Wen DY, He Y, Pang YY, Chen G
OncoTargets and Therapy 2017, 10:1711-1723
Published Date: 21 March 2017
Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum]
Xu J, Liu X, Yang S, Zhang X, Shi Y
OncoTargets and Therapy 2017, 10:1709-1710
Published Date: 21 March 2017
Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature [Corrigendum]
Yang X, Cao YD, Chen C, Liu L, Wang C, Liu SC
OncoTargets and Therapy 2017, 10:1707-1708
Published Date: 21 March 2017
Suppression of microRNA-629 enhances sensitivity of cervical cancer cells to 1′S-1′-acetoxychavicol acetate via regulating RSU1
Phuah NH, Azmi MN, Awang K, Nagoor NH
OncoTargets and Therapy 2017, 10:1695-1705
Published Date: 20 March 2017
Primary pancreatic lymphoma: two case reports and a literature review
Yu L, Chen Y, Xing L
OncoTargets and Therapy 2017, 10:1687-1694
Published Date: 20 March 2017
Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma
Ning X, Deng Y
OncoTargets and Therapy 2017, 10:1673-1686
Published Date: 20 March 2017
Role of cytokines and chemokines in alcohol-induced tumor promotion
Chen D, Zhang F, Ren H, Luo J, Wang S
OncoTargets and Therapy 2017, 10:1665-1671
Published Date: 17 March 2017
Human omental adipose-derived mesenchymal stem cell-conditioned medium alters the proteomic profile of epithelial ovarian cancer cell lines in vitro
Zhang YL, Dong WH, Wang JJ, Cai J, Wang ZH
OncoTargets and Therapy 2017, 10:1655-1663
Published Date: 17 March 2017
Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas
Jain S, Song R, Xie J
OncoTargets and Therapy 2017, 10:1645-1653
Published Date: 16 March 2017
Evaluation of efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma using magnetic resonance diffusion-weighted imaging
Wu X, Wang J, Ji J, Chen M, Song J
OncoTargets and Therapy 2017, 10:1637-1643
Published Date: 16 March 2017
MicroRNA-145 inhibits the activation of the mTOR signaling pathway to suppress the proliferation and invasion of invasive pituitary adenoma cells by targeting AKT3 in vivo and in vitro
Zhou K, Fan Y, Wu P, Duysenbi S, Feng Z, Du G, Zhang T
OncoTargets and Therapy 2017, 10:1625-1635
Published Date: 16 March 2017
CDKL1 promotes tumor proliferation and invasion in colorectal cancer
Qin C, Ren L, Ji M, Lv S, Wei Y, Zhu D, Lin Q, Xu P, Chang W, Xu J
OncoTargets and Therapy 2017, 10:1613-1624
Published Date: 16 March 2017
TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling
Dai Y, Duan H, Duan C, Zhu H, Zhou R, Pei H, Shen L
OncoTargets and Therapy 2017, 10:1603-1611
Published Date: 14 March 2017
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
McCulloch D, Brown C, Iland H
OncoTargets and Therapy 2017, 10:1585-1601
Published Date: 14 March 2017
SDF1-3'A polymorphism is associated with increased risk of hematological malignancy: a meta-analysis
Zhang X, Fan Y, Li Z
OncoTargets and Therapy 2017, 10:1575-1583
Published Date: 14 March 2017
Mechanism of immune evasion in breast cancer
Wang M, Zhang C, Song Y, Wang Z, Wang Y, Luo F, Xu Y, Zhao Y, Wu Z, Xu Y
OncoTargets and Therapy 2017, 10:1561-1573
Published Date: 14 March 2017
Knockdown of IQGAP1 inhibits proliferation and epithelial–mesenchymal transition by Wnt/β-catenin pathway in thyroid cancer
Su D, Liu Y, Song T
OncoTargets and Therapy 2017, 10:1549-1559
Published Date: 13 March 2017
Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study
Yang J, Li S, Lv M, Wu Y, Chen Z, Shen Y, Wang B, Chen L, Yi M, Yang J
OncoTargets and Therapy 2017, 10:1535-1548
Published Date: 13 March 2017
Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma
Vatte C, Al Amri AM, Cyrus C, Chathoth S, Acharya S, Hashim TM, Al Ali Z, Alshreadah ST, Alsayyah A, Al-Ali AK
OncoTargets and Therapy 2017, 10:1527-1533
Published Date: 13 March 2017
Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report
Deng L, Wang Y, Lu W, Liu Q, Wu J, Jin J
OncoTargets and Therapy 2017, 10:1521-1525
Published Date: 13 March 2017
MTA1 promotes proliferation and invasion in human gastric cancer cells [Retraction]
Yao Y, Feng S, Xiao M, Li Y, Yang L, Gong J
OncoTargets and Therapy 2017, 10:1519-1520
Published Date: 10 March 2017
Adverse prognostic impact of TGFB1 T869C polymorphism in non-small-cell lung cancer
Sang Y, Bi X, Liu Y, Zhang W, Wang D
OncoTargets and Therapy 2017, 10:1513-1518
Published Date: 10 March 2017
Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells
Chen W, Zhao K, Miao C, Xu A, Zhang J, Zhu J, Su S, Wang Z
OncoTargets and Therapy 2017, 10:1503-1512
Published Date: 9 March 2017
Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer
Aydin AM, Woldu SL, Hutchinson RC, Boegemann M, Bagrodia A, Lotan Y, Margulis V, Krabbe LM
OncoTargets and Therapy 2017, 10:1487-1502
Published Date: 9 March 2017
Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors
Guo W, Zheng YB, Xu B, Ma F, Li C, Zhang XQ, Wang Y, Chang XT
OncoTargets and Therapy 2017, 10:1475-1485
Published Date: 8 March 2017
Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors
Guo C, Chen X, Xiao W, Wang Q, Sun K, Wang Z
OncoTargets and Therapy 2017, 10:1465-1474
Published Date: 7 March 2017
Chronological changes in lung cancer surgery in a single Japanese institution
Nakamura H, Sakai H, Kimura H, Miyazawa T, Marushima H, Saji H
OncoTargets and Therapy 2017, 10:1459-1464
Published Date: 6 March 2017
Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer
Sarri AJ, Dias R, Laurienzo CE, Gonçalves MCP, Dias DS, Moriguchi SM
OncoTargets and Therapy 2017, 10:1451-1457
Published Date: 6 March 2017
Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma
Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z
OncoTargets and Therapy 2017, 10:1441-1449
Published Date: 6 March 2017
GSTM1 polymorphism is related to risks of nasopharyngeal cancer and laryngeal cancer: a meta-analysis
Zhang F, Wu X, Niu J, Kang X, Cheng L, Lv Y, Wu M
OncoTargets and Therapy 2017, 10:1433-1440
Published Date: 6 March 2017
MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK
Chen P, Xu W, Luo Y, Zhang Y, He Y, Yang S, Yuan Z
OncoTargets and Therapy 2017, 10:1423-1431
Published Date: 6 March 2017
Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia
Koprivnikar J, McCloskey J, Faderl S
OncoTargets and Therapy 2017, 10:1413-1422
Published Date: 6 March 2017
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?
Ali MA, Lacin S, Abdel-Wahab R, Uemura M, Hassan M, Rashid A, Duda DG, Kaseb AO
OncoTargets and Therapy 2017, 10:1403-1412
Published Date: 3 March 2017
HMGB1 is negatively correlated with the development of endometrial carcinoma and prevents cancer cell invasion and metastasis by inhibiting the process of epithelial-to-mesenchymal transition
Luan XR, Ma CJ, Wang P, Lou FL
OncoTargets and Therapy 2017, 10:1389-1402
Published Date: 3 March 2017
Arterial stiffness in hematologic malignancies
Mozos I, Borzak G, Caraba A, Mihaescu R
OncoTargets and Therapy 2017, 10:1381-1388
Published Date: 3 March 2017
The world of targeted therapies in kidney cancers: pitfalls, tips and tricks
Vallard A, Trone JC, Langrand-Escure J, Espenel S, Guy JB, Rancoule C, Xia YX, El Meddeb Hamrouni A, Ben Mrad M, Magné N
OncoTargets and Therapy 2017, 10:1375-1380
Published Date: 3 March 2017
Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma
Qiao Y, Li J, Shi C, Wang W, Qu X, Xiong M, Sun Y, Li D, Zhao X, Zhang D
OncoTargets and Therapy 2017, 10:1363-1373
Published Date: 3 March 2017
MicroRNA-148a suppresses proliferation and invasion potential of non-small cell lung carcinomas via regulation of STAT3
He M, Xue Y
OncoTargets and Therapy 2017, 10:1353-1361
Published Date: 2 March 2017
125I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy：a comparison with best supportive care
Song J, Fan X, Zhao Z, Chen M, Chen W, Wu F, Zhang D, Chen L, Tu J, Ji J
OncoTargets and Therapy 2017, 10:1345-1352
Published Date: 2 March 2017
Evidence from a meta-analysis: is nivolumab neurotoxic in cancer patients?
Kong X, Kong Y
OncoTargets and Therapy 2017, 10:1335-1344
Published Date: 1 March 2017
Clarifying the molecular mechanism associated with carfilzomib resistance in human multiple myeloma using microarray gene expression profile and genetic interaction network
Zheng Z, Liu T, Zheng J, Hu J
OncoTargets and Therapy 2017, 10:1327-1334
Published Date: 1 March 2017
Salinomycin repressed the epithelial–mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway
Li R, Dong T, Hu C, Lu J, Dai J, Liu P
OncoTargets and Therapy 2017, 10:1317-1325
Published Date: 28 February 2017
Downregulation of long noncoding RNA HOTAIRM1 promotes monocyte/dendritic cell differentiation through competitively binding to endogenous miR-3960
Xin J, Li J, Feng Y, Wang L, Zhang Y, Yang R
OncoTargets and Therapy 2017, 10:1307-1315
Published Date: 1 March 2017
Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) – non-interventional study
Losem C, Koenigsmann M, Rudolph C
OncoTargets and Therapy 2017, 10:1295-1305
Published Date: 28 February 2017
Discrimination of serous cystadenoma from mucinous cystadenoma in the pancreas with contrast-enhanced ultrasonography: a prospective study in 61 patients
Sun Y, Zhou F, Liu F, Hu Y, Tan S, Liang P, Linghu EQ, Yu X
OncoTargets and Therapy 2017, 10:1285-1294
Published Date: 28 February 2017
Sequential treatment of tyrosine kinase inhibitor and platinum-based doublet chemotherapy on EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled clinical trials
Qiao L, Wang J, Long G, Jiang Y
OncoTargets and Therapy 2017, 10:1279-1284
Published Date: 28 February 2017
MicroRNA-194 modulates epithelial–mesenchymal transition in human colorectal cancer metastasis
Cai H, Chen X, Tang Y, Deng Y
OncoTargets and Therapy 2017, 10:1269-1278
Published Date: 28 February 2017
Arenobufagin activates p53 to trigger esophageal squamous cell carcinoma cell apoptosis in vitro and in vivo
Lv J, Lin S, Peng P, Cai C, Deng J, Wang M, Li X, Lin R, Lin Y, Fang A, Li Q
OncoTargets and Therapy 2017, 10:1261-1267
Published Date: 28 February 2017
Application of carbon nanoparticles in lymph node dissection and parathyroid protection during thyroid cancer surgeries: a systematic review and meta-analysis
Wang L, Yang D, Lv JY, Yu D, Xin SJ
OncoTargets and Therapy 2017, 10:1247-1260
Published Date: 27 February 2017
miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma
Luan WK, Qian Y, Ni X, Bu XF, Xia Y, Wang JL, Ruan HR, Ma SJ, Xu B
OncoTargets and Therapy 2017, 10:1237-1246
Published Date: 27 February 2017
A new tumor suppressor lncRNA RP11-190D6.2 inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells
Tong W, Yang L, Yu Q, Yao J, He A
OncoTargets and Therapy 2017, 10:1227-1235
Published Date: 27 February 2017
The expression of aplysia ras homolog I (ARHI) and its inhibitory effect on cell biological behavior in esophageal squamous cell carcinoma
Mao Y, Han Y, Shi W
OncoTargets and Therapy 2017, 10:1217-1226
Published Date: 27 February 2017
Toll-like receptor-4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women
Semlali A, Jalouli M, Parine NR, Al Amri A, Arafah M, Al Naeem A, Abdullah Ajaj S, Rouabhia M, Alanazi MS
OncoTargets and Therapy 2017, 10:1207-1216
Published Date: 24 February 2017
Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort
Zhou G, Liu X, Wang X, Jin D, Chen Y, Li G, Li C, Fu D, Xu W, Wang X
OncoTargets and Therapy 2017, 10:1199-1206
Published Date: 24 February 2017
Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial–mesenchymal transition
Xu Y, Wang B, Zhang F, Wang A, Du X, Hu P, Zhu Y, Fang Z
OncoTargets and Therapy 2017, 10:1191-1198
Published Date: 24 February 2017
Preoperative lymphocyte-to-monocyte ratio predicts survival in primary hepatitis B-virus positive hepatocellular carcinoma after curative resection
Li G, Ji J, Yang F, Xu H, Bai Y
OncoTargets and Therapy 2017, 10:1181-1189
Published Date: 23 February 2017
Aberrant histone modification in CD19+ B cells of the patients with chronic lymphocytic leukemia
Zhou K, Zhang Q, Liu Y, Xiong Y, Wu S, Yang J, Zhou H, Liu X, Wei X, Song Y
OncoTargets and Therapy 2017, 10:1173-1179
Published Date: 23 February 2017
Prognostic and clinicopathologic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma: evidence from a meta-analysis
Huang Y, Sun Y, Peng P, Zhu S, Sun W, Zhang P
OncoTargets and Therapy 2017, 10:1165-1172
Published Date: 23 February 2017
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
Recine F, Bongiovanni A, Riva N, Fausti V, De Vita A, Mercatali L, Liverani C, Miserocchi G, Amadori D, Ibrahim T
OncoTargets and Therapy 2017, 10:1155-1164
Published Date: 23 February 2017
Association between TP53 gene Arg72Pro polymorphism and Wilms’ tumor risk in a Chinese population
Fu W, Zhuo Z, Jia W, Zhu J, Zhu S, Lin Z, Wang F, Xia H, He J, Liu G
OncoTargets and Therapy 2017, 10:1149-1154
Published Date: 23 February 2017
Long-term survival after a favorable response to anti-EGFR antibody plus chemotherapy to treat bone marrow metastasis: a case report of KRAS-wildtype rectal cancer
Nakamura S, Fukui T, Suzuki S, Takeda H, Watanabe K, Yoshioka T
OncoTargets and Therapy 2017, 10:1143-1147
Published Date: 23 February 2017
Intrahepatic cholangiocarcinoma: current perspectives
Buettner S, van Vugt JLA, IJzermans JNM, Groot Koerkamp B
OncoTargets and Therapy 2017, 10:1131-1142
Published Date: 22 February 2017
Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: a retrospective study
Zhao YX, Liu S, Hu YB, Ge YY, Lv DM
OncoTargets and Therapy 2017, 10:1123-1129
Published Date: 22 February 2017
miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8
Liu Y, Zhang B, Shi T, Qin H
OncoTargets and Therapy 2017, 10:1115-1122
Published Date: 24 February 2017
Internal mammary lymph node management – further direction
Vrana D, Gatek J
OncoTargets and Therapy 2017, 10:1111-1114
Published Date: 21 February 2017
Impact of gefitinib in early stage treatment on circulating cytokines and lymphocytes for patients with advanced non–small cell lung cancer
Sheng J, Fang W, Liu X, Xing S, Zhan J, Ma Y, Huang Y, Zhou N, Zhao H, Zhang L
OncoTargets and Therapy 2017, 10:1101-1110
Published Date: 21 February 2017
Decrease of miR-622 expression suppresses migration and invasion by targeting regulation of DYRK2 in colorectal cancer cells
Wang Y, Sun J, Wei X, Luan L, Zeng X, Wang C, Zhao W
OncoTargets and Therapy 2017, 10:1091-1100
Published Date: 22 February 2017
Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine – a Phase I trial
Guetz S, Tufman A, von Pawel J, Rittmeyer A, Borgmeier A, Ferré P, Edlich B, Huber RM
OncoTargets and Therapy 2017, 10:1081-1089
Published Date: 21 February 2017
SIX1 overexpression predicts poor prognosis and induces radioresistance through AKT signaling in esophageal squamous cell carcinoma
He Z, Li G, Tang L, Li Y
OncoTargets and Therapy 2017, 10:1071-1079
Published Date: 21 February 2017
Tbx2 confers poor prognosis in glioblastoma and promotes temozolomide resistance with change of mitochondrial dynamics
Yi F, Du J, Ni W, Liu W
OncoTargets and Therapy 2017, 10:1059-1069
Published Date: 20 February 2017
MicroRNA-320 inhibits invasion and induces apoptosis by targeting CRKL and inhibiting ERK and AKT signaling in gastric cancer cells
Zhao Y, Dong Q, Wang E
OncoTargets and Therapy 2017, 10:1049-1058
Published Date: 20 February 2017
Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma
Che K, Zhao Y, Qu X, Pang Z, Ni Y, Zhang T, Du J, Shen H
OncoTargets and Therapy 2017, 10:1039-1047
Published Date: 20 February 2017
miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1
Zheng L, Chen J, Zhou Z, He Z
OncoTargets and Therapy 2017, 10:1027-1038
Published Date: 20 February 2017
Overexpression of the long non-coding RNA, linc-UBC1, is associated with poor prognosis and facilitates cell proliferation, migration, and invasion in colorectal cancer
Gao X, Wen J, Gao P, Zhang G, Zhang G
OncoTargets and Therapy 2017, 10:1017-1026
Published Date: 22 February 2017
Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells
Mang YY, Li L, Ran JH, Zhang SN, Liu J, Li LB, Chen YM, Liu J, Gao Y, Ren G
OncoTargets and Therapy 2017, 10:1003-1016
Published Date: 20 February 2017
Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury [Corrigendum]
Mizuno T, Sato W, Ishikawa K, Terao Y, Takahashi K, Noda Y, Yuzawa Y, Nagamatsu T
OncoTargets and Therapy 2017, 10:1001-1002
Published Date: 21 February 2017
Prognostic role of long noncoding RNA NEAT1 in various carcinomas: a meta-analysis
Chen T, Wang H, Yang P, He ZY
OncoTargets and Therapy 2017, 10:993-1000
Published Date: 17 February 2017
Breast and cervical cancer-screening uptake among females in Ardabil, northwest Iran: a community-based study
Farzaneh E, Heydari H, Shekarchi AA, Kamran A
OncoTargets and Therapy 2017, 10:985-992
Published Date: 17 February 2017
Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis
Yi SY, Zeng LJ, Kuang Y, Cao ZJ, Zheng CJ, Zhang Y, Liao M, Yang L
OncoTargets and Therapy 2017, 10:973-984
Published Date: 17 February 2017
BRAFV600 mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study
Cohn AL, Day B, Abhyankar S, McKenna E, Riehl T, Puzanov I
OncoTargets and Therapy 2017, 10:965-971
Published Date: 17 February 2017
Axl promotes the proliferation, invasion and migration of Wilms’ tumor and can be used as a prognostic factor
Zhu S, Liu G, Fu W, Hu J, Fu K, Jia W
OncoTargets and Therapy 2017, 10:955-963
Published Date: 16 February 2017
Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis
Hao Y, Fu Q, Guo Y, Ye M, Zhao H, Wang Q, Peng X, Li Q, Wang R, Xiao W
OncoTargets and Therapy 2017, 10:945-953
Published Date: 16 February 2017
Polydatin regulates proliferation, apoptosis and autophagy in multiple myeloma cells through mTOR/p70s6k pathway
Yang B, Zhao S
OncoTargets and Therapy 2017, 10:935-944
Published Date: 16 February 2017
The superiority of 256-slice spiral computed tomography angiography for preoperative evaluation of surrounding arteries in patients with gastric cancer
Wu D, Zhao L, Liu Y, Wang J, Hu W, Feng X, Lv Z, Li Y, Yao X
OncoTargets and Therapy 2017, 10:927-933
Published Date: 16 February 2017
Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis
Lan X, Li S, Gao H, Nanding A, Quan L, Yang C, Ding S, Xue Y
OncoTargets and Therapy 2017, 10:919-926
Published Date: 16 February 2017
Association between VEGF–460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
Tan JY, Jiang L, Cheng XW, Wang CL, Chen JS, Huang XQ, Xie P, Xia DM, Wang RS, Zhang Y
OncoTargets and Therapy 2017, 10:909-918
Published Date: 15 February 2017
Carfilzomib boosted combination therapy for relapsed multiple myeloma
Steiner RE, Manasanch EE
OncoTargets and Therapy 2017, 10:895-907
Published Date: 15 February 2017
miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma
Xie F, Yuan Y, Xie L, Ran P, Xiang X, Huang Q, Qi G, Guo X, Xiao C, Zheng S
OncoTargets and Therapy 2017, 10:885-894
Published Date: 15 February 2017
Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma
Yu S, Zhou Z, Cai Q, Liang F, Han P, Chen R, Huang X
OncoTargets and Therapy 2017, 10:879-884
Published Date: 15 February 2017
The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy
Liu X, Li M, Zhao F, Zhu Y, Luo Y, Kong L, Zhu H, Zhang Y, Shi F, Yu J
OncoTargets and Therapy 2017, 10:871-877
Published Date: 14 February 2017
Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis
Li Z, Yin SC, Zhang L, Liu WG, Chen B, Xing H
OncoTargets and Therapy 2017, 10:859-870
Published Date: 14 February 2017
Correlations of microvascular blood flow of contrast-enhanced ultrasound and HGF/c-Met signaling pathway with clinicopathological features and prognosis of patients with hepatocellular carcinoma
Zhuang PH, Xu L, Gao L, Lu W, Ruan LT, Yang J
OncoTargets and Therapy 2017, 10:847-857
Published Date: 14 February 2017
Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series
Zhang H, Chen F, Wang Z, Wu S
OncoTargets and Therapy 2017, 10:837-845
Published Date: 14 February 2017
The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma
Fu P, Chen F, Pan Q, Zhao X, Zhao C, Cho WC, Chen H
OncoTargets and Therapy 2017, 10:819-835
Published Date: 14 February 2017
AIM2 regulates viability and apoptosis in human colorectal cancer cells via the PI3K/Akt pathway
Chen JJ, Wang ZJ, Yu SS
OncoTargets and Therapy 2017, 10:811-817
Published Date: 13 February 2017
Effects of HGF gene polymorphisms and protein expression on transhepatic arterial chemotherapeutic embolism efficacy and prognosis in patients with primary liver cancer
Chen HY, Chen YM, Wu J, Yang FC, Lv Z, Qian YG, Zheng SS
OncoTargets and Therapy 2017, 10:803-810
Published Date: 13 February 2017
RNAi for contactin 2 inhibits proliferation of U87-glioma stem cells by downregulating AICD, EGFR, and HES1
Guo Y, Zhang PD, Zhang HT, Zhang P, Xu RX
OncoTargets and Therapy 2017, 10:791-801
Published Date: 13 February 2017
Clinicopathological significance of ZEB-1 and E-cadherin proteins in patients with oral cavity squamous cell carcinoma
Yao X, Sun S, Zhou X, Zhang Q, Guo W, Zhang L
OncoTargets and Therapy 2017, 10:781-790
Published Date: 13 February 2017
Efficacy of eribulin in breast cancer: a short report on the emerging new data
Eslamian G, Wilson C, Young RJ
OncoTargets and Therapy 2017, 10:773-779
Published Date: 13 February 2017
Induction of PD-L1 expression by epidermal growth factor receptor–mediated signaling in esophageal squamous cell carcinoma
Zhang W, Pang Q, Yan C, Wang Q, Yang J, Yu S, Liu X, Yuan Z, Wang P, Xiao Z
OncoTargets and Therapy 2017, 10:763-771
Published Date: 13 February 2017
MiR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting HOXA1
Wang J, Tang W, Liao M, Liu Y, Ai X
OncoTargets and Therapy 2017, 10:753-761
Published Date: 10 February 2017
Two SNPs in the promoter region of Toll-like receptor 4 gene are not associated with smoking in Saudi Arabia
Kohailan M, Alanazi M, Rouabhia M, Al Amri A, Parine NR, Semlali A
OncoTargets and Therapy 2017, 10:745-752
Published Date: 9 February 2017
CUL4A promotes proliferation and metastasis of colorectal cancer cells by regulating H3K4 trimethylation in epithelial–mesenchymal transition
Sui X, Zhou H, Zhu L, Wang D, Fan S, Zhao W
OncoTargets and Therapy 2017, 10:735-743
Published Date: 9 February 2017
Preoperative albumin-to-globulin ratio and prognostic nutrition index predict prognosis for glioblastoma
Xu WZ, Li F, Xu ZK, Chen X, Sun B, Cao JW, Liu YG
OncoTargets and Therapy 2017, 10:725-733
Published Date: 8 February 2017
β-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma
Yang CM, Ji S, Li Y, Fu LY, Jiang T, Meng FD
OncoTargets and Therapy 2017, 10:711-724
Published Date: 20 February 2017
Common variations within HACE1 gene and neuroblastoma susceptibility in a Southern Chinese population
Zhang Z, Zhang R, Zhu J, Wang F, Yang T, Zou Y, He J, Xia H
OncoTargets and Therapy 2017, 10:703-709
Published Date: 8 February 2017
ARHGAP1 overexpression inhibits proliferation, migration and invasion of C-33A and SiHa cell lines
Li JP, Liu Y, Yin YH
OncoTargets and Therapy 2017, 10:691-701
Published Date: 7 February 2017
USP21 promotes cell proliferation and metastasis through suppressing EZH2 ubiquitination in bladder carcinoma
Chen Y, Zhou B, Chen D
OncoTargets and Therapy 2017, 10:681-689
Published Date: 7 February 2017
miR182 activates the Ras–MEK–ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1
Wang JH, Wang W, Li JC, Wu LJ, Song M, Meng QG
OncoTargets and Therapy 2017, 10:667-679
Published Date: 7 February 2017
Prognostic implications of Kindlin proteins in human osteosarcoma
Ning K, Zhang H, Wang Z, Li K
OncoTargets and Therapy 2017, 10:657-665
Published Date: 7 February 2017
Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia
Huber H, Edenhofer S, Estenfelder S, Stilgenbauer S
OncoTargets and Therapy 2017, 10:645-656
Published Date: 7 February 2017
Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway
Cui Y, Li Q, Li H, Wang Y, Wang H, Chen W, Zhang S, Cao J, Liu T
OncoTargets and Therapy 2017, 10:627-643
Published Date: 3 February 2017
High expression of glucose-regulated protein 78 (GRP78) is associated with metastasis and poor prognosis in patients with esophageal squamous cell carcinoma
Ren P, Chen C, Yue J, Zhang J, Yu Z
OncoTargets and Therapy 2017, 10:617-625
Published Date: 9 February 2017
FLT3 inhibitors: clinical potential in acute myeloid leukemia
Hospital MA, Green AS, Maciel TT, Moura IC, Leung AY, Bouscary D, Tamburini J
OncoTargets and Therapy 2017, 10:607-615
Published Date: 3 February 2017
Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase
Alakel N, Middeke JM, Schetelig J, Bornhäuser M
OncoTargets and Therapy 2017, 10:597-605
Published Date: 2 February 2017
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial
Tabernero J, Kunzmann V, Scheithauer W, Reni M, Shiansong Li J, Ferrara S, Djazouli K
OncoTargets and Therapy 2017, 10:591-596
Published Date: 2 February 2017
Expression of microRNA-30c via lentivirus vector inhibits the proliferation and enhances the sensitivity of highly aggressive ccRCC Caki-1 cells to anticancer agents
Yang HL, Song EL, Shen GR, Zhu TH, Jiang TW, Shen H, Niu LP, Wang B, Lu ZY, Qian JP
OncoTargets and Therapy 2017, 10:579-590
Published Date: 2 February 2017
Exploring targeted therapy of osteosarcoma using proteomics data
Chaiyawat P, Settakorn J, Sangsin A, Teeyakasem P, Klangjorhor J, Soongkhaw A, Pruksakorn D
OncoTargets and Therapy 2017, 10:565-577
Published Date: 1 February 2017
Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung
Nakamura T, Matsumine A, Takao M, Nakatsuka A, Matsubara T, Asanuma K, Sudo A
OncoTargets and Therapy 2017, 10:559-564
Published Date: 31 January 2017
Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of life
Severi S, Grassi I, Nicolini S, Sansovini M, Bongiovanni A, Paganelli G
OncoTargets and Therapy 2017, 10:551-557
Published Date: 27 January 2017
miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer
Yang F, Li Y, Xu L, Zhu Y, Gao H, Zhen L, Fang L
OncoTargets and Therapy 2017, 10:543-550
Published Date: 27 January 2017
Clinical investigation into the initial diagnosis and treatment of 539 patients with stage IV lung cancer
Shao Q, Liu S, Wang W, zhang Y, Li F, Li J
OncoTargets and Therapy 2017, 10:535-541
Published Date: 31 January 2017
The clinical significance of the Ezrin gene and circulating tumor cells in osteosarcoma
Zhong GX, Feng SD, Shen RK, Wu Z, Chen F, Zhu X
OncoTargets and Therapy 2017, 10:527-533
Published Date: 8 February 2017
Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim–Chester disease
Váradi Z, Bánusz R, Csomor J, Kállay K, Varga E, Kertész G, Csóka M
OncoTargets and Therapy 2017, 10:521-526
Published Date: 24 January 2017
Differential pharmacology and clinical utility of sonidegib in advanced basal cell carcinoma
Wahid M, Jawed A, Dar SA, Mandal RK, Haque S
OncoTargets and Therapy 2017, 10:515-520
Published Date: 24 January 2017
Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma
Miguel A, Sendra L, Noé V, Ciudad CJ, Dasi F, Hervas D, Herrero MJ, Aliño SF
OncoTargets and Therapy 2017, 10:503-514
Published Date: 23 January 2017
Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis
Wang J, Yu M, Guan S, Zhang G, Wang J, Cheng Y
OncoTargets and Therapy 2017, 10:493-502
Published Date: 23 January 2017
Silence of long noncoding RNA PANDAR switches low-dose curcumin-induced senescence to apoptosis in colorectal cancer cells
Chen T, Yang P, Wang H, He ZY
OncoTargets and Therapy 2017, 10:483-491
Published Date: 21 January 2017
Parity association with clinicopathological factors in invasive breast cancer: a retrospective analysis
Shen SD, Zhong SZ, Xiao GF, Zhou HB, Huang WH
OncoTargets and Therapy 2017, 10:477-481
Published Date: 21 January 2017
Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors
Zulfiqar B, Mahroo A, Nasir K, Farooq RK, Jalal N, Rashid MU, Asghar K
OncoTargets and Therapy 2017, 10:463-476
Published Date: 21 January 2017
Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis
Liu W, Wang X, Sun J, Yang Y, Li W, Song J
OncoTargets and Therapy 2017, 10:453-461
Published Date: 23 January 2017
Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma
Fang S, Zhang H, Zhang Y, Xie W
OncoTargets and Therapy 2017, 10:447-452
Published Date: 18 January 2017
Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel
Huang T, Yang L, Wang G, Ding G, Peng B, Wen Y, Wang Z
OncoTargets and Therapy 2017, 10:439-446
Published Date: 18 January 2017
Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status
Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Sangatsuda Y, Suzuki SO, Shono T, Mizoguchi M, Iihara K
OncoTargets and Therapy 2017, 10:429-437
Published Date: 18 January 2017
Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis
Liang CJ, Xu YC, Li GM, Zhao TJ, Xia F, Li GQ, Zhang D, Wu JX
OncoTargets and Therapy 2017, 10:417-428
Published Date: 18 January 2017
Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer
Zang JL, Hu Y, Xu XY, Ni J, Yan DL, Liu SW, He J, Xue J, Wu JZ, Feng JF
OncoTargets and Therapy 2017, 10:409-415
Published Date: 18 January 2017
Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature
Yang X, Cao YD, Chen C, Liu L, Wang C, Liu SC
OncoTargets and Therapy 2017, 10:397-407
Published Date: 18 January 2017
FBLN4 as candidate gene associated with long-term and short-term survival with primary glioblastoma
Li F, Li YP, Zhang K, Li Y, He P, Liu YJ, Yuan H, Lu H, Liu J, Che S, Li Z, Bie L
OncoTargets and Therapy 2017, 10:387-395
Published Date: 16 January 2017
Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study
Beisland C, Johannesen TB, Klepp O, Axcrona U, Torgersen KM, Kowalski J, Solli O, Sandin R, Oldenburg J
OncoTargets and Therapy 2017, 10:371-385
Published Date: 16 January 2017
Validation of a novel prognostic scoring system using inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma
Hirahara N, Fujii Y, Yamamoto T, Hyakudomi R, Hirayama T, Taniura T, Ishitobi K, Tajima Y
OncoTargets and Therapy 2017, 10:363-370
Published Date: 13 January 2017
Letter to the editor regarding "Prognostic role of microRNA-150 in various carcinomas: a meta-analysis"
Li M, Yang Y
OncoTargets and Therapy 2017, 10:361-362
Published Date: 13 January 2017
Advances in antiangiogenic treatment of small-cell lung cancer
Lu H, Jiang Z
OncoTargets and Therapy 2017, 10:353-359
Published Date: 12 January 2017
Chidamide in the treatment of peripheral T-cell lymphoma
Chan TS, Tse E, Kwong YL
OncoTargets and Therapy 2017, 10:347-352
Published Date: 12 January 2017
Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy
Chen J, Liu L, Xu J
OncoTargets and Therapy 2017, 10:339-345
Published Date: 11 January 2017
Radiosynthesis and pharmacokinetics of [18F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice
Yang Z, Liu J, Huang Q, Zhang Z, Zhang J, Pan Y, Yang Y, Cheng D
OncoTargets and Therapy 2017, 10:329-338
Published Date: 11 January 2017
Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis
Yin SC, Li Z, Huang JY, Miao ZF, Zhang JY, Lu CY, Xu H, Xu HM
OncoTargets and Therapy 2017, 10:319-327
Published Date: 10 January 2017
Expression of phosphatase of regenerating liver-3 is associated with prognosis of Wilms’ tumor
Sun F, Li W, Wang L, Jiao C
OncoTargets and Therapy 2017, 10:311-317
Published Date: 10 January 2017
Association of MTHFR C677T and A1298C polymorphisms with oral cancer susceptibility: evidence from a meta-analysis
Jiang S, Xu J, Zhuo Z, Hua Z
OncoTargets and Therapy 2017, 10:303-310
Published Date: 10 January 2017
Clinical outcomes of patients with metachronous second primary lung adenocarcinomas
Zhao H, Yang H, Han K, Xu J, Yao F, Zhao Y, Fan L, Gu H, Shen Z
OncoTargets and Therapy 2017, 10:295-302
Published Date: 10 January 2017
Apoptotic induction and inhibition of NF-κB signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2'-oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis: an in vitro study
Abbaspour Babaei M, Zaman Huri H, Kamalidehghan B, Yeap SK, Ahmadipour F
OncoTargets and Therapy 2017, 10:277-294
Published Date: 10 January 2017
Correlation of SASH1 expression and ultrasonographic features in breast cancer
Gong X, Wu J, Wu J, Liu J, Gu H, Shen H
OncoTargets and Therapy 2017, 10:271-276
Published Date: 10 January 2017
Strategies of temozolomide in future glioblastoma treatment
Lee CY
OncoTargets and Therapy 2017, 10:265-270
Published Date: 9 January 2017
Basal oxidative stress ratio of head and neck squamous cell carcinomas correlates with nodal metastatic spread in patients under therapy
Dequanter D, Dok R, Nuyts S
OncoTargets and Therapy 2017, 10:259-263
Published Date: 9 January 2017
RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis
Shou FY, Xu F, Li G, Zhao ZH, Mao Y, Yang FF, Wang HM, Guo HY
OncoTargets and Therapy 2017, 10:247-257
Published Date: 9 January 2017
Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection
Fan L, Yang H, Yao F, Zhao Y, Gu H, Han K, Zhao H
OncoTargets and Therapy 2017, 10:239-245
Published Date: 6 January 2017
MTHFR C677T polymorphism and breast, ovarian cancer risk: a meta-analysis of 19,260 patients and 26,364 controls
He L, Shen Y
OncoTargets and Therapy 2017, 10:227-238
Published Date: 6 January 2017
VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma
Nadiminti K, Singh Abbi KK, Mott SL, Dozeman L, Tricot A, Schultz A, Behrends S, Zhan F, Tricot G
OncoTargets and Therapy 2017, 10:217-226
Published Date: 6 January 2017
Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer
Gao H, Song X, Kang T, Yan B, Feng L, Gao L, Ai L, Liu X, Yu J, Li H
OncoTargets and Therapy 2017, 10:205-216
Published Date: 5 January 2017
Multivoxel magnetic resonance spectroscopy identifies enriched foci of cancer stem-like cells in high-grade gliomas
He T, Qiu T, Wang X, Gui H, Wang X, Hu Q, Xia H, Qi G, Wu J, Ma H
OncoTargets and Therapy 2017, 10:195-203
Published Date: 4 January 2017
The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer
Dong J, Zhang Z, Gu T, Xu SF, Dong LX, Li X, Fu BH, Fu ZZ
OncoTargets and Therapy 2017, 10:185-194
Published Date: 29 December 2016
A comparative study of target volumes based on 18F-FDG PET-CT and ten phases of 4DCT for primary thoracic squamous esophageal cancer
Guo Y, Li J, Zhang P, Zhang Y
OncoTargets and Therapy 2017, 10:177-184
Published Date: 6 January 2017
Pediatric papillary thyroid cancer: current management challenges
Verburg FA, Van Santen HM, Luster M
OncoTargets and Therapy 2017, 10:165-175
Published Date: 28 December 2016
Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings
Shimizu K, Okita R, Saisho S, Maeda A, Nojima Y, Nakata M
OncoTargets and Therapy 2017, 10:153-163
Published Date: 28 December 2016
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphoma
Zhang Q, Cao J, Xue K, Liu X, Ji D, Guo Y, Hong X
OncoTargets and Therapy 2017, 10:145-151
Published Date: 22 December 2016
Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
Kwak TW, Park SB, Kim HJ, Jeong YI, Kang DH
OncoTargets and Therapy 2017, 10:137-144
Published Date: 22 December 2016
Decreased miR-503 expression in gastric cancer is inversely correlated with serum carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker
Wu D, Cao G, Huang Z, Jin K, Hu H, Yu J, Zeng Y
OncoTargets and Therapy 2017, 10:129-135
Published Date: 23 December 2016
Comparing efficacy and survivals of initial treatments for elderly patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials
Liu X, Chen J, He YA, Meng X, Li K, He CK, Liu S
OncoTargets and Therapy 2017, 10:121-128
Published Date: 22 December 2016
High expression of long noncoding RNA HULC is a poor predictor of prognosis and regulates cell proliferation in glioma
Yan H, Tian R, Zhang M, Wu J, Ding M, He J
OncoTargets and Therapy 2017, 10:113-120
Published Date: 21 December 2016
nab-Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors
Soliman HH
OncoTargets and Therapy 2017, 10:101-112
Published Date: 21 December 2016
Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological study
Wang Y, Meng F, Liu Y, Chen X
OncoTargets and Therapy 2017, 10:95-100
Published Date: 20 December 2016
Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China
Tang H, Wu Y, Qin Y, Wang H, Wang L, Guan X, Luo S, Wang Q
OncoTargets and Therapy 2017, 10:85-94
Published Date: 20 December 2016
RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src
Zhang X, Song Y, Song N, Zhang Y, Zhang L, Wang Y, Wang Z, Qu X, Liu Y
OncoTargets and Therapy 2017, 10:73-83
Published Date: 5 January 2017
Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review
He W, Zou C, Tian ZK, Tan WY, Shen WX, Chen JH, Liu LP, Xu RL
OncoTargets and Therapy 2017, 10:67-72
Published Date: 20 December 2016
A novel synthetic Asiatic acid derivative induces apoptosis and inhibits proliferation and mobility of gastric cancer cells by suppressing STAT3 signaling pathway
Wang G, Jing Y, Cao LS, Gong CC, Gong ZN, Cao XR
OncoTargets and Therapy 2017, 10:55-66
Published Date: 20 December 2016
Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma
Cheng Y, Xing SG, Jia WD, Huang M, Bian NN
OncoTargets and Therapy 2017, 10:47-54
Published Date: 19 December 2016
Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP
Lei R, Xue M, Zhang L, Lin ZQ
OncoTargets and Therapy 2017, 10:35-46
Published Date: 19 December 2016
Atypical aleukemic presentation of large granular lymphocytic leukemia: a case report
Bagacean C, Tempescul A, Patiu M, Fetica B, Bumbea H, Zdrenghea M
OncoTargets and Therapy 2017, 10:31-34
Published Date: 19 December 2016
Potential role of immunotherapy in advanced non-small-cell lung cancer
de Mello RA, Veloso AF, Esrom Catarina P, Nadine S, Antoniou G
OncoTargets and Therapy 2017, 10:21-30
Published Date: 16 December 2016
J-pouch versus Roux-en-Y reconstruction after gastrectomy: functional assessment and quality of life (randomized trial)
Zonca P, Maly T, Ihnat P, Peteja M, Kraft O, Kuca K
OncoTargets and Therapy 2017, 10:13-19
Published Date: 16 December 2016
Association between TLR-9 polymorphisms and colon cancer susceptibility in Saudi Arabian female patients
Semlali A, Parine NR, Al Amri A, Azzi A, Arafah M, Kohailan M, Shaik JP, Almadi MA, Aljebreen AM, Alharbi O, Ali Azzam N, Rouabhia M, Alanazi MS
OncoTargets and Therapy 2017, 10:1-11
Published Date: 16 December 2016
Non-secretory multiple myeloma: from biology to clinical management
Dupuis MM, Tuchman SA
OncoTargets and Therapy 2016, 9:7583-7590
Published Date: 15 December 2016
Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives
Mulet-Margalef N, Garcia-del-Muro X
OncoTargets and Therapy 2016, 9:7573-7582
Published Date: 15 December 2016
Lipopolysaccharide-induced α-catenin downregulation enhances the motility of human colorectal cancer cells in an NF-κB signaling-dependent manner
Cheng G, Yang S, Zhang G, Xu Y, Liu X, Sun W, Zhu L
OncoTargets and Therapy 2016, 9:7563-7571
Published Date: 14 December 2016
Evaluation of the efficacy of chemoradiotherapy in cervical cancer using diffusion-weighted imaging and apparent diffusion coefficient
Ju F
OncoTargets and Therapy 2016, 9:7555-7561
Published Date: 13 December 2016
Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role
Cochetti G, Poli G, Guelfi G, Boni A, Egidi MG, Mearini E
OncoTargets and Therapy 2016, 9:7545-7553
Published Date: 13 December 2016
The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning
Zhu J, Simon A, Haigron P, Lafond C, Acosta O, Shu H, Castelli J, Li B, De Crevoisier R
OncoTargets and Therapy 2016, 9:7537-7544
Published Date: 12 December 2016
A pilot study employing hepatic intra-arterial irinotecan injection of drug-eluting beads as salvage therapy in liver metastatic colorectal cancer patients without extrahepatic involvement: the first southern Italy experience
Ranieri G, Niccoli Asabella A, Altini C, Fazio V, Caporusso L, Marech I, Vinciarelli G, Macina F, de Ceglia D, Fanelli M, Ammendola M, Rubini G, Gadaleta CD
OncoTargets and Therapy 2016, 9:7527-7535
Published Date: 12 December 2016
β-Elemene treatment of glioblastoma: a single-center retrospective study
Ma C, Zhou W, Yan Z, Qu M, Bu X
OncoTargets and Therapy 2016, 9:7521-7526
Published Date: 12 December 2016
Correlation between epidermal growth factor receptor tyrosine kinase inhibitor efficacy and circulating tumor cell levels in patients with advanced non-small cell lung cancer
He W, Li W, Jiang B, Chang L, Jin C, Tu C, Li Y
OncoTargets and Therapy 2016, 9:7515-7520
Published Date: 12 December 2016
Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells
Souza e Silva V, Chinen LTD, Abdallah EA, Damascena A, Paludo J, Chojniak R, Dettino ALA, Mello CAL, Alves VS, Fanelli MF
OncoTargets and Therapy 2016, 9:7503-7513
Published Date: 13 December 2016
Overexpression and clinical significance of MYC-associated zinc finger protein in pancreatic carcinoma
Zhu X, Luo W, Liang W, Tang F, Bei C, Ren Y, Qin L, Tan C, Zhang Y, Tan S
OncoTargets and Therapy 2016, 9:7493-7501
Published Date: 12 December 2016
Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells
Ye T, Su J, Huang C, Yu D, Dai S, Huang X, Chen B, Zhou M
OncoTargets and Therapy 2016, 9:7481-7492
Published Date: 12 December 2016
Biomarkers in pancreatic adenocarcinoma: current perspectives
Swords DS, Firpo MA, Scaife CL, Mulvihill SJ
OncoTargets and Therapy 2016, 9:7459-7467
Published Date: 9 December 2016
Comprehensive profile of differentially expressed circular RNAs reveals that hsa_circ_0000069 is upregulated and promotes cell proliferation, migration, and invasion in colorectal cancer
Guo J, Li J, Zhu C, Feng W, Shao J, Wan L, Huang M, He J
OncoTargets and Therapy 2016, 9:7451-7458
Published Date: 9 December 2016
Comparison of the clinical features and hematopoietic stem cell transplantation outcomes of mediastinal malignant germ cell tumors with nonmediastinal extragonadal placements
Ocal N, Yildiz B, Karadurmus N, Dogan D, Ozaydin S, Ocal R, Ozturk M, Arpaci F, Bilgic H
OncoTargets and Therapy 2016, 9:7445-7450
Published Date: 9 December 2016
Omega-3 polyunsaturated fatty acids in the prevention of postoperative complications in colorectal cancer: a meta-analysis
Xie H, Chang Y
OncoTargets and Therapy 2016, 9:7435-7443
Published Date: 9 December 2016
Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patients
Wen X, Lu F, Liu S
OncoTargets and Therapy 2016, 9:7425-7433
Published Date: 8 December 2016
Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population
Yan WY, Hu J, Xie L, Cheng L, Yang M, Li L, Shi J, Liu BR, Qian X
OncoTargets and Therapy 2016, 9:7415-7424
Published Date: 8 December 2016
Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis
Shi H, Wang X, Wang J, Pan J, Liu J, Ye B
OncoTargets and Therapy 2016, 9:7409-7414
Published Date: 8 December 2016
Identification of feature genes for smoking-related lung adenocarcinoma based on gene expression profile data
Liu Y, Ni R, Zhang H, Miao L, Wang J, Jia W, Wang Y
OncoTargets and Therapy 2016, 9:7397-7407
Published Date: 7 December 2016
Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran
Dolatkhah R, Somi MH, Asvadi Kermani I, Bonyadi M, Sepehri B, Boostani K, Azadbakht S, Fotouhi N, Farassati F, Dastgiri S
OncoTargets and Therapy 2016, 9:7385-7395
Published Date: 7 December 2016
Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway
Kang Y, Hu W, Bai E, Zheng H, Liu Z, Wu J, Jin R, Zhao C, Liang G
OncoTargets and Therapy 2016, 9:7373-7384
Published Date: 5 December 2016
Mutations in hepatitis B virus small S genes predict postoperative survival in hepatocellular carcinoma
Peng L, Yang G, Wu C, Wang WS, Wu J, Guo Z
OncoTargets and Therapy 2016, 9:7367-7372
Published Date: 2 December 2016
Next-generation sequencing: advances and applications in cancer diagnosis
Serratì S, De Summa S, Pilato B, Petriella D, Lacalamita R, Tommasi S, Pinto R
OncoTargets and Therapy 2016, 9:7355-7365
Published Date: 2 December 2016
Structure–activity relationships study of mTOR kinase inhibition using QSAR and structure-based drug design approaches
Lakhlili W, Yasri A, Ibrahimi A
OncoTargets and Therapy 2016, 9:7345-7353
Published Date: 2 December 2016
History and progression of Fat cadherins in health and disease
Zhang X, Liu J, Liang X, Chen J, Hong J, Li L, He Q, Cai X
OncoTargets and Therapy 2016, 9:7337-7343
Published Date: 1 December 2016
Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors
Yu H, Zhang LL, Du X, Sheng XG
OncoTargets and Therapy 2016, 9:7331-7335
Published Date: 1 December 2016
Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel
Khosravian P, Shafiee Ardestani M, Khoobi M, Ostad SN, Dorkoosh FA, Akbari Javar H, Amanlou M
OncoTargets and Therapy 2016, 9:7315-7330
Published Date: 1 December 2016
Long-term benefit of sunitinib in patients with metastatic renal cell carcinoma in Latin America: retrospective analysis of patient clinical characteristics
Smaletz O, Chacón M, de Oliveira Koch L, de Carvalho Rocha DR, Cardoso FC
OncoTargets and Therapy 2016, 9:7309-7314
Published Date: 30 November 2016
Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1
Zhang J, Fu J, Pan Y, Zhang X, Shen L
OncoTargets and Therapy 2016, 9:7297-7307
Published Date: 1 December 2016
CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer
Yang K, Gao K, Hu G, Wen Y, Lin C, Li X
OncoTargets and Therapy 2016, 9:7285-7295
Published Date: 30 November 2016
A randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small-cell lung cancer
Garon EB, Neidhart JD, Gabrail NY, de Oliveira MR, Balkissoon J, Kabbinavar F
OncoTargets and Therapy 2016, 9:7275-7283
Published Date: 30 November 2016
Androgen deprivation therapy as backbone therapy in the management of prostate cancer
Merseburger AS, Alcaraz A, von Klot CA
OncoTargets and Therapy 2016, 9:7263-7274
Published Date: 29 November 2016
Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression
Xue F, Liu YH, Zhang HW, Wen Y, Yan L, Tang Q, Xiao EH, Zhang DY
OncoTargets and Therapy 2016, 9:7253-7261
Published Date: 28 November 2016
The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma
Azzouqa AG, Stevenson JP
OncoTargets and Therapy 2016, 9:7247-7252
Published Date: 25 November 2016
Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives
Davidson M, Starling N
OncoTargets and Therapy 2016, 9:7235-7245
Published Date: 25 November 2016
Comparison of survival rates between 3D conformal radiotherapy and intensity-modulated radiotherapy in patients with stage Ⅲ non–small cell lung cancer
Kong M, Hong SE
OncoTargets and Therapy 2016, 9:7227-7234
Published Date: 24 November 2016
E2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol
Hu YX, He HL, Lu J, Wang Y, Xiao PF, Li JQ, Li J, Sun YN, Lv H, Fan JJ, Yao YH, Chai YH, Hu SY
OncoTargets and Therapy 2016, 9:7219-7225
Published Date: 22 November 2016
Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time
Baek N, Seo OW, Kim M, Hulme J, An SSA
OncoTargets and Therapy 2016, 9:7207-7218
Published Date: 22 November 2016
High expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma
Na N, Si T, Huang Z, Miao B, Hong L, Li H, Qiu J, Qiu J
OncoTargets and Therapy 2016, 9:7199-7205
Published Date: 22 November 2016
Effect of smoking on the genetic makeup of toll-like receptors 2 and 6
Kohailan M, Alanazi M, Rouabhia M, Alamri A, Parine NR, Alhadheq A, Basavarajappa S, Abdullah Al-Kheraif AA, Semlali A
OncoTargets and Therapy 2016, 9:7187-7198
Published Date: 21 November 2016
The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma
Wang J, Wang SZ, Song XM, Zeng WJ, Wang SY, Chen F, Ding H
OncoTargets and Therapy 2016, 9:7177-7185
Published Date: 21 November 2016
Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity
Liang P, Huang C, Liang S, Li Y, Huang S, Lian Z, Liu J, Tang Y, Lu H
OncoTargets and Therapy 2016, 9:7169-7175
Published Date: 18 November 2016
Next-generation sequence detects ARAP3 as a novel oncogene in papillary thyroid carcinoma
Wang QX, Chen ED, Cai YF, Zhou YL, Zheng ZC, Wang YH, Jin YX, Jin WX, Zhang XH, Wang OC
OncoTargets and Therapy 2016, 9:7161-7167
Published Date: 18 November 2016
BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy
Chowdhary M, Patel KR, Danish HH, Lawson DH, Khan MK
OncoTargets and Therapy 2016, 9:7149-7159
Published Date: 12 December 2016
Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
Wu F, Lu H, Zhu S, Li Z, Zou L, Bai T, Chen J, Yang T, Liang S
OncoTargets and Therapy 2016, 9:7141-7147
Published Date: 1 December 2016
Meta-analysis of the impact of thioprine S-methyltransferase polymorphisms on the tolerable 6-mercaptopurine dose considering initial dose and ethnic difference
Kim MG, Ko M, Kim IW, Oh JM
OncoTargets and Therapy 2016, 9:7133-7139
Published Date: 18 November 2016
Deferred radiotherapy and upfront procarbazine–ACNU–vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade
Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Suzuki SO, Iwaki T, Shono T, Mizoguchi M, Iihara K
OncoTargets and Therapy 2016, 9:7123-7131
Published Date: 17 November 2016
Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells
Xie L, Zhao T, Cai J, Su Y, Wang Z, Dong W
OncoTargets and Therapy 2016, 9:7115-7122
Published Date: 17 November 2016
Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases
Zeng ZM, Luo FF, Zou LX, He RQ, Pan DH, Chen X, Xie TT, Li YQ, Peng ZG, Chen G
OncoTargets and Therapy 2016, 9:7105-7114
Published Date: 17 November 2016
A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolation
Frithiof H, Aaltonen K, Ryden L
OncoTargets and Therapy 2016, 9:7095-7103
Published Date: 16 November 2016
Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial
Harrington KJ, Andtbacka RHI, Collichio F, Downey G, Chen L, Szabo Z, Kaufman HL
OncoTargets and Therapy 2016, 9:7081-7093
Published Date: 16 November 2016
Lrig1 is a positive prognostic marker in hepatocellular carcinoma
Yang B, Dai C, Tan RM, Zhang B, Meng X, Ye J, Wang XQ, Wei L, He F, Chen ZS
OncoTargets and Therapy 2016, 9:7071-7079
Published Date: 15 November 2016
Meta-analysis of outcomes of patients with stage IV colorectal cancer managed with chemotherapy/radiochemotherapy with and without primary tumor resection
Lee KC, Ou YC, Hu WH, Liu CC, Chen HH
OncoTargets and Therapy 2016, 9:7059-7069
Published Date: 15 November 2016
MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1
Xu D, Chen XF, He QY, Luo CQ
OncoTargets and Therapy 2016, 9:7047-7057
Published Date: 15 November 2016
Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer
Yang F, Lv S, Lv L, Liu Y, Dong S, Yao Z, Dai X, Zhang X, Wang O
OncoTargets and Therapy 2016, 9:7039-7045
Published Date: 15 November 2016
Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma
Lin M, Tian MM, Zhang WP, Xu L, Jin P
OncoTargets and Therapy 2016, 9:7029-7037
Published Date: 14 November 2016
ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma
Chen L, Liu MM, Liu H, Lu D, Zhao XD, Yang XJ
OncoTargets and Therapy 2016, 9:7019-7028
Published Date: 14 November 2016
CT-diagnosed severe skull base bone destruction predicts distant bone metastasis in early N-stage nasopharyngeal carcinoma
Yi W, Liu ZG, Li X, Tang J, Jiang CB, Hu JY, Tu ZW, Wang H, Niu DL, Xia YF
OncoTargets and Therapy 2016, 9:7011-7017
Published Date: 14 November 2016
MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1
Hu ZL, Cui YH, Zhou YH, Zhou KY, Qiao XQ, Li CQ, Wang S
OncoTargets and Therapy 2016, 9:6999-7009
Published Date: 14 November 2016
The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis
Zhai R, Tang F, Gong JH, Zhang J, Lei B, Li B, Wei YC, Liang XS, Tang B, He SQ
OncoTargets and Therapy 2016, 9:6987-6998
Published Date: 24 November 2016
Role of p14ARF and p15INK4B promoter methylation in patients with lung cancer: a systematic meta-analysis
Yang X, Yang L, Dai W, Ye B
OncoTargets and Therapy 2016, 9:6977-6985
Published Date: 11 November 2016
Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis
Su X, Jiang X, Wang W, Wang H, Xu X, Lin A, Teng X, Wu H, Teng L
OncoTargets and Therapy 2016, 9:6965-6976
Published Date: 11 November 2016
Portulacerebroside A inhibits adhesion, migration, and invasion of human leukemia HL60 cells and U937 cells through the regulation of p38/JNK signaling pathway
Ye QD, Liao XL, Fu P, Dou JY, Chen K, Jiang H
OncoTargets and Therapy 2016, 9:6953-6963
Published Date: 11 November 2016
Comparison of internal target volumes defined on 3-dimensional, 4-dimensonal, and cone-beam CT images of non-small-cell lung cancer
Li F, Li J, Ma Z, Zhang Y, Xing J, Qi H, Shang D
OncoTargets and Therapy 2016, 9:6945-6951
Published Date: 17 November 2016
Paxillin functions as an oncogene in human gliomas by promoting cell migration and invasion
Chen B, Xia L, Xu C, Xiao F, Wang Y
OncoTargets and Therapy 2016, 9:6935-6943
Published Date: 9 November 2016
Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells
Pileczki V, Pop L, Braicu C, Budisan L, Bolba Morar G, del C Monroig-Bosque P, Sandulescu RV, Berindan-Neagoe I
OncoTargets and Therapy 2016, 9:6921-6933
Published Date: 11 November 2016
A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma
Zhao YY, Liu L, Zhou T, Zhou NN, Yang YP, Hou X, Li Y, Zhao HY, Huang Y, Zhang L
OncoTargets and Therapy 2016, 9:6915-6920
Published Date: 8 November 2016
miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial–mesenchymal transition
Zhang XG, Zhang T, Yang K, Zhang MH, Wang KM
OncoTargets and Therapy 2016, 9:6909-6914
Published Date: 8 November 2016
Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection
Zhong JH, Ke Y, Zhu SL, Wang L, Luo CP, Gong WF, You XM, Ma L, Xiang BD, Li LQ
OncoTargets and Therapy 2016, 9:6897-6907
Published Date: 10 November 2016
Genetic variation rs7930 in the miR-4273-5p target site is associated with a risk of colorectal cancer
Lee AR, Park J, Jung KJ, Jee SH, Kim-Yoon SJ
OncoTargets and Therapy 2016, 9:6885-6895
Published Date: 7 November 2016
Hürthle cell carcinoma: current perspectives
Ahmadi S, Stang M, Jiang XS, Sosa JA
OncoTargets and Therapy 2016, 9:6873-6884
Published Date: 7 November 2016
NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells
Zhong Y, Shen S, Zhou Y, Mao F, Lin Y, Guan J, Xu Y, Zhang S, Liu X, Sun Q
OncoTargets and Therapy 2016, 9:6865-6871
Published Date: 7 November 2016
FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma
El-Hamamsy M, Ghali RR, Saad AS, Shaheen SM, Salem AM
OncoTargets and Therapy 2016, 9:6857-6863
Published Date: 7 November 2016
Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma
Jeannot V, Busser B, Vanwonterghem L, Michallet S, Ferroudj S, Cokol M, Coll JL, Ozturk M, Hurbin A
OncoTargets and Therapy 2016, 9:6843-6855
Published Date: 9 November 2016
Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma
Xu Y, Guo Q, Lin J, Chen B, Wen J, Lu T, Xu Y, Zhang M, Pan J, Lin S
OncoTargets and Therapy 2016, 9:6835-6841
Published Date: 4 November 2016
Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management
Wu S, Mo M, Wang Y, Zhang N, Li J, Di G, Shao Z, Wu J, Liu G
OncoTargets and Therapy 2016, 9:6829-6834
Published Date: 4 November 2016
Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening
Iovanescu D, Frandes M, Lungeanu D, Burlea A, Miutescu BP, Miutescu E
OncoTargets and Therapy 2016, 9:6819-6828
Published Date: 4 November 2016
Differentiation between adrenal adenomas and nonadenomas using dynamic contrast-enhanced computed tomography
Wang XF, Li KG, Sun HR, Zhao JL, Zheng LF, Zhang ZL, Bai RJ, Zhang GX
OncoTargets and Therapy 2016, 9:6809-6817
Published Date: 3 November 2016
Association of TIMP-2-418G/C and TIMP-2-303G/A with gastric cancer: a meta-analysis
Yang Y, Xiong Y, Li J, Wu C, Jiang J
OncoTargets and Therapy 2016, 9:6801-6808
Published Date: 3 November 2016
Total versus subtotal gastrectomy for distal gastric cancer: meta-analysis of randomized clinical trials
Kong L, Yang N, Shi L, Zhao G, Wang M, Zhang Y
OncoTargets and Therapy 2016, 9:6795-6800
Published Date: 7 November 2016
Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking
Coppola C, Riccio G, Barbieri A, Monti MG, Piscopo G, Rea D, Arra C, Maurea C, De Lorenzo C, Maurea N
OncoTargets and Therapy 2016, 9:6785-6794
Published Date: 2 November 2016
Cervical nodal necrosis is an independent survival predictor in nasopharyngeal carcinoma: an observational cohort study
Luo Y, Ren J, Zhou P, Gao Y, Yang G, Lang J
OncoTargets and Therapy 2016, 9:6775-6783
Published Date: 1 November 2016
The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies
Shen ZS, Zhou CC, Li JY, Deng HX, Li Q, Wang J
OncoTargets and Therapy 2016, 9:6763-6773
Published Date: 31 October 2016
Minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysis
Lv L, Hu WD, Ren YC, Wei XX
OncoTargets and Therapy 2016, 9:6751-6762
Published Date: 31 October 2016
Positive expression of KIF20A indicates poor prognosis of glioma patients
Duan J, Huang W, Shi H
OncoTargets and Therapy 2016, 9:6741-6749
Published Date: 2 November 2016
A current perspective on stereotactic body radiation therapy for pancreatic cancer
Hong JC, Czito BG, Willett CG, Palta M
OncoTargets and Therapy 2016, 9:6733-6739
Published Date: 31 October 2016
Effect of VEGF-C siRNA and endostatin on ring formation and proliferation of esophageal squamous cell carcinoma lymphatic endothelial cells
Zheng YP, Sun MM, Chen JY, He LL, Zhao N, Chen KS
OncoTargets and Therapy 2016, 9:6727-6732
Published Date: 31 October 2016
High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma
Zhang L, Xiu DR, Zhan J, He XK, Guo LM, Wang JL, Tao M, Fu W, Zhang HQ
OncoTargets and Therapy 2016, 9:6719-6726
Published Date: 31 October 2016
Elevated HABP1 protein expression correlates with progression and poor survival in patients with gastric cancer
Gao H, Yao Q, Lan X, Li S, Wu J, Zeng G, Xue Y
OncoTargets and Therapy 2016, 9:6711-6718
Published Date: 31 October 2016
Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis
Chen Z, Shao Y, Wang K, Cao W, Xiong Y, Wu R, Luo S, Xu X, He X
OncoTargets and Therapy 2016, 9:6701-6710
Published Date: 28 October 2016
Efficacy and toxicities of adding molecular targeted agents to first-line chemotherapy in the treatment of advanced biliary tract cancer: a systematic review and meta-analysis
Zhao S, Miao Y, Wang R, Guo H, Jin F, Guo X, Luo T
OncoTargets and Therapy 2016, 9:6695-6700
Published Date: 28 October 2016
Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients
Kurtz JE, Soubeyran P, Michallet M, Luporsi E, Albrand H
OncoTargets and Therapy 2016, 9:6689-6693
Published Date: 28 October 2016
Association between prognostic survival of human colorectal carcinoma and ZNRF3 expression
Yu N, Zhu H, Tao Y, Huang Y, Song X, Zhou Y, Li Y, Pei Q, Tan Q, Pei H
OncoTargets and Therapy 2016, 9:6679-6687
Published Date: 28 October 2016
Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis
Artene S, Turcu-Stiolica A, Hartley R, Ciurea ME, Daianu O, Brindusa C, Alexandru O, Tataranu LG, Purcaru SO, Dricu A
OncoTargets and Therapy 2016, 9:6669-6677
Published Date: 4 November 2016
SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer
Komiya K, Nakamura T, Nakashima C, Takahashi K, Umeguchi H, Watanabe N, Sato A, Takeda Y, Kimura S, Sueoka-Aragane N
OncoTargets and Therapy 2016, 9:6663-6668
Published Date: 27 October 2016
The medicinal fungus Antrodia cinnamomea regulates DNA repair and enhances the radiosensitivity of human esophageal cancer cells
Liu YM, Liu YK, Wang LW, Huang YC, Huang PI, Tsai TH, Chen YJ
OncoTargets and Therapy 2016, 9:6651-6661
Published Date: 27 October 2016
Investigation of cyclin D1 rs9344 G>A polymorphism in colorectal cancer: a meta-analysis involving 13,642 subjects
Qiu H, Cheng C, Wang Y, Kang M, Tang W, Chen S, Gu H, Liu C, Chen Y
OncoTargets and Therapy 2016, 9:6641-6650
Published Date: 27 October 2016
MLL1 promotes cervical carcinoma cell tumorigenesis and metastasis through interaction with β-catenin
Qiang R, Cai N, Wang X, Wang L, Cui K, Wang X, Li X
OncoTargets and Therapy 2016, 9:6631-6640
Published Date: 28 October 2016
BCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancer
Zhao H, Wang WL, Zhao QH, Hu GM, Deng KH, Liu YL
OncoTargets and Therapy 2016, 9:6619-6629
Published Date: 26 October 2016
Inhibitory effects of silibinin on proliferation and lung metastasis of human high metastasis cell line of salivary gland adenoid cystic carcinoma via autophagy induction
Jiang C, Jin S, Jiang Z, Wang J
OncoTargets and Therapy 2016, 9:6609-6618
Published Date: 26 October 2016
Effective treatment with icotinib in lung adenocarcinoma with EGFR and ALK co-alterations and brain metastasis
Ye CY, Wang J, Zheng S, Chai Y
OncoTargets and Therapy 2016, 9:6605-6608
Published Date: 26 October 2016
miR-497 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer cells by targeting fos-related antigen-1
Zhang N, Shen Q, Zhang P
OncoTargets and Therapy 2016, 9:6597-6604
Published Date: 25 October 2016
The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancer
Liu YY, Tu L, Wang L, Long J, Wang J, Wang Y, Luo F, Cao D
OncoTargets and Therapy 2016, 9:6581-6595
Published Date: 25 October 2016
Dysfunction of microRNA-32 regulates ubiquitin ligase FBXW7 in multiple myeloma disease
Hua J, Ding T, Yang L
OncoTargets and Therapy 2016, 9:6573-6579
Published Date: 25 October 2016
Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study
Cai CF, Sun JY, He Z, Lin HX, Liu FR, Wang Y
OncoTargets and Therapy 2016, 9:6569-6572
Published Date: 25 October 2016
Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy in Saudi Arabia
Maklad AM, Bayoumi Y, Senosy Hassan MA, Elawadi AA, AlHussain H, Elyamany A, Aldhahri SF, Al-Qahtani KH, AlQahtani M, Tunio MA
OncoTargets and Therapy 2016, 9:6561-6567
Published Date: 25 October 2016
Cell-free DNA as a diagnostic marker for cancer: current insights
Salvi S, Gurioli G, De Giorgi U, Conteduca V, Tedaldi G, Calistri D, Casadio V
OncoTargets and Therapy 2016, 9:6549-6559
Published Date: 25 October 2016
WISP-1 overexpression upregulates cell proliferation in human salivary gland carcinomas via regulating MMP-2 expression
Li FJ, Wang XJ, Zhou XL
OncoTargets and Therapy 2016, 9:6539-6548
Published Date: 21 October 2016
The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer
Jin F, Han A, Shi F, Kong L, Yu J
OncoTargets and Therapy 2016, 9:6529-6537
Published Date: 21 October 2016
Novel therapeutic strategies for patients with triple-negative breast cancer
Zhang JF, Liu J, Wang Y, Zhang B
OncoTargets and Therapy 2016, 9:6519-6528
Published Date: 21 October 2016
High-dose irradiation in combination with toll-like receptor 9 agonist CpG oligodeoxynucleotide 7909 downregulates PD-L1 expression via the NF-κB signaling pathway in non-small cell lung cancer cells
Chen X, Zhang Q, Luo Y, Gao C, Zhuang X, Xu G, Qaio T
OncoTargets and Therapy 2016, 9:6511-6518
Published Date: 21 October 2016
The diagnostic value of 99TcM-2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethyl dihydrogen phosphate hypoxia imaging and its evaluation performance for radiotherapy efficacy in non-small-cell lung cancer
Yang Y, Han G, Xu W
OncoTargets and Therapy 2016, 9:6499-6509
Published Date: 21 October 2016
Snake venom causes apoptosis by increasing the reactive oxygen species in colorectal and breast cancer cell lines
Al-Asmari AK, Riyasdeen A, Al-Shahrani MH, Islam M
OncoTargets and Therapy 2016, 9:6485-6498
Published Date: 20 October 2016
The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China
Xu J, Ding G, Zhang X, Jin B, Lou Y, Zhang Y, Wang H, Wu D, Han B
OncoTargets and Therapy 2016, 9:6479-6484
Published Date: 20 October 2016
Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer
Lorusso L, Pieruzzi L, Biagini A, Sabini E, Valerio L, Giani C, Passannanti P, Pontillo-Contillo B, Battaglia V, Mazzeo S, Molinaro E, Elisei R
OncoTargets and Therapy 2016, 9:6467-6477
Published Date: 20 October 2016
Dephosphorylated cofilin expression is associated with poor prognosis in cases of human breast cancer: a tissue microarray analysis
Maimaiti Y, Liu ZM, Tan J, Abudureyimu K, Huang BX, Liu CP, Guo YW, Wang CW, Nie X, Zhou J, Huang T
OncoTargets and Therapy 2016, 9:6461-6466
Published Date: 19 October 2016
Inhibitory effect of quercetin on epithelial to mesenchymal transition in SK-MEL-28 human melanoma cells defined by in vitro analysis on 3D collagen gels
Patel DH, Sharma N
OncoTargets and Therapy 2016, 9:6445-6459
Published Date: 19 October 2016
Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER database
Lin MQ, Li YP, Wu SG, Sun JY, Lin HX, Zhang SY, He ZY
OncoTargets and Therapy 2016, 9:6435-6444
Published Date: 19 October 2016
Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma
Mürtz P, Penner AH, Pfeiffer AK, Sprinkart AM, Pieper CC, König R, Block W, Schild HH, Willinek WA, Kukuk GM
OncoTargets and Therapy 2016, 9:6425-6433
Published Date: 19 October 2016
Prognostic nutritional index serves as a predicative marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma
Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z
OncoTargets and Therapy 2016, 9:6417-6423
Published Date: 19 October 2016
Double-edged role of G protein-coupled estrogen receptor 1 in breast cancer prognosis: an analysis of 167 breast cancer samples and online data sets
Yang F, Shao ZM
OncoTargets and Therapy 2016, 9:6407-6415
Published Date: 25 October 2016
Biomarker and competing endogenous RNA potential of tumor-specific long noncoding RNA in chromophobe renal cell carcinoma
He HT, Xu M, Kuang Y, Han XY, Wang MQ, Yang Q
OncoTargets and Therapy 2016, 9:6399-6406
Published Date: 18 October 2016
Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma
Sun P, Zhang F, Chen C, Ren C, Bi XW, Yang H, An X, Wang FH, Jiang WQ
OncoTargets and Therapy 2016, 9:6389-6397
Published Date: 17 October 2016
Synergistic suppression effect on tumor growth of ovarian cancer by combining cisplatin with a manganese superoxide dismutase-armed oncolytic adenovirus
Wang S, Shu J, Chen L, Chen X, Zhao J, Li S, Mou X, Tong X
OncoTargets and Therapy 2016, 9:6381-6388
Published Date: 17 October 2016
miR-32 functions as a tumor suppressor and directly targets SOX9 in human non–small cell lung cancer [Retraction]
Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, Yu L
OncoTargets and Therapy 2016, 9:6379-6380
Published Date: 20 October 2016
MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma [Retraction]
Lin FO, Yao LJ, Xiao J, Liu DF, Ni ZY
OncoTargets and Therapy 2016, 9:6377-6378
Published Date: 20 October 2016
Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice
Passaro A, Lazzari C, Karachaliou N, Spitaleri G, Pochesci A, Catania C, Rosell R, de Marinis F
OncoTargets and Therapy 2016, 9:6361-6376
Published Date: 17 October 2016
Cancer: fundamentals behind pH targeting and the double-edged approach
Koltai T
OncoTargets and Therapy 2016, 9:6343-6360
Published Date: 17 October 2016
Rare frequency of gene variation and survival analysis in thymic epithelial tumors
Song Z, Yu X, Zhang Y
OncoTargets and Therapy 2016, 9:6337-6342
Published Date: 14 October 2016
Alveolar rhabdomyosarcoma of the sphenoid sinus mimicking optic neuritis presenting with intermittent visual loss in an adult
Liu W, Jiang L, Jin Y, Yang BT, Lai TYY
OncoTargets and Therapy 2016, 9:6333-6336
Published Date: 14 October 2016
hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy
Muratori L, Petroni G, Antonuzzo L, Boni L, Iorio J, Lastraioli E, Bartoli G, Messerini L, Di Costanzo F, Arcangeli A
OncoTargets and Therapy 2016, 9:6325-6332
Published Date: 14 October 2016
18F-fludrodeoxyglucose maximal standardized uptake value and metabolic tumor burden are associated with major chemotherapy-related tumor markers in NSCLC patients
Bai L, Guo CH, Wang JS, Liu X, Li Y, Li M, Guo YM, Duan XY
OncoTargets and Therapy 2016, 9:6315-6324
Published Date: 14 October 2016
Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experience
Lin L, Zhao J, Hu J, Huang F, Han J, He Y, Cao X
OncoTargets and Therapy 2016, 9:6305-6314
Published Date: 14 October 2016
Prognostic value of endocan expression in cancers: evidence from meta-analysis
Huang X, Chen C, Wang X, Zhang JY, Ren BH, Ma DW, Xia L, Xu XY, Xu L
OncoTargets and Therapy 2016, 9:6297-6304
Published Date: 13 October 2016
Primary adenoid cystic carcinoma of the trachea with thyroid invasion: a case report and literature review
Qi D, Feng L, Li J, Liu B, Zhang Q
OncoTargets and Therapy 2016, 9:6291-6296
Published Date: 13 October 2016
Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation
Gong ZJ, Guo W, Sun YF, Zhang X, Qiu SJ, Zhou J, Fan J, Yang XR
OncoTargets and Therapy 2016, 9:6281-6290
Published Date: 13 October 2016
CT-detected solitary thyroid calcification: an important imaging feature for papillary carcinoma
Yang T, Huang Y, Jing X, Gai X, Li W
OncoTargets and Therapy 2016, 9:6273-6279
Published Date: 13 October 2016
Locally advanced rectal cancer: management challenges
Kokelaar RF, Evans MD, Davies M, Harris DA, Beynon J
OncoTargets and Therapy 2016, 9:6265-6272
Published Date: 13 October 2016
Epidermal growth factor receptor and B7-H3 expression in esophageal squamous tissues correlate to patient prognosis
Song J, Shi W, Zhang Y, Sun M, Liang X, Zheng S
OncoTargets and Therapy 2016, 9:6257-6263
Published Date: 12 October 2016
miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process
Pan Y, Zhang J, Fu H, Shen L
OncoTargets and Therapy 2016, 9:6247-6255
Published Date: 11 October 2016
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
De Vita A, Mercatali L, Recine F, Pieri F, Riva N, Bongiovanni A, Liverani C, Spadazzi C, Miserocchi G, Amadori D, Ibrahim T
OncoTargets and Therapy 2016, 9:6233-6246
Published Date: 11 October 2016
Differential expression of two activating transcription factor 5 isoforms in papillary thyroid carcinoma
Vicari L, La Rosa C, Forte S, Calabrese G, Colarossi C, Aiello E, Salluzzo S, Memeo L
OncoTargets and Therapy 2016, 9:6225-6231
Published Date: 11 October 2016
Influence of MDM2 polymorphisms on squamous cell carcinoma susceptibility: a meta-analysis
Yu H, Li H, Zhang J, Liu G
OncoTargets and Therapy 2016, 9:6211-6224
Published Date: 11 October 2016
miR-203 facilitates tumor growth and metastasis by targeting fibroblast growth factor 2 in breast cancer
He S, Zhang G, Dong H, Ma M, Sun Q
OncoTargets and Therapy 2016, 9:6203-6210
Published Date: 11 October 2016
Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells
Liu L, Wang ZH, Han J, Tang C, Chen N, Lin Z, Peng PJ
OncoTargets and Therapy 2016, 9:6195-6201
Published Date: 11 October 2016
Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma
Zhu S, Miao CW, Wang ZT, Peng L, Li B
OncoTargets and Therapy 2016, 9:6187-6193
Published Date: 13 October 2016
Biomarker discovery to improve prediction of breast cancer survival: using gene expression profiling, meta-analysis, and tissue validation
Meng L, Xu Y, Xu C, Zhang W
OncoTargets and Therapy 2016, 9:6177-6185
Published Date: 11 October 2016
Invasive atypical thymic carcinoid: three case reports and literature review
Zhu S, Wang Z, Liu W, Zong S, Li B
OncoTargets and Therapy 2016, 9:6171-6176
Published Date: 11 October 2016
The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy’s efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patients
Zhang B, Zhao L, Yuan Z, Pang Q, Wang P
OncoTargets and Therapy 2016, 9:6161-6169
Published Date: 11 October 2016
miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52
Chen H, Xu H, Meng YG, Zhang Y, Chen JY, Wei XN
OncoTargets and Therapy 2016, 9:6151-6160
Published Date: 11 October 2016
Chemotherapy combined with high-dose extended-field radiotherapy for stage I extranodal nasal-type natural killer/T-cell lymphoma
Luo J, Cao C, Zhu Y, Liu P, Liu L, Lu K, Zhang N, Zhou N
OncoTargets and Therapy 2016, 9:6147-6150
Published Date: 11 October 2016
Effectiveness of tyrosine kinase inhibitors on uncommon E709X epidermal growth factor receptor mutations in non-small-cell lung cancer
Wu JY, Shih JY
OncoTargets and Therapy 2016, 9:6137-6145
Published Date: 11 October 2016
Prognostic value of microRNA-126 and CRK expression in gastric cancer
Yue S, Shi H, Han J, Zhang T, Zhu W, Zhang D
OncoTargets and Therapy 2016, 9:6127-6135
Published Date: 11 October 2016
Impact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancer
Boér K
OncoTargets and Therapy 2016, 9:6119-6125
Published Date: 11 October 2016
Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas
Auezova R, Ryskeldiev N, Doskaliyev A, Kuanyshev Y, Zhetpisbaev B, Aldiyarova N, Ivanova N, Akshulakov S, Auezova L
OncoTargets and Therapy 2016, 9:6111-6117
Published Date: 11 October 2016
Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer
He J, Jin Y, Chen Y, Yao HB, Xia YJ, Ma YY, Wang W, Shao QS
OncoTargets and Therapy 2016, 9:6099-6109
Published Date: 7 October 2016
Primary breast diffuse large B-cell lymphoma in the era of rituximab
Zhang N, Cao C, Zhu Y, Liu P, Liu L, Lu K, Luo J, Zhou N
OncoTargets and Therapy 2016, 9:6093-6097
Published Date: 7 October 2016
IL-10-1082A/G, -592C/A, and -819T/C polymorphisms in association with lung cancer susceptibility: a meta-analysis
Liu L, Zheng F
OncoTargets and Therapy 2016, 9:6083-6091
Published Date: 7 October 2016
Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors
Fan Y, Ma K, Wang C, Ning J, Hu Y, Dong D, Dong X, Geng Q, Li E, Wu Y
OncoTargets and Therapy 2016, 9:6075-6082
Published Date: 6 October 2016
New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?
Van Der Steen N, Caparello C, Rolfo C, Pauwels P, Peters GJ, Giovannetti E
OncoTargets and Therapy 2016, 9:6065-6074
Published Date: 6 October 2016
A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report
Kashima J, Okuma Y, Hishima T
OncoTargets and Therapy 2016, 9:6059-6063
Published Date: 12 October 2016
Relationships between MGMT promoter methylation and gastric cancer: a meta-analysis
Yu D, Cao T, Han YD, Huang FS
OncoTargets and Therapy 2016, 9:6049-6057
Published Date: 5 October 2016
Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to date
Weisel K
OncoTargets and Therapy 2016, 9:6037-6048
Published Date: 5 October 2016
Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole
Sun SL, Wang FC, Dou HL, Zhang LQ, Li JW
OncoTargets and Therapy 2016, 9:6029-6036
Published Date: 5 October 2016
Recurrence pattern of squamous cell carcinoma in the midthoracic esophagus: implications for the clinical target volume design of postoperative radiotherapy
Wang X, Luo Y, Li M, Yan H, Sun M, Fan T
OncoTargets and Therapy 2016, 9:6021-6027
Published Date: 3 October 2016
miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway
Shen B, Yu S, Zhang Y, Yuan Y, Li X, Zhong J, Feng J
OncoTargets and Therapy 2016, 9:6009-6019
Published Date: 3 October 2016
Infliximab enhances the therapeutic effects of 5-fluorouracil resulting in tumor regression in colon cancer
Liu F, Ai F, Tian L, Liu S, Zhao L, Wang X
OncoTargets and Therapy 2016, 9:5999-6008
Published Date: 3 October 2016
CX-5461 induces autophagy and inhibits tumor growth via mammalian target of rapamycin-related signaling pathways in osteosarcoma
Li L, Li Y, Zhao J, Fan S, Wang L, Li X
OncoTargets and Therapy 2016, 9:5985-5997
Published Date: 29 September 2016
Association analysis of DACT1 genetic variants and gastric cancer risk in a Chinese Han population: a case–control study
Huang C, Wang YN, Fan H, Ma X, Tang R, Huan XK, Zhu Y, Xu ZK, Xu H, Yang L
OncoTargets and Therapy 2016, 9:5975-5983
Published Date: 29 September 2016
Expression of OVOL2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma
Fu H, Qi L, Chen L, He Y, Zhang N, Guo H
OncoTargets and Therapy 2016, 9:5963-5973
Published Date: 29 September 2016
Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma
Wei GB, Lu YY, Liao RW, Chen QS, Zhang KQ
OncoTargets and Therapy 2016, 9:5955-5961
Published Date: 28 September 2016
BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects
Abedin SM, Boddy CS, Munshi HG
OncoTargets and Therapy 2016, 9:5943-5953
Published Date: 28 September 2016
MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches
Markowitz J, Abrams Z, Jacob NK, Zhang X, Hassani JN, Latchana N, Wei L, Regan KE, Brooks TR, Uppati SR, Levine KM, Bekaii-Saab T, Kendra KL, Lesinski GB, Howard JH, Olencki T, Payne PR, Carson WE III
OncoTargets and Therapy 2016, 9:5931-5941
Published Date: 29 September 2016
The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study
Jia YX, Li TF, Zhang DD, Fan ZM, Fan HJ, Yan J, Chen LJ, Tang H, Qin YR, Li XY
OncoTargets and Therapy 2016, 9:5919-5929
Published Date: 27 September 2016
Combination of cold atmospheric plasma and iron nanoparticles in breast cancer: gene expression and apoptosis study
Jalili A, Irani S, Mirfakhraie R
OncoTargets and Therapy 2016, 9:5911-5917
Published Date: 28 September 2016
Complications of ultrasound-guided percutaneous microwave ablation of renal cell carcinoma
Dong XJ, Li X, Yu J, Yu MA, Yu XL, Liang P
OncoTargets and Therapy 2016, 9:5903-5909
Published Date: 26 September 2016
Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study
Wang Y, Sun XR, Feng WM, Bao Y, Zheng YY
OncoTargets and Therapy 2016, 9:5897-5902
Published Date: 26 September 2016
Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification
Ren T, Lin SD, Wang ZF, Shang AJ
OncoTargets and Therapy 2016, 9:5883-5895
Published Date: 27 September 2016
Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy
Wang L, Bi XW, Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ
OncoTargets and Therapy 2016, 9:5875-5881
Published Date: 26 September 2016
The efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials
Huang J, Zhang Y, Sheng J, Zhang H, Fang W, Zhan J, Zhou T, Chen Y, Liu L, Zhang L
OncoTargets and Therapy 2016, 9:5867-5874
Published Date: 23 September 2016
Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date
Vachhani P, Chen H
OncoTargets and Therapy 2016, 9:5855-5866
Published Date: 23 September 2016
Nanoradiopharmaceuticals for breast cancer imaging: development, characterization, and imaging in inducted animals
Sarcinelli MA, Albernaz MS, Szwed M, Iscaife A, Leite KRM, Junqueira MS, Bernardes ES, da Silva EO, Tavares MIB, Santos-Oliveira R
OncoTargets and Therapy 2016, 9:5847-5854
Published Date: 23 September 2016
Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma
Barrios CH, Herchenhorn D, Chacón M, Cabrera-Galeana P, Sajben P, Zhang K
OncoTargets and Therapy 2016, 9:5839-5845
Published Date: 23 September 2016
Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection
Yu SS, Quinn DI, Dorff TB
OncoTargets and Therapy 2016, 9:5825-5837
Published Date: 23 September 2016
An evaluation of the diagnostic efficacy of fine needle aspiration biopsy in patients operated for a thyroid nodular goiter
Janczak D, Pawlowski W, Dorobisz T, Janczak D, Dorobisz K, Leśniak M, Ziomek A, Chabowski M
OncoTargets and Therapy 2016, 9:5819-5823
Published Date: 22 September 2016
Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors
Yıldız Y, Sokmensuer C, Yalcin S
OncoTargets and Therapy 2016, 9:5809-5817
Published Date: 22 September 2016
Anatomic distribution of supraclavicular lymph node in patients with esophageal cancer
Xing J, Luo Y, Wang X, Gao M, Sun M, Ding X, Fan T, Yu J
OncoTargets and Therapy 2016, 9:5803-5808
Published Date: 22 September 2016
A clear cell adenocarcinoma of the gallbladder with hepatoid differentiation: case report and review of literature
Zhang C, Zhang W, Mu D, Shi X, Zhao L
OncoTargets and Therapy 2016, 9:5797-5802
Published Date: 22 September 2016
Apparent diffusion coefficient values detected by diffusion-weighted imaging in the prognosis of patients with locally advanced esophageal squamous cell carcinoma receiving chemoradiation
Liu S, Zhen F, Sun N, Chen J, Cao Y, Zhang S, Cheng H, Ge X, Sun X
OncoTargets and Therapy 2016, 9:5791-5796
Published Date: 21 September 2016
A case report and literature review of primary resistant Hodgkin lymphoma: a response to anti-PD-1 after failure of autologous stem cell transplantation and brentuximab vedotin
Xu PP, Wang F, Guan CY, Ouyang J, Shao XY, Chen B
OncoTargets and Therapy 2016, 9:5781-5789
Published Date: 21 September 2016
Prognostic value of decreased microRNA-133a in solid cancers: a meta-analysis
Xiao J, Zou Y, Lu X, Xie B, Yu Q, He B, He B, Chen Q
OncoTargets and Therapy 2016, 9:5771-5779
Published Date: 21 September 2016
Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer
Wang X, Teng F, Kong L, Yu J
OncoTargets and Therapy 2016, 9:5761-5770
Published Date: 20 September 2016
The expression of NEDD9 and E-cadherin correlates with metastasis and poor prognosis in triple-negative breast cancer patients
Li P, Sun T, Yuan Q, Pan G, Zhang J, Sun D
OncoTargets and Therapy 2016, 9:5751-5759
Published Date: 19 September 2016
The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer
Jiang HC, Chen CS, Sun QM, Wu J, Qiu LJ, Gao CE, Liu WQ, Yang J, Jun N, Dong J
OncoTargets and Therapy 2016, 9:5737-5750
Published Date: 26 September 2016
Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study
Chen XR, Liang JZ, Ma SX, Fang WF, Zhou NN, Liao H, Li DL, Chen LK
OncoTargets and Therapy 2016, 9:5729-5736
Published Date: 19 September 2016
Proton beam therapy: clinical utility and current status in prostate cancer
Yamoah K, Johnstone PA
OncoTargets and Therapy 2016, 9:5721-5727
Published Date: 16 September 2016
A negative regulation loop of long noncoding RNA HOTAIR and p53 in non-small-cell lung cancer
Zhai N, Xia Y, Yin R, Liu J, Gao F
OncoTargets and Therapy 2016, 9:5713-5720
Published Date: 16 September 2016
Identifying module biomarkers from gastric cancer by differential correlation network
Liu X, Chang X
OncoTargets and Therapy 2016, 9:5701-5711
Published Date: 19 September 2016
Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients [Retraction]
Wang Y, Cheng Y, Yu G, Jia B, Hu Z, Zhang L
OncoTargets and Therapy 2016, 9:5699-5700
Published Date: 20 September 2016
Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer
Ai D, Guan Y, Liu XJ, Zhang CF, Wang P, Liang HL, Guo QS
OncoTargets and Therapy 2016, 9:5693-5698
Published Date: 16 September 2016
MicroRNA expression profiles predict progression and clinical outcome in lung adenocarcinoma
Lin K, Xu T, He BS, Pan YQ, Sun HL, Peng HX, Hu XX, Wang SK
OncoTargets and Therapy 2016, 9:5679-5692
Published Date: 15 September 2016
Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma
Doan HQ, Silapunt S, Migden MR
OncoTargets and Therapy 2016, 9:5671-5678
Published Date: 14 September 2016
Weekly nanoparticle albumin bound-paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma
Wang HY, Yao ZH, Tang H, Zhao Y, Zhang XS, Yao SN, Yang SJ, Liu YY
OncoTargets and Therapy 2016, 9:5663-5669
Published Date: 23 September 2016
Primary gastric anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma
Tian C, Zhang Y
OncoTargets and Therapy 2016, 9:5659-5661
Published Date: 13 September 2016
A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass
Takatori E, Shoji T, Takada A, Nagasawa T, Omi H, Kagabu M, Honda T, Miura F, Takeuchi S, Sugiyama T
OncoTargets and Therapy 2016, 9:5651-5657
Published Date: 13 September 2016
The association of PTEN hypermethylation and breast cancer: a meta-analysis
Luo S, Chen J, Mo X
OncoTargets and Therapy 2016, 9:5643-5650
Published Date: 12 September 2016
Clinical utility of 5-aminolevulinic acid HCl to better visualize and more completely remove gliomas
Halani SH, Adamson DC
OncoTargets and Therapy 2016, 9:5629-5642
Published Date: 12 September 2016
Eribulin in the management of inoperable soft-tissue sarcoma: patient selection and survival
Thomas C, Movva S
OncoTargets and Therapy 2016, 9:5619-5627
Published Date: 9 September 2016
Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms
Ko SH, Baeg MK, Bae WJ, Kim P, Choi MG
OncoTargets and Therapy 2016, 9:5611-5617
Published Date: 9 September 2016
Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients
Suner A, Buyukhatipoglu H, Aktas G, Kus T, Ulaslı M, Oztuzcu S, Kalender ME, Sevinc A, Kul S, Camci C
OncoTargets and Therapy 2016, 9:5603-5609
Published Date: 9 September 2016
Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma
Wang J, Liu F, Ao P, Li X, Zheng H, Wu D, Zhang N, She J, Yuan J, Wu X
OncoTargets and Therapy 2016, 9:5597-5602
Published Date: 9 September 2016
Role of post mastectomy radiation therapy in breast cancer patients with T1–2 and 1–3 positive lymph nodes
Cihan YB, Sarigoz T
OncoTargets and Therapy 2016, 9:5587-5595
Published Date: 9 September 2016
Proton therapy for early stage prostate cancer: is there a case?
Chan TY, Tan PW, Tang JI
OncoTargets and Therapy 2016, 9:5577-5586
Published Date: 9 September 2016
The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis
Wei BJ, Yao MY, Xing CY, Wang W, Yao J, Hong Y, Liu Y, Fu PF
OncoTargets and Therapy 2016, 9:5567-5575
Published Date: 8 September 2016
Accelerated partial breast irradiation in an Asian population: dosimetric findings and preliminary results of a multicatheter interstitial program
Koh YV, Tan PW, Buhari SA, Iau P, Chan CW, Shen L, Tan SH, Tang JI
OncoTargets and Therapy 2016, 9:5561-5566
Published Date: 8 September 2016
Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer
Xian Y, Zhang S, Wang X, Qin J, Wang W, Wu H
OncoTargets and Therapy 2016, 9:5553-5560
Published Date: 7 September 2016
The clinical effects of low-dose splenic irradiation combined with chest three-dimensional conformal radiotherapy on patients with locally advanced non-small-cell lung cancer: a randomized clinical trial
Yu H, Qu Y, Shang Q, Yan C, Jiang P, Wang X, Liang D, Jiang T
OncoTargets and Therapy 2016, 9:5545-5552
Published Date: 7 September 2016
Novel chlorambucil-conjugated anionic linear-globular PEG-based second-generation dendrimer: in vitro/in vivo improved anticancer activity
Assadi A, Najafabadi VS, Shandiz SAS, Boroujeni AS, Ashrafi S, Vaziri AZ, Ghoreishi SM, Aghasadeghi MR, Ebrahimi SES, Pirali-Hamedani M, Ardestani MS
OncoTargets and Therapy 2016, 9:5531-5543
Published Date: 7 September 2016
Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980–2013): an analysis of population-based data in relation to socio-economic changes
Banas T, Juszczyk G, Pitynski K, Nieweglowska D, Ludwin A, Czerw A
OncoTargets and Therapy 2016, 9:5521-5530
Published Date: 7 September 2016
Polymorphisms in the XPC gene and gastric cancer susceptibility in a Southern Chinese population
Hua RX, Zhuo ZJ, Shen GP, Zhu J, Zhang SD, Xue WQ, Li XZ, Zhang PF, He J, Jia WH
OncoTargets and Therapy 2016, 9:5513-5519
Published Date: 7 September 2016
Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report
Garcia-Recio M, Martinez-Serra J, Bento L, Ramos R, Gines J, Daumal J, Sampol A, Gutierrez A
OncoTargets and Therapy 2016, 9:5507-5511
Published Date: 7 September 2016
Sunitinib: the antiangiogenic effects and beyond
Hao Z, Sadek I
OncoTargets and Therapy 2016, 9:5495-5505
Published Date: 8 September 2016
Osimertinib making a breakthrough in lung cancer targeted therapy
Zhang H
OncoTargets and Therapy 2016, 9:5489-5493
Published Date: 6 September 2016
Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancers
Jin CY, Zhang XY, Sun M, Zhang YF, Zhang GX, Wang B
OncoTargets and Therapy 2016, 9:5483-5488
Published Date: 6 September 2016
A comparison study of pancreatic acinar cell carcinoma with ductal adenocarcinoma using computed tomography in Chinese patients
Wang Q, Wang X, Guo R, Li G
OncoTargets and Therapy 2016, 9:5475-5481
Published Date: 6 September 2016
Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence
Wang X, Goldstein D, Crowe PJ, Yang JL
OncoTargets and Therapy 2016, 9:5461-5473
Published Date: 6 September 2016
Association between insulin-like growth factor-binding protein-3 polymorphism -202 A/C and the risk of prostate cancer: a meta-analysis
Qin Z, Li X, Tang J, Jiang X, Yu Y, Wang C, Xu W, Hua Y, Yu B, Zhang W
OncoTargets and Therapy 2016, 9:5451-5459
Published Date: 6 September 2016
Identifying candidate agents for lung adenocarcinoma by walking the human interactome
Sun Y, Zhang R, Jiang Z, Xia R, Zhang J, Liu J, Chen F
OncoTargets and Therapy 2016, 9:5439-5450
Published Date: 1 September 2016
Clinical potential of necitumumab in non-small cell lung carcinoma
Genova C, Hirsch FR
OncoTargets and Therapy 2016, 9:5427-5437
Published Date: 31 August 2016
Long noncoding RNA SPRY4-IT1 promotes malignant development of colorectal cancer by targeting epithelial–mesenchymal transition
Cao D, Ding Q, Yu W, Gao M, Wang Y
OncoTargets and Therapy 2016, 9:5417-5425
Published Date: 30 August 2016
Efficacy and safety of anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy for metastatic colorectal cancer in first-line and second-line therapies: a meta-analysis
Wang H, Ma B, Gao P, Song Y, Xu Q, Hu Y, Zhang C, Wang Z
OncoTargets and Therapy 2016, 9:5405-5416
Published Date: 30 August 2016
Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example
Gerratana L, De Maglio G, De Pellegrin A, Follador A, Rihawi K, Pizzolitto S, Puglisi F, Fasola G
OncoTargets and Therapy 2016, 9:5399-5404
Published Date: 30 August 2016
Long-term results of definitive concurrent chemoradiotherapy using S-1 in the treatment of geriatric patients with esophageal cancer
Lv S, Fang M, Yang J, Zhan W, Jia Y, Xu H, Song T
OncoTargets and Therapy 2016, 9:5389-5397
Published Date: 6 September 2016
Pitavastatin suppressed liver cancer cells in vitro and in vivo
You HY, Zhang WJ, Xie XM, Zheng ZH, Zhu HL, Jiang FZ
OncoTargets and Therapy 2016, 9:5383-5388
Published Date: 29 August 2016
Verteporfin, a suppressor of YAP–TEAD complex, presents promising antitumor properties on ovarian cancer
Feng J, Gou J, Jia J, Yi T, Cui T, Li Z
OncoTargets and Therapy 2016, 9:5371-5381
Published Date: 29 August 2016
Limb-salvage treatment of en-block resected distal femoral tumors with endoprosthesis of all-polyethylene tibial component: a 9-year follow-up study
Tang F, Zhou Y, Min L, Zhang WL, Shi R, Luo Y, Duan H, Tu CQ
OncoTargets and Therapy 2016, 9:5361-5369
Published Date: 13 September 2016
ALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway
Jiang J, Liu Y, Tang Y, Li L, Zeng R, Zeng S, Zhong M
OncoTargets and Therapy 2016, 9:5349-5360
Published Date: 29 August 2016
The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis
Song XY, Li BY, Zhou EX, Wu FX
OncoTargets and Therapy 2016, 9:5339-5347
Published Date: 26 August 2016
Knockdown of peroxisome proliferator-activated receptor gamma coactivator-1 alpha increased apoptosis of human endometrial cancer HEC-1A cells
Yang H, Yang R, Liu H, Ren Z, Wang C, Li D, Ma X
OncoTargets and Therapy 2016, 9:5329-5338
Published Date: 24 August 2016
Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma
Deng Y, Pang Q, Miao RC, Chen W, Zhou YY, Bi JB, Liu SS, Zhang JY, Qu K, Liu C
OncoTargets and Therapy 2016, 9:5317-5328
Published Date: 24 August 2016
Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma
Lin DZ, Qu N, Shi RL, Lu ZW, Ji QH, Wu WL
OncoTargets and Therapy 2016, 9:5307-5316
Published Date: 24 August 2016
Knockdown of Sall4 inhibits intrahepatic cholangiocarcinoma cell migration and invasion in ICC-9810 cells
Zhu L, Huang FZ, Deng G, Nie W, Huang W, Xu HB, Zheng SP, Yi ZJ, Wan T
OncoTargets and Therapy 2016, 9:5297-5305
Published Date: 24 August 2016
Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1
Nakahara Y, Takagi Y, Hosomi Y, Kagei A, Yamamoto T, Sawada T, Yomota M, Okuma Y, Mikura S, Okamura T
OncoTargets and Therapy 2016, 9:5287-5295
Published Date: 24 August 2016
An isolated orbital mass with proptosis and diplopia: an uncommon metastasis from intracranial olfactory neuroblastoma in a Chinese patient
Shen JQ, Cui HG, Feng S
OncoTargets and Therapy 2016, 9:5281-5286
Published Date: 24 August 2016
Expression and prognostic significance of unique ULBPs in pancreatic cancer
Chen J, Zhu XX, Xu H, Fang HZ, Zhao JQ
OncoTargets and Therapy 2016, 9:5271-5279
Published Date: 25 August 2016
Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma
Guo HS, Xing YH, Mu AL, Li X, Li TS, Bian X, Yang CM, Zhang XL, Liu YF, Wang XG
OncoTargets and Therapy 2016, 9:5257-5270
Published Date: 25 August 2016
MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer
Liu D, Xia H, Wang F, Chen C, Long J
OncoTargets and Therapy 2016, 9:5245-5255
Published Date: 23 August 2016
Prognostic significance of TAZ expression in various cancers: a meta-analysis
Feng J, Ren P, Gou J, Li Z
OncoTargets and Therapy 2016, 9:5235-5244
Published Date: 23 August 2016
Association between BHMT gene rs3733890 polymorphism and cancer risk: evidence from a meta-analysis
Xu Y, Yan C, Hao Z, Zhou J, Fan S, Tai S, Yang C, Zhang L, Liang C
OncoTargets and Therapy 2016, 9:5225-5233
Published Date: 22 August 2016
Evaluation of the characteristics of hepatic focal nodular hyperplasia: correlation between dynamic contrast-enhanced multislice computed tomography and pathological findings
Zhang HT, Gao XY, Xu QS, Chen YT, Song YP, Yao ZW
OncoTargets and Therapy 2016, 9:5217-5224
Published Date: 22 August 2016
Surgical procedures for papillary thyroid carcinoma located in the thyroid isthmus: an intention-to-treat analysis
Lei JY, Zhu JQ, Li ZH, Gong RX, Wei T
OncoTargets and Therapy 2016, 9:5209-5216
Published Date: 22 August 2016
B-cell-specific Moloney murine leukemia virus integration site 1: potential stratification factor and therapeutic target for epithelial ovarian cancer
Zhao Q, Gui T, Qian Q, Li L, Shen K
OncoTargets and Therapy 2016, 9:5203-5208
Published Date: 22 August 2016
Effect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKT
Zhang Y, Huang SN, Leng YH, Chen X, Liu TT, Wang HL, Wei FL, Luo DZ, Chen G, Wei ZX
OncoTargets and Therapy 2016, 9:5195-5202
Published Date: 29 August 2016
MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt signaling pathway
Xiao J, Lin HY, Zhu YY, Zhu YP, Chen LW
OncoTargets and Therapy 2016, 9:5181-5193
Published Date: 22 August 2016
Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study
Huang WT, Wang HL, Yang H, Ren FH, Luo YH, Huang CQ, Liang YY, Liang HW, Chen G, Dang YW
OncoTargets and Therapy 2016, 9:5163-5180
Published Date: 22 August 2016
EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy
Chang H, Oh J, Zhang X, Kim YJ, Lee JH, Lee CT, Chung JH, Lee JS
OncoTargets and Therapy 2016, 9:5153-5162
Published Date: 19 August 2016
Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma
Qu Z, Yuan CH, Yin CQ, Guan Q, Chen H, Wang FB
OncoTargets and Therapy 2016, 9:5143-5152
Published Date: 18 August 2016
Co-expression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance
Jia W, Wang W, Ji CS, Niu JY, Lv YJ, Zhou HC, Hu B
OncoTargets and Therapy 2016, 9:5133-5142
Published Date: 18 August 2016
Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinoma
Lv X, Xia WX, Ke LR, Yang J, Qiu WZ, Yu YH, Liang H, Huang XJ, Liu GY, Zeng Q, Guo X, Xiang YQ
OncoTargets and Therapy 2016, 9:5123-5131
Published Date: 18 August 2016
Comparison of long-term survival between temozolomide-based chemoradiotherapy and radiotherapy alone for patients with low-grade gliomas after surgical resection
Gai XJ, Wei YM, Tao HM, An DZ, Sun JT, Li BS
OncoTargets and Therapy 2016, 9:5117-5121
Published Date: 17 August 2016
Immune checkpoint inhibitors: the new frontier in non–small cell lung cancer treatment
El-Osta HE, Shahid K, Mills GM, Peddi P
OncoTargets and Therapy 2016, 9:5101-5116
Published Date: 16 August 2016
MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK
Cheng Y, Zhang X, Li P, Yang C, Tang J, Deng X, Yang X, Tao J, Lu Q, Li P
OncoTargets and Therapy 2016, 9:5091-5099
Published Date: 16 August 2016
The clinicopathological significance of hMLH1 hypermethylation in non-small-cell lung cancer: a meta-analysis and literature review
Han Y, Shi K, Zhou SJ, Yu DP, Liu ZD
OncoTargets and Therapy 2016, 9:5081-5090
Published Date: 16 August 2016
Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel
Kus T, Aktas G, Kalender ME, Demiryurek AT, Ulasli M, Oztuzcu S, Sevinc A, Kul S, Camci C
OncoTargets and Therapy 2016, 9:5073-5080
Published Date: 12 August 2016
Clinicopathological role of miR-30a-5p in hepatocellular carcinoma tissues and prediction of its function with bioinformatics analysis
Huang WT, Chen ZX, He RQ, Wu YZ, Yin SY, Liang XN, Chen G, Yang H, Peng ZG, Yang LH
OncoTargets and Therapy 2016, 9:5061-5071
Published Date: 12 August 2016
Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells
Liu P, Zhang H, Wu X, Guo L, Wang F, Xia G, Chen B, Yin H, Wang Y, Li X
OncoTargets and Therapy 2016, 9:5049-5059
Published Date: 12 August 2016
New utility of an old marker: serum low-density lipoprotein predicts histopathological response of neoadjuvant chemotherapy in locally advanced gastric cancer
Zhou JC, Guo JF, Teng RY, Wang QC, Wang J, Wei Q, Li ZD, Shen JG, Wang LB
OncoTargets and Therapy 2016, 9:5041-5047
Published Date: 12 August 2016
PD-L1 expression in human cancers and its association with clinical outcomes
Wang X, Teng FF, Kong L, Yu JM
OncoTargets and Therapy 2016, 9:5023-5039
Published Date: 12 August 2016
Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk model
Shi RL, Qu N, Yang SW, Ma B, Lu ZW, Wen D, Sun GH, Wang Y, Ji QH
OncoTargets and Therapy 2016, 9:5015-5022
Published Date: 12 August 2016
Long noncoding RNA ZNFX1-AS1 suppresses growth of hepatocellular carcinoma cells by regulating the methylation of miR-9
Wang T, Ma SC, Qi X, Tang X, Cui D, Wang Z, Chi J, Li P, Zhai B
OncoTargets and Therapy 2016, 9:5005-5014
Published Date: 12 August 2016
Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer
Wang SW, Ren J, Yan YL, Xue CF, Tan L, Ma XW
OncoTargets and Therapy 2016, 9:4993-5003
Published Date: 16 August 2016
Successful treatment of angiosarcoma of the scalp with apatinib: a case report
Ji G, Hong L, Yang P
OncoTargets and Therapy 2016, 9:4989-4992
Published Date: 11 August 2016
Clinical implications of transforming growth factor-beta–induced gene-h3 protein expression in lung cancer
He CJ, Sun DW, Bai X, Li YB, Xu H, Xu SD
OncoTargets and Therapy 2016, 9:4983-4987
Published Date: 11 August 2016
ATG7 promotes the tumorigenesis of lung cancer but might be dispensable for prognosis predication: a clinicopathologic study
Sun SX, Wang ZH, Tang F, Hu PC, Yang ZT, Xue C, Gong J, Shi L, Xie CH
OncoTargets and Therapy 2016, 9:4975-4981
Published Date: 11 August 2016
Anorectal melanoma metastatic to the breast: a case report and review of the literature
Feng L, Qi DJ, Zhang QF
OncoTargets and Therapy 2016, 9:4969-4974
Published Date: 10 August 2016
Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases
Zhang Y, Luo J, He RQ, Huang WT, Li ZY, Li P, Dang YW, Chen G, Li SK
OncoTargets and Therapy 2016, 9:4959-4968
Published Date: 10 August 2016
Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned
Pinilla-Ibarz J, Sweet KL, Corrales-Yepez GM, Komrokji RS
OncoTargets and Therapy 2016, 9:4937-4957
Published Date: 10 August 2016
Antihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant setting
Seber S, Solmaz D, Yetisyigit T
OncoTargets and Therapy 2016, 9:4929-4935
Published Date: 9 August 2016
A rare case report of primary bone lymphoma and a brief review of the literature
Wang J, Fan S, Liu J, Song B,
OncoTargets and Therapy 2016, 9:4923-4928
Published Date: 9 August 2016
Preoperative neutrophil–lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer
Ma C, Lu B, Diao C, Zhao K, Wang X, Ma B, Lu B, Sun E
OncoTargets and Therapy 2016, 9:4917-4922
Published Date: 8 August 2016
Incidental gallbladder cancer after cholecystectomy: 1990 to 2014
Dorobisz T, Dorobisz K, Chabowski M, Pawłowski W, Janczak D, Patrzałek D, Janczak D
OncoTargets and Therapy 2016, 9:4913-4916
Published Date: 8 August 2016
The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review
Zhang XL, Yu JM, Li MH, Zhu H, Sun XD, Kong L
OncoTargets and Therapy 2016, 9:4901-4911
Published Date: 8 August 2016
High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway
Yang XY, Zhang MY, Zhou Q, Wu SY, Zhao Y, Gu WY, Pan J, Cen JN, Chen ZX, Guo WG, Chen CS, Yan WH, Hu SY
OncoTargets and Therapy 2016, 9:4887-4899
Published Date: 8 August 2016
A new prognostic score based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
Zhu L, Li X, Shen Y, Cao Y, Fang X, Chen J, Yuan Y
OncoTargets and Therapy 2016, 9:4879-4886
Published Date: 8 August 2016
Modulation of expression of the nuclear receptor NR0B2 (small heterodimer partner 1) and its impact on proliferation of renal carcinoma cells
Prestin K, Olbert M, Hussner J, Isenegger TL, Gliesche DG, Böttcher K, Zimmermann U, Meyer zu Schwabedissen HE
OncoTargets and Therapy 2016, 9:4867-4878
Published Date: 8 August 2016
Oncogenic NanogP8 expression regulates cell proliferation and migration through the Akt/mTOR signaling pathway in human gastric cancer – SGC-7901cell line
Jiang Z, Liu Y, Wang C
OncoTargets and Therapy 2016, 9:4859-4866
Published Date: 9 August 2016
Salvage therapies in relapsed and/or refractory myeloma: what is current and what is the future?
Thumallapally N, Yu H, Asti D, Vennepureddy A, Terjanian T
OncoTargets and Therapy 2016, 9:4843-4858
Published Date: 5 August 2016
Survival benefit and safety of the combinations of FOLFOXIRI ± bevacizumab versus the combinations of FOLFIRI ± bevacizumab as first-line treatment for unresectable metastatic colorectal cancer: a meta-analysis
Xu W, Kuang M, Gong Y, Cao C, Chen J, Tang C
OncoTargets and Therapy 2016, 9:4833-4842
Published Date: 4 August 2016
PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis
Qian D, Cheng J, Ding X, Chen X, Chen X, Guan Y, Zhang B, Wang J, Er P, Qiu M, Zeng X, Guo Y, Wang H, Zhao L, Xie D, Yuan Z, Wang P, Pang Q
OncoTargets and Therapy 2016, 9:4821-4831
Published Date: 3 August 2016
A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer
Karakas Y, Esin E, Lacin S, Ceyhan K, Heper AO, Yalcin S
OncoTargets and Therapy 2016, 9:4815-4820
Published Date: 3 August 2016
Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients
Gu X, Gao XS, Xiong W, Guo W, Han L, Bai Y, Peng C, Cui M, Xie M
OncoTargets and Therapy 2016, 9:4805-4813
Published Date: 2 August 2016
Efficacy of targeted agents in the treatment of elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis
Chen J, Chen J, Wu X, Shi T, Kang M
OncoTargets and Therapy 2016, 9:4797-4803
Published Date: 2 August 2016
Cutaneous basal cell carcinoma arising within a keloid scar: a case report
Goder M, Kornhaber R, Bordoni D, Winkler E, Haik J, Tessone A
OncoTargets and Therapy 2016, 9:4793-4796
Published Date: 2 August 2016
Comparison of planning target volumes based on three-dimensional and four-dimensional CT imaging of thoracic esophageal cancer
Wang W, Li JB, Zhang YJ, Shao Q, Xu M, Fan TY, Wang JZ
OncoTargets and Therapy 2016, 9:4785-4791
Published Date: 2 August 2016
Induction of apoptosis by Armillaria mellea constituent armillarikin in human hepatocellular carcinoma
Chen YJ, Chen CC, Huang HL
OncoTargets and Therapy 2016, 9:4773-4783
Published Date: 1 August 2016
Docetaxel-loaded lipid microbubbles combined with ultrasound-triggered microbubble destruction for targeted tumor therapy in MHCC-H cells
Zhang Y, Chang R, Li MQ, Zhao K, Zheng HZ, Zhou XD
OncoTargets and Therapy 2016, 9:4763-4771
Published Date: 1 August 2016
Risk factors and patterns of lymph node involvement in primary gastric large B-cell lymphoma: implications for target definition
Zhang X, Wang P, Zhao L, Yuan Z, Wang P
OncoTargets and Therapy 2016, 9:4757-4762
Published Date: 29 July 2016
Oral administration of sunitinib malate for long-term survival of a patient with multiple lung metastases from renal leiomyosarcoma
Li X, Gao H, Tang C, Liu X
OncoTargets and Therapy 2016, 9:4753-4756
Published Date: 29 July 2016
Oncological outcome after lung metastasis in patients presenting with localized chondrosarcoma at extremities: Tokai Musculoskeletal Oncology Consortium study
Nakamura T, Matsumine A, Yamada S, Tsukushi S, Kawanami K, Ohno T, Katagiri H, Sugiura H, Yamada K, Yamada Y, Sudo A, Nishida Y
OncoTargets and Therapy 2016, 9:4747-4751
Published Date: 29 July 2016
Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesis
Wang J, Zhu C
OncoTargets and Therapy 2016, 9:4737-4746
Published Date: 29 July 2016
RBBP6: a potential biomarker of apoptosis induction in human cervical cancer cell lines
Moela P, Motadi LR
OncoTargets and Therapy 2016, 9:4721-4735
Published Date: 29 July 2016
Primary yolk sac tumor of the gluteus: a case report and literature review
Li B, Jiang QQ, Zhang ST, Zhou Y, Zhang QF, OuYang L
OncoTargets and Therapy 2016, 9:4715-4719
Published Date: 2 August 2016
MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4
Yu M, Lin Y, Zhou Y, Jin H, Hou B, Wu Z, Li Z, Jian Z, Sun J
OncoTargets and Therapy 2016, 9:4705-4714
Published Date: 29 July 2016
Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy
Nemecek R, Berkovcova J, Radova L, Kazda T, Mlcochova J, Vychytilova-Faltejskova P, Slaby O, Svoboda M
OncoTargets and Therapy 2016, 9:4695-4703
Published Date: 28 July 2016
The impact of the extent of surgical resection on survival of gastric cancer patients
Angelov KG, Vasileva MB, Grozdev KS, Toshev SY, Sokolov MB, Todorov GT
OncoTargets and Therapy 2016, 9:4687-4694
Published Date: 28 July 2016
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma
Azzariti A, Brunetti O, Porcelli L, Graziano G, Iacobazzi RM, Signorile M, Scarpa A, Lorusso V, Silvestris N
OncoTargets and Therapy 2016, 9:4681-4686
Published Date: 28 July 2016
Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patients
Tang N, Wang Z
OncoTargets and Therapy 2016, 9:4671-4679
Published Date: 27 July 2016
Albumin concentrations plus neutrophil lymphocyte ratios for predicting overall survival after curative resection for gastric cancer
Sun X, Wang J, Liu J, Chen S, Liu X
OncoTargets and Therapy 2016, 9:4661-4669
Published Date: 27 July 2016
Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer
Liu C, Huang Z, Wang QS, Sun B, Ding LJ, Meng XY, Wu SK
OncoTargets and Therapy 2016, 9:4653-4660
Published Date: 27 July 2016
Clinical implication of long noncoding RNA 91H expression profile in osteosarcoma patients
Xia WK, Lin QF, Shen D, Liu ZL, Su J, Mao WD
OncoTargets and Therapy 2016, 9:4645-4652
Published Date: 26 July 2016
Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review
Wang HY, Zhu H, Kong L, Yu JM
OncoTargets and Therapy 2016, 9:4639-4644
Published Date: 26 July 2016
MiR-203 is involved in the laryngeal carcinoma pathogenesis via targeting VEGFA and Cox-2
Xu L, Shen B, Chen TT, Dong P
OncoTargets and Therapy 2016, 9:4629-4637
Published Date: 26 July 2016
Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study
Mu Y, Wang WH, Xie JP, Zhang YX, Yang YP, Zhou CH
OncoTargets and Therapy 2016, 9:4617-4627
Published Date: 25 July 2016
Identification of crucial microRNAs and genes in hypoxia-induced human lung adenocarcinoma cells
Geng Y, Deng L, Su D, Xiao J, Ge D, Bao Y, Jing H
OncoTargets and Therapy 2016, 9:4605-4616
Published Date: 25 July 2016
Postoperative hepatitis B virus reactivation in hepatitis B virus-related hepatocellular carcinoma patients with hepatitis B virus DNA levels <500 copies/mL
Xie ZB, Wang XB, Fu DL, Zhong JH, Yang XW, Li LQ
OncoTargets and Therapy 2016, 9:4593-4603
Published Date: 25 July 2016
Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma
Sun Y, Hou L, Yang Y, Xie H, Yang Y, Li Z, Zhao H, Gao W, Su B
OncoTargets and Therapy 2016, 9:4583-4591
Published Date: 25 July 2016
Network analysis reveals potential markers for pediatric adrenocortical carcinoma
Kulshrestha A, Suman S, Ranjan R
OncoTargets and Therapy 2016, 9:4569-4581
Published Date: 26 July 2016
Clinical observation of gene expression-guided chemoradiation therapy for nonsurgical esophageal squamous cell carcinoma patients: a retrospective analysis of 36 cases
Yang Z, Dai HH, Lv DX, Feng AL, Shu WB, Han JQ
OncoTargets and Therapy 2016, 9:4561-4568
Published Date: 25 July 2016
Green synthesis, characterization, and anticancer activity of hyaluronan/zinc oxide nanocomposites
Namvar F, Azizi S, Rahman HS, Mohamad R, Rasedee A, Soltani M, Rahim RA
OncoTargets and Therapy 2016, 9:4549-4559
Published Date: 26 July 2016
Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-oesophageal junction adenocarcinoma
Davidson M, Smyth EC, Cunningham D
OncoTargets and Therapy 2016, 9:4539-4548
Published Date: 25 July 2016
The effect of clove-based herbal mouthwash on radiation-induced oral mucositis in patients with head and neck cancer: a single-blind randomized preliminary study
Kong M, Hwang DS, Yoon SW, Kim J
OncoTargets and Therapy 2016, 9:4533-4538
Published Date: 22 July 2016
Efficacy of pemetrexed-based regimen in relapsed advanced thymic epithelial tumors and its association with thymidylate synthase level
Qian X, Song Z
OncoTargets and Therapy 2016, 9:4527-4531
Published Date: 22 July 2016
Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies
Ma JT, Sun X, Huang LT, Xiong ZC, Yuan M, Zhang SL, Han CB
OncoTargets and Therapy 2016, 9:4517-4526
Published Date: 22 July 2016
MicroRNA-490 inhibits tumorigenesis and progression in breast cancer
Zhao L, Zheng XY
OncoTargets and Therapy 2016, 9:4505-4516
Published Date: 22 July 2016
Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studies
Jiang X, Zhang M, Bai XY, Li S, Wu H
OncoTargets and Therapy 2016, 9:4491-4503
Published Date: 22 July 2016
Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis
Luo T, Chen J, Liu JJ, Li H, You XM, Wang HL, Zhu SL, Li LQ
OncoTargets and Therapy 2016, 9:4483-4489
Published Date: 21 July 2016
Clinical significance of TIPE expression in gastric carcinoma
Hu R, Qiu X, Hong S, Meng L, Hong X, Qiu J, Yang J, Zhuang G, Liu Z
OncoTargets and Therapy 2016, 9:4473-4481
Published Date: 25 July 2016
Mast cells positive to tryptase, endothelial cells positive to protease-activated receptor-2, and microvascular density correlate among themselves in hepatocellular carcinoma patients who have undergone surgery
Ammendola M, Sacco R, Sammarco G, Piardi T, Zuccalà V, Patruno R, Zullo A, Zizzo N, Nardo B, Marech I, Crovace A, Gadaleta CD, Pessaux P, Ranieri G
OncoTargets and Therapy 2016, 9:4465-4471
Published Date: 21 July 2016
Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia
Chen YJ, Fang LW, Su WC, Hsu WY, Yang KC, Huang HL
OncoTargets and Therapy 2016, 9:4453-4464
Published Date: 20 July 2016
Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results
Pham PV, Le HT, Vu BT, Pham VQ, Le PM, Phan NLC, Trinh NV, Nguyen HTL, Nguyen ST, Nguyen TL, Phan NK
OncoTargets and Therapy 2016, 9:4441-4451
Published Date: 21 July 2016
Congenital anomalies of the genitourinary system can help in diagnosis of the primary site of metastatic cancer: a case report and a review of the literature
Deptala A, Romanowicz A, Czerw A, Walecki J, Rogowski W, Nasierowska-Guttmejer A
OncoTargets and Therapy 2016, 9:4435-4440
Published Date: 20 July 2016
JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway
Liu Y, Wang YR, Ding GH, Yang TS, Yao L, Hua J, He ZG, Qian MP
OncoTargets and Therapy 2016, 9:4425-4433
Published Date: 20 July 2016
Functions and mechanisms of long noncoding RNAs in lung cancer
Peng ZZ, Zhang CF, Duan CJ
OncoTargets and Therapy 2016, 9:4411-4424
Published Date: 20 July 2016
FAT10 is associated with the malignancy and drug resistance of non-small cell lung cancer
Xue F, Zhu L, Meng QW, Wang L, Chen XS, Zhao YB, Xing Y, Wang XY, Cai L
OncoTargets and Therapy 2016, 9:4397-4409
Published Date: 19 July 2016
MK-2206 co-treatment with 5-fluorouracil or doxorubicin enhances chemosensitivity and apoptosis in gastric cancer by attenuation of Akt phosphorylation
Jin PP, Wong CC, Mei SB, He XK, Qian Y, Sun LM
OncoTargets and Therapy 2016, 9:4387-4396
Published Date: 19 July 2016
The expression status of TRX, AR, and cyclin D1 correlates with clinicopathological characteristics and ER status in breast cancer
Huang WS, Nie WW, Zhang WW, Wang YR, Zhu A, Guan XX
OncoTargets and Therapy 2016, 9:4377-4385
Published Date: 19 July 2016
Coffee consumption and risk of hepatocellular carcinoma: a meta-analysis of eleven epidemiological studies
Bai K, Cai Q, Jiang Y, Lv L
OncoTargets and Therapy 2016, 9:4369-4375
Published Date: 19 July 2016
Inhibition of microRNA-126 promotes the expression of Spred1 to inhibit angiogenesis in hepatocellular carcinoma after transcatheter arterial chemoembolization: in vivo study
Ji JS, Xu M, Song JJ, Zhao ZW, Chen MJ, Chen WQ, Tu JF, Yang XM
OncoTargets and Therapy 2016, 9:4357-4367
Published Date: 19 July 2016
Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer
Ricciardi GR, Franchina T, Russo A, Schifano S, Ferraro G, Adamo V
OncoTargets and Therapy 2016, 9:4351-4355
Published Date: 21 July 2016
Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction
Lu X, Duan L, Xie H, Lu X, Lu D, Lu D, Jiang N, Chen Y
OncoTargets and Therapy 2016, 9:4343-4349
Published Date: 18 July 2016
Association between CD14 SNP -159 C/T and gastric cancer: an independent case–control study and an updated meta-analysis
Gong AM, Li XY, Xie YQ, Jia ZD, Li YX, Zou YY, Xu CQ, Wang ZY
OncoTargets and Therapy 2016, 9:4337-4342
Published Date: 18 July 2016
Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance
Pyszniak M, Tabarkiewicz J, Łuszczki JJ
OncoTargets and Therapy 2016, 9:4323-4336
Published Date: 18 July 2016
Ectopic micronodular thymoma with lymphoid stroma in the cervical region: a rare case associated with Langerhans cells proliferation
Yu M, Meng Y, Xu B, Zhao L, Zhang QF
OncoTargets and Therapy 2016, 9:4317-4322
Published Date: 18 July 2016
MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12
Liang T, Li L, Cheng Y, Ren C, Zhang G
OncoTargets and Therapy 2016, 9:4307-4315
Published Date: 15 July 2016
Lung cancer with concurrent EGFR mutation and ROS1 rearrangement: a case report and review of the literature
Zhu YC, Xu CW, Ye XQ, Yin MX, Zhang JX, Du KQ, Zhang ZH, Hu J
OncoTargets and Therapy 2016, 9:4301-4305
Published Date: 15 July 2016
Clinical study on the influence of motion and other factors on stereotactic radiotherapy in the treatment of adrenal gland tumor
Wang J, Li F, Dong Y, Song Y, Yuan Z
OncoTargets and Therapy 2016, 9:4295-4299
Published Date: 15 July 2016
Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma
Tang WW, Liu ZH, Yang TX, Wang HJ, Cao XF
OncoTargets and Therapy 2016, 9:4289-4293
Published Date: 14 July 2016
Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies
Wu JY, Hu LR, Chen MY, Cao WJ, Chen HC, He TP
OncoTargets and Therapy 2016, 9:4277-4288
Published Date: 14 July 2016
Theaflavins suppress tumor growth and metastasis via the blockage of the STAT3 pathway in hepatocellular carcinoma
Shao JP, Meng QY, Li YY
OncoTargets and Therapy 2016, 9:4265-4275
Published Date: 14 July 2016
Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma
Sun P, Chen C, Zhang F, Yang H, Bi XW, An X, Wang FH, Jiang WQ
OncoTargets and Therapy 2016, 9:4257-4264
Published Date: 13 July 2016
Comparison of tumor markers using different detection devices [Retraction]
Tao R, Tu SH, Liu C, Yang Q, Zhu M, Shen JF
OncoTargets and Therapy 2016, 9:4255-4256
Published Date: 15 July 2016
Long noncoding RNA AFAP1-AS1, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis
Liu FT, Xue QZ, Zhu PQ, Luo HL, Zhang Y, Hao TF
OncoTargets and Therapy 2016, 9:4247-4254
Published Date: 12 July 2016
Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus
Zhang YF, Wei W, Wang JH, Xu L, Jian PE, Xiao CZ, Zhong XP, Shi M, Guo RP
OncoTargets and Therapy 2016, 9:4239-4246
Published Date: 12 July 2016
Interleukin-32α inactivates JAK2/STAT3 signaling and reverses interleukin-6-induced epithelial–mesenchymal transition, invasion, and metastasis in pancreatic cancer cells
Chen J, Wang S, Su J, Chu G, You H, Chen Z, Sun H, Chen B, Zhou M
OncoTargets and Therapy 2016, 9:4225-4237
Published Date: 11 July 2016
Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo
Zhang H, Chen R, Yang S, Liu W, Li K, Zhang H, Zhu X, Chen B
OncoTargets and Therapy 2016, 9:4215-4224
Published Date: 11 July 2016
Survival prognostic factors for patients with synchronous brain oligometastatic non-small-cell lung carcinoma receiving local therapy
Bai H, Xu J, Yang H, Jin B, Lou Y, Wu D, Han B
OncoTargets and Therapy 2016, 9:4207-4213
Published Date: 11 July 2016
Decreased expression of SLC39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer
Xu XM, Wang CG, Zhu YD, Chen WH, Shao SL, Jiang FN, Liao QD
OncoTargets and Therapy 2016, 9:4197-4205
Published Date: 11 July 2016
Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation
Zhu Y, Li M, Kong L, Yu J
OncoTargets and Therapy 2016, 9:4187-4196
Published Date: 11 July 2016
Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations
Chen D, Song Z, Cheng G
OncoTargets and Therapy 2016, 9:4181-4186
Published Date: 8 July 2016
Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial
von Au A, Milloth E, Diel I, Stefanovic S, Hennigs A, Wallwiener M, Heil J, Golatta M, Rom J, Sohn C, Schneeweiss A, Schuetz F, Domschke C
OncoTargets and Therapy 2016, 9:4173-4180
Published Date: 8 July 2016
Polymorphism in IGFBP3 gene is associated with prostate cancer risk: an updated meta-analysis
Qie YK, Nian XW, Liu XS, Hu HL, Zhang CW, Xie LG, Han RF, Wu CL, Xu Y
OncoTargets and Therapy 2016, 9:4163-4171
Published Date: 7 July 2016
Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer
Teng Y, Wang ZT, Ma L, Zhang L, Guo Y, Gu M, Wang ZY, Wang Y, Yue W
OncoTargets and Therapy 2016, 9:4151-4162
Published Date: 7 July 2016
Blood oxygenation level-dependent magnetic resonance imaging during carbogen breathing: differentiation between prostate cancer and benign prostate hyperplasia and correlation with vessel maturity
Di N, Mao N, Cheng W, Pang H, Ren Y, Wang N, Liu X, Wang B
OncoTargets and Therapy 2016, 9:4143-4150
Published Date: 7 July 2016
Fundamental effects of PD-1 antibody on the body: a brief report
Wang W, Liu B, Liu G, Guo W
OncoTargets and Therapy 2016, 9:4137-4141
Published Date: 7 July 2016
Long-term survival and prognosis for primary clear cell carcinoma of the liver after hepatectomy
Chen ZS, Zhu SL, Qi LN, Li LQ
OncoTargets and Therapy 2016, 9:4129-4135
Published Date: 6 July 2016
Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer
Liu H, Huang C, Wu L, Wen B
OncoTargets and Therapy 2016, 9:4121-4127
Published Date: 6 July 2016
Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer
Kotaka M, Ikeda F, Tsujie M, Yoshioka S, Nakamoto Y, Ishii T, Kyogoku T, Kato T, Tsuji A, Kobayashi M
OncoTargets and Therapy 2016, 9:4113-4120
Published Date: 7 July 2016
Expression of G protein-coupled receptor 56 is associated with tumor progression in non-small-cell lung carcinoma patients
Song Y, Li A, Zhang L, Duan L
OncoTargets and Therapy 2016, 9:4105-4112
Published Date: 5 July 2016
Targeted therapy for localized non-small-cell lung cancer: a review
Paleiron N, Bylicki O, André M, Rivière E, Grassin F, Robinet G, Chouaïd C
OncoTargets and Therapy 2016, 9:4099-4104
Published Date: 5 July 2016
The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases
Pieper CC, Meyer C, Sprinkart AM, Block W, Ahmadzadehfar H, Schild HH, Mürtz P, Kukuk GM
OncoTargets and Therapy 2016, 9:4089-4098
Published Date: 5 July 2016
LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo
Chen L, Yang HX, Xiao YB, Tang XX, Li YQ, Han QQ, Fu JP, Yang YY, Zhu YC
OncoTargets and Therapy 2016, 9:4075-4087
Published Date: 4 July 2016
A meta-analysis of combination therapy versus single-agent therapy in anthracycline- and taxane-pretreated metastatic breast cancer: results from nine randomized Phase III trials
Xu L, Wu X, Hu C, Zhang ZY, Zhang L, Liang SJ, Xu YC, Zhang FC
OncoTargets and Therapy 2016, 9:4061-4074
Published Date: 4 July 2016
Quality of life and cosmetic result of single-port access endoscopic thyroidectomy via axillary approach in patients with papillary thyroid carcinoma
Huang JK, Ma L, Song WH, Lu BY, Huang YB, Dong HM
OncoTargets and Therapy 2016, 9:4053-4059
Published Date: 4 July 2016
Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis
De Santis S, Borghesi C, Ricciardi S, Giovannoni D, Fulvi A, Migliorino MR, Marcassa C
OncoTargets and Therapy 2016, 9:4043-4052
Published Date: 4 July 2016
Icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study
He W, Zhang Y, Xiong Y, Dai FJ, Fan QX
OncoTargets and Therapy 2016, 9:4037-4041
Published Date: 1 July 2016
Chromatin assembly factor 1, subunit A (P150) facilitates cell proliferation in human hepatocellular carcinoma
Xu M, Jia Y, Liu Z, Ding L, Tian R, Gu H, Wang Y, Zhang H, Tu K, Liu Q
OncoTargets and Therapy 2016, 9:4023-4035
Published Date: 1 July 2016
Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis
Wei B, Yang S, Zhang B, Feng Y
OncoTargets and Therapy 2016, 9:4015-4022
Published Date: 1 July 2016
Histone deacetylase inhibitor sodium butyrate suppresses proliferation and promotes apoptosis in osteosarcoma cells by regulation of the MDM2–p53 signaling
Xie C, Wu B, Chen B, Shi Q, Guo J, Fan Z, Huang Y
OncoTargets and Therapy 2016, 9:4005-4013
Published Date: 4 July 2016
Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case report
Sun B, Ding LJ, Wu S, Meng XY, Song S
OncoTargets and Therapy 2016, 9:3997-4003
Published Date: 1 July 2016
ALK-positive anaplastic large cell lymphoma with soft tissue involvement in a young woman
Gao KH, Li HT, Huang CH, Li HZ, Fang J, Tian C
OncoTargets and Therapy 2016, 9:3993-3996
Published Date: 1 July 2016
Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancreatic stump and other stump
Zeng XL, Wang HH, Meng MB, Wu ZQ, Song YC, Zhuang HQ, Qian D, Li FT, Zhao LJ, Yuan ZY, Wang P
OncoTargets and Therapy 2016, 9:3985-3992
Published Date: 30 June 2016
High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial–mesenchymal transition in gastric cancer
Yan Y, Zhang J, Li JH, Liu X, Wang JZ, Qu HY, Wang JS, Duan XY
OncoTargets and Therapy 2016, 9:3975-3983
Published Date: 30 June 2016
Synergism between PGC-1α and estrogen in the survival of endometrial cancer cells via the mitochondrial pathway
Yang H, Yang R, Liu H,α Ren Z, Kong F, Li D, Ma X
OncoTargets and Therapy 2016, 9:3963-3973
Published Date: 30 June 2016
Pri-let-7a-1 rs10739971 polymorphism is associated with gastric cancer prognosis and might affect mature let-7a expression
Li Y, Xu Q, Liu J, He C, Yuan Q, Xing C, Yuan Y
OncoTargets and Therapy 2016, 9:3951-3962
Published Date: 4 July 2016
The roles of serum CXCL16 in circulating Tregs and gastrointestinal stromal tumor cells
Xing YN, Zhang JY, Xu HM
OncoTargets and Therapy 2016, 9:3939-3949
Published Date: 29 June 2016
Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma
Yan Y, Xie M, Zhang L, Zhou X, Xie H, Zhou L, Zheng S, Wang W
OncoTargets and Therapy 2016, 9:3925-3937
Published Date: 30 June 2016
Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review
Xia QS, Xu J, Chen HY, Gao YZ, Gong FL, Hu LY, Yang L
OncoTargets and Therapy 2016, 9:3917-3923
Published Date: 29 June 2016
Meta-analysis of cold-knife conization versus loop electrosurgical excision procedure for cervical intraepithelial neoplasia
Jiang YM, Chen CX, Li L
OncoTargets and Therapy 2016, 9:3907-3915
Published Date: 29 June 2016
Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma
Zhang B, Li R, Chang CX, Han Y, Shi SB, Tian J
OncoTargets and Therapy 2016, 9:3901-3906
Published Date: 29 June 2016
Association between pesticide exposure and risk of kidney cancer: a meta-analysis
Xie B, Hu YF, Liang Z, Liu B, Zheng XY, Xie LP
OncoTargets and Therapy 2016, 9:3893-3900
Published Date: 28 June 2016